INSECTICIDAL ANTHRANILAMIDES

Abstract: This invention provides compounds of Formula (1), their <i>N</i>-oxides and agriculturally suitable salts wherein A, B, J, R<1>, R<2>, R<3> and R<4> and n are as defined in the disclosure. Also disclosed are methods for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidally effective amount of a compound of Formula (1) and compositions containing the compounds of Formula (1).

Description: TITLE INSECTICIDAL ANTHRANILAMIDES BACKGROUND OF THE INVENTION This invention relates to certain anthranilamides, their N-oxides, agriculturally suitable salts and compositions, and methods of their use as arthropodicides in both agronomic and nonagronomic environments. The control of arthropod pests is extremely important in achieving high crop efficiency. Arthropod damage to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer. The control of arthropod pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health is also important. Many products are commercially available for these purposes, but the need continues for new compounds that are more effective, less costly, less toxic, environmentally safer or have different modes of action. ΝL 9202078 discloses N-acyl anthranilic acid derivatives of Formula i as insecticides wherein, inter alia, X is a direct bond; Y is H or C r C 6 alkyl; Z is ΝH 2 , NH(C r C 3 alkyl) or N(C r C 3 alkyl) 2 ; and R 1 through R 9 are independently H, halogen, C^-Cg alkyl, phenyl, hydroxy, C^-Cg alkoxy or C 1 -C 7 acyloxy. SUMMARY OF THE INVENTION This invention pertains to a method for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidaily effective amount of a compound of Formula 1, its N-oxide or agriculturally suitable salts wherein A and B are independently O or S; each J is independently a phenyl or naphfhyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 ; or each J is independently a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R 7 ; n is 1 to 4; R 1 is H; or alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO2, hydroxy, C1-C4 alkoxy, C j -04 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C2-C4 alkoxycarbonyl, C1-C4 alk lamino, C 2 -C 8 dialkylamino and C 3 -C 6 cycloalkylamino; or R 1 is C 2 -C 6 alkylcarbonyl, C 2 -C6 alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C(=A)J; R 2 is H, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 alkoxy, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C -Cg cycloalkylamino, C2-C 6 alkoxycarbonyl or C^-Cg alkylcarbonyl; R 3 is H; G; Cj-Cg alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C 3 -Cg cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, G, CN, NO2, hydroxy, C1-C4 alkoxy, C1-C4 haloalkoxy, C r C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C 2 -C 6 alkoxycarbonyl, C 2 -C 6 alkylcarbonyl, C3-C6 trialkylsilyl, or a phenyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from the group consisting of C^- C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C 3 -Cg cycloalkyl, C1-C4 haloalkyl, C 2 - C haloalkenyl, C2-C4 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C 1 -C 4 alkoxy, C r C4 haloalkoxy, CJ-C4 alkylthio, alkylsulfϊnyl, CJ-C4 alkylsulfonyl, Cj-C4 alkylamino, C2-C 8 dialkylamino, C3-C6 cycloalkylamino, C 3 -C 6 (alkyl)cycloalkylamino, C -C 4 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 - Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C -Cg frialkylsilyl; C j - C4 alkoxy; C 1 -C alkylamino; C2-C 8 dialkylamino; C 3 -C 6 cycloalkylamino; C - Cg alkoxycarbonyl or C2-C6 alkylcarbonyl; or R 2 and R 3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, said ring may be optionally substituted with 1 to 4 substituents selected from the group consisting of C1-C2 alkyl, halogen, CN, NO2 and C1-C2 alkoxy; G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O) 2 and optionally substituted with 1 to 4 substituents selected from the group consisting of C r C 2 alkyl, halogen, CN, NO 2 and 0^2 alkoxy; each R 4 is independently H, C j -Cg alkyl, C2-Cg alkenyl, C 2 -Cg alkynyl, C 3 -Cg cycloalkyl, C^-Cg haloalkyl, C2"Cg haloalkenyl, C2-Cg haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , hydroxy, C j -C4 alkoxy, C j -04 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfϊnyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C3-C6 cycloalkylamino, or C 3 -Cg frialkylsilyl; or each R 4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C r C4 alkyl, C 2 -C 4 alkenyl, C2-C4 alkynyl, C 3 -Cg cycloalkyl, 0^04 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, -C4 haloalkoxy, C 1 -C 4 alkylthio, C 1 -C4 alkylsulfinyl, Cj- C4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C dialkylamino, C 3 -Cg cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, Q2-C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 - Cg frialkylsilyl; each R 5 is independently Cj-Cg alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, Cj-Cg haloalkyl, C 2 -Cg haloalkenyl, C 2 -C 6 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C 6 alkoxy, C^ haloalkoxy, C^Cg alkylthio, C 1 -C 6 alkylsulfϊnyl, C j -Cg aU ylsulfonyl, Cj-Cg haloalkylthio, Cj-Cg haloalkylsulfϊnyl, C^-Cg haloalkylsulfonyl, C j -Cg alkylamino, C -Cj 2 dialkylamino, or C 3 -Cg cycloalkylamino, C 2 -Cg alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C dialkylaminocarbonyl, C3-C6 frialkylsilyl; or (R 5 ) 2 when attached to adjacent carbon atoms can be taken together as -OCF 2 O-, -CF 2 CF 2 O-, or -OCF 2 CF 2 O-; each R 6 is independently H, halogen, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 - Cg cycloalkyl, C1-C4 alkoxy or C 2 -C 4 alkoxycarbonyl; or each R 6 is independently a phenyl, benzyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from the group consisting of C j -C4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -Cg cycloalkyl, C1-C4 haloalkyl, C2-C4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO2, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C alkylcarbonyl, C 2 -C6 alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C dialkylaminocarbonyl or C 3 -Cg frialkylsilyl; each R 7 is independently H, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -Cg alkynyl, C 3 -C 6 cycloalkyl, Cj-Cg haloalkyl, C 2 -Cg haloalkenyl, C -Cg haloalkynyl, C -Cg halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C 4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfϊnyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C6 cycloalkylamino, C 2 -C 6 alkylcarbonyl, C2-Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl, C 3 -C 6 frialkylsilyl; or each R 7 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from the group consisting of C1-C4 alkyl, C2-C4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, 0^4 haloalkyl, Q2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, C1-C4 alkoxy, C 1 -C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C!-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -Cg frialkylsilyl; provided that (1) when A and B are both O, R 2 is H or C r C 3 alkyl, R 3 is H or C r C 3 alkyl and R 4 is H, halogen, C^-Cg alkyl, phenyl, hydroxy or C^-Cg alkoxy, then one R 5 is other than halogen, C j -Cg alkyl, hydroxy or C j -Cg alkoxy; or (2) J is other than an optionally substituted 1,2,3-thiadiazole. This invention also pertains to compounds of Formula 1, their N-oxides and agriculturally suitable salts wherein A and B are independently O or S; each J is independently a phenyl or naphthyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 ; or each J is independently a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R 7 ; n is 1 to 4; R 1 is H; or Cj-Cg alkyl, C -Cg alkenyl, C 2 -C 6 alkynyl or C3-C5 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO 2 , hydroxy, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C2-C4 alkoxycarbonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino and C 3 -Cg cycloalkylamino; or R 1 is C -Cg alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C dialkylaminocarbonyl or C(=A)J; R 2 is H, C^-Cg alkyl, C 2 -C6 alkenyl, C 2 -C6 alkynyl, C3-C6 cycloalkyl, C1-C4 alkoxy, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C2-C 6 alkoxycarbonyl or C2-Cg alkylcarbonyl; R 3 is H; C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO 2 , hydroxy, C1-C4 alkoxy, C 1 -C4 haloalkoxy, C^- C 4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C -C 6 alkoxycarbonyl, -C< alkylcarbonyl, C3-C5 frialkylsilyl, or a phenoxy ring optionally substituted with one to three substituents independently selected from the group consisting of 0^4 alkyl, C 2 -C alkenyl, C 2 -C alkynyl, C 3 -C 6 cycloalkyl, C1-C4 haloalkyl, C 2 -C haloalkenyl, C2-C4 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C r C 4 haloalkoxy, C j -C4 alkylthio, C j -04 alkylsulfinyl, C1-C4 alkylsulfonyl, C!-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 - Cg cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -C6 alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 - G 6 frialkylsilyl; C r C 4 alkoxy; C C4 alkylamino; C 2 -C 8 dialkylamino; C -C 6 cycloalkylamino; C2-C 6 alkoxycarbonyl or C 2 -Cs alkylcarbonyl; or R 2 and R 3 can be taken together with the nifrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, said ring may be optionally substituted with 1 to 4 substituents selected from the group consisting of Cι-C 2 alkyl, halogen, CN, NO 2 and C r C 2 alkoxy; each R 4 is independently H, C^-Cg alkyl, C 2 -C 6 alkenyl, C 2 -Cg alkynyl, C 3 -C 6 cycloalkyl, Cι~C 6 haloalkyl, C 2 -C 6 haloalkenyl, C 2 -C6 haloalkynyl, C3-C 6 halocycloalkyl, halogen, CN, NO 2 , hydroxy, Cj-C4 alkoxy, Cι-C haloalkoxy, C r C 4 alkylthio, C r C 4 alkylsulfϊnyl, C 1 -C 4 alkylsulfonyl, Cι-C haloalkylthio, CJ-C4 haloalkylsulfϊnyl, C 1 -C 4 haloalkylsulfonyl, Cι-C 4 alkylamino, C 2 -C 8 dialkylamino, C3-C6 cycloalkylamino, or C 3 -Cg frialkylsilyl; or each R 4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C r C alkyl, C -C alkenyl, C 2 -C alkynyl, C 3 -C 6 cycloalkyl, C r C 4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, Cj-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C - C 4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 - C 6 frialkylsilyl; each R 5 is independently C^-Cg haloalkyl, C 2 -Cg haloalkenyl, C 2 -C 6 haloalkynyl, C 3 -C 6 halocycloalkyl, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C ] -C alkylsulfonyl, C1-C4 haloalkylthio, C -C4 haloalkylsulfϊnyl, C -C4 haloalkylsulfonyl, CN, NO 2 , C1-C4 alkoxycarbonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 2 -C 6 alkylcarbonyl, C 2 -C6 alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, or C 3 -C dialkylaminocarbonyl; or (R 5 )2 attached to adjacent carbon atoms can be taken together as -OCF 2 O-, -CF 2 CF 2 O-, or -OCF 2 CF 2 O-; each R 6 is independently H, halogen, C^-Cg alkyl, C -Cg alkenyl, C 2 -Cg alkynyl, C 3 - C cycloalkyl, C j -C4 alkoxy or C 2 -C alkoxycarbonyl; or each R 6 is independently a phenyl, benzyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from the group consisting of C1-C 4 alkyl, C 2 -C 4 alkenyl, C2-C4 alkynyl, C 3 -Cg cycloalkyl, 0^4 haloalkyl, C2-C4 haloalkenyl, C2-C4 , h n ι™ιι™ i r .r , τ ^ι ιv v i 5 halosen. CN. NOo. Ci-d alkoxv. Ci-d haloalkoxy, C r C alkylthio, C1-C4 alkylsulfϊnyl, C!-C alkylsulfonyl, C r C4 alkylamino, C 2 -C dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C 4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -C 6 frialkylsilyl; each R 7 is independently H, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C 6 haloalkyl, C 2 -C 6 haloalkenyl, C 2 -C 6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C 4 alkoxy, C r C4 haloalkoxy, Cj-C4 alkylthio, C1-C4 alkylsulfϊnyl, CJ-C4 alkylsulfonyl, C1-C4 haloalkylthio, C r C haloalkylsulfϊnyl, C r C haloalkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 2 -C 6 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C -C6 alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl, C 3 -Cg frialkylsilyl; or each R 7 is independently a phenyl, benzyl, benzoyl, phenoxy or 5- or 6-membered heteroaromatic ring 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from the group consisting of C1-C4 alkyl, C 2 -C alkenyl, C 2 -C 4 alkynyl, C 3 -C6 cycloalkyl, C 1 -C4 haloalkyl, C 2 -C 4 haloalkenyl, Q2-C4 haloalkynyl, C 3 - Cg halocycloalkyl, halogen, CN, NO 2 , 0^4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C3- cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C 2 -C alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -C6 alkylaminocarbonyl, C3~C 8 dialkylaminocarbonyl or C 3 -C 6 frialkylsilyl; provided that (i) at least one R 4 and at least one R 7 are other than H; (ii) J is other than an optionally substituted 1,2,3-thiadiazole; (iii) when J is an optionally substituted pyridine and R 2 is H, R 3 is other than H or CH 3 ; (iv) when J is an optionally substituted pyridine, then R 7 cannot be CONH 2 , C 2 -Cg alkylaminocarbonyl or C 3 -C 8 dialkylaminocarbonyl; (v) when J is an optionally substituted pyrazole, tefrazole or pyrimidine, then R 2 and R 3 cannot both be hydrogen. This invention also pertains to arthropodicidal compositions comprising an arthropodicidaUy effective amount of a compound of Formula 1 and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. DETAILS OF THE INVENTION In the above recitations, the term "alkyl", used either alone or in compound words such as "alkylthio" or "haloalkyl" includes straight-chain or branched alkyl, such as, methyl, ethyl, n-propyl, z ' -propyl, or the different butyl, pentyl or hexyl isomers. The term "1-2 alkyl" indicates that one or two of the available positions for that substituent may be alkyl. "Alkenyl" includes straight-chain or branched alkeήes such as 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers. "Alkenyl" also includes polyenes such as 1,2-propadienyl and 2,4-hexadienyl. "Alkynyl" includes straight-chain or branched alkynes such as 1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers. "Alkynyl" can also include moieties comprised ofmultiple triple bonds such as 2,5-hexadiynyl. "Alkoxy" includes, for example, methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers. "Alkoxy alkyl" denotes alkoxy substitution on alkyl. Examples of "alkoxyalkyl" include CH 3 OCH 2 , CH 3 OCH 2 CH 2 , CH 3 CH 2 OCH 2 , CH 3 CH 2 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 . "Alkylthio" includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers. "Cycloalkyl" includes, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. The term "heterocyclic ring" or heterocyclic ring system" denotes rings or ring systems in which at least one ring atom is not carbon and comprises 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulfur, provided that each heterocyclic ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs. The heterocyclic ring can be attached through any available carbon or nitrogen by replacement of hydrogen on said carbon or nitrogen. The term "aromatic ring system" denotes fully unsaturated carbocycles and heterocycles in which the polycyclic ring system is aromatic (where aromatic indicates that the Huckel rule is satisfied for the ring system). The term "heteroaromatic ring" denotes fully aromatic rings in which at least one ring atom is not carbon and comprises 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulfur, provided that each heterocyclic ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs (where aromatic indicates that the Huckel rule is satisfied). The heterocyclic ring can be attached through any available carbon or nitrogen by replacement of hydrogen on said carbon or nitrogen. The term "aromatic heterocyclic ring system" includes fully aromatic heterocycles and heterocycles in which at least one ring of a polycyclic ring system is aromatic (where aromatic indicates that the Huckel rule is satisfied). The term "fused heterobicyclic ring system" includes a ring system comprised of two fused rings in which at least one ring atom is not carbon and can be aromatic or non aromatic, as defined above. The term "halogen", either alone or in compound words such as "haloalkyl", includes flnn ino Mnri-na. lwnmin- n inAi-na when used in comnound words such as "haloalkyl", said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of "haloalkyl" include F 3 C, C1CH 2 , CF3CH 2 and CF 3 CC1 2 . The terms "haloalkenyl", "haloalkynyl", "haloalkoxy", and the like, are defined analogously to the term "haloalkyl". Examples of "haloalkenyl" include (C1) 2 C=CHCH 2 and CF 3 CH 2 CH=CHCH 2 . Examples of "haloalkynyl" include HC≡CCHCl, CF 3 C≡C, CC1 3 C≡C and FCH 2 C≡CCH 2 . Examples of "haloalkoxy" include CF 3 O, CCl 3 CH 2 O, HCF 2 CH 2 CH 2 O and CF 3 CH 2 O. The total number of carbon atoms in a substituent group is indicated by the "C j -C j " prefix where i and j are numbers from 1 to 6. For example, C1-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C 2 alkoxyalkyl designates CH 3 OCH 2 ; C 3 alkoxyalkyl designates, for example, CH 3 CH(OCH 3 ), CH 3 OCH 2 CH 2 or CH 3 CH 2 OCH 2 ; and C4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH 3 CH 2 CH 2 OCH 2 and CH 3 CH OCH 2 CH 2 . In the above recitations, when a compound of Formula 1 contains a heterocyclic ring, all substituents are attached to this ring through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen. When a group contains a substituent which can be hydrogen, for example R 3 , then, when this substituent is taken as hydrogen, it is recognized that this is equivalent to said group being unsubstituted. Compounds of this invention can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. Accordingly, the compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form. The present invention comprises compounds selected from Formula 1, N-oxides and agriculturally suitable salts thereof. One skilled in the art will appreciate that not all nitrogen containing heterocycles can form N-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form N-oxides. One skilled in the art will also recognize that tertiary amines can form N-oxides. Synthetic methods for the preparation of N-oxides of heterocycles and tertiary amines are very well known by one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and -chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethydioxirane. These methods fnr the nrenaratinn nf N-n i e ς hn p been extensivelv described and reviewed in the literature, see for example: T. L. Gilchrist in Comprehensive Organic Synthesis, vol. 7, pp 748-750, S. N. Ley, Ed., Pergamon Press; M. Tisler and B. Stanovnik in Comprehensive Heterocyclic Chemistry, vol. 3, pp 18-19, A. J. Boulton and A. McKillop, Eds., Pergamon Press; M. R. Grimmett and B. R. T. Keene in Advances in Heterocyclic Chemistry, vol. 43, pp 139-151, A. R. Kafritzky, Ed., Academic Press; M. Tisler and B. Stanovnik in Advances in Heterocyclic Chemistry, vol. 9, pp 285-291, A. R. Kafritzky and A. J. Boulton, Eds., Academic Press; and G. W. H. Cheeseman and E. S. G. Werstiuk in Advances in Heterocyclic Chemistry, vol. 22, pp 390-392, A. R. Kafritzky and A. J. Boulton, Eds., Academic Press. The salts of the compounds of the invention include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids. Of note are certain compounds of Formula II π wherein X and Y are O; m is 1 to 5; n is 1 to 4; R 1 is H; or C j -Cg alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or C 3 -C 6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CΝ, ΝO 2 , hydroxy, C1-C4 alkoxy, γ- ^ alkylthio, Cι~C 4 alkylsulfmyl, C1-C4 alkylsulfonyl, C2-C4 alkoxycarbonyl, C1-C4 alkylamino, C2-C3 dialkylamino and C 3 -Cg cycloalkylamino; or R 1 is C2-C 6 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -C6 alkylaminocarbonyl or C 3 -C 8 dialkylaminocarbonyl; R 2 is H, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 alkoxy, C2-C4 alkylamino, C 2 -C 8 dialkylamino, C3-C6 cycloalkylamino, C 2 -Cg alkoxycarbonyl or C 2 -Cg alkylcarbonyl; R 3 is t-propyl or t-butyl; and each R 4 and R 5 are independently H, -Cg alkyl, C 2 -C 6 alkenyl, C -C 6 alkynyl, C 3 -C 6 cycloalkyl, Cj-Cg haloalkyl, C -C 6 haloalkenyl, C -C 6 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C 4 alkoxy, 0^04 haloalkoxy, C1-C4 alkylthio, Cj-04 alkylsulfϊnyl, C j -C4 alkylsulfonyl, Cj-04 haloalkylthio, C1-C4 haloalkylsulfϊnyl, C1-C4 haloalkylsulfonyl, C1-C4 alkoxycarbonyl, C1-C4 alkylamino, C 2 -Cg dialkylamino, C 3 -Cg cycloalkylamino, C 2 -Cg alkylcarbonyl, C -Cg alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl, C3-C6 frialkylsilyl; or each R 4 and R 5 are independently phenyl optionally substituted with C1-C4 alkyl, C 2 -C 4 alkenyl, C 2 -C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haolalkyl, C 2 -C4 haloalkenyl, C 2 -C haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C1-C4 haloalkoxy, Cj-C4 alkylthio, C^C^ alkylsulfϊnyl, C j -04 alkylsulfonyl C1-C4 alkoxycarbonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C3-C6 frialkylsilyl. Also of note are methods for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidaUy effective amount of a compound of Formula II and insecticidal compositions thereof. Also of note are certain compounds of Formula III III wherein A and B are independently O or S; J is a phenyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 , or a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R 7 ; n is 1 to 4; R 1 is H; or C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or C 3 -C 6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO 2 , hydroxy, Cι-C alkoxy, 0^4 alkylthio, C j -C^ alkylsulfϊnyl, Cι-C 4 alkylsulfonyl, C 2 -C alkoxycarbonyl, 0^4 alkylamino, C 2 -C 8 dialkylamino and C3-C6 cycloalkylamino; or R 1 is C 2 -C 6 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cβ alkylaminocarbonyl or C3-C 8 dialkylaminocarbonyl; R 2 is H, Cj-Cg alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C4 alkoxy, Cj-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 2 -C6 alkoxycarbonyl or C 2 -Cg alkylcarbonyl; R 3 is H; or C j -Cg aU yl, C 2 -Cg alkenyl, C 2 -C 6 alkynyl or C 3 -C 6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO , hydroxy, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl and C j -C4 alkylsulfonyl; or R 2 and R 3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, said ring may be optionally substituted with 1 to 4 substituents selected from the group consisting of Cj-C 2 alkyl, halogen, CN, NO 2 and Cι-C 2 alkoxy; each R 4 is independently H, C^Cg alkyl, C 2 -C 6 alkenyl, C 2 -C6 alkynyl, C 3 -C 6 cycloalkyl, C^-Cg haloalkyl, C 2 -Cg haloalkenyl, C 2 -C6 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, 0^04 alkoxy, C r C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, Cχ-04 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfϊnyl, C1-C4 haloalkylsulfonyl, Cj-04 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C2-C alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -C6 alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl, C 3 -Cg trialkylsUyl; or each R 4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C1-C4 alkyl, C -C 4 alkenyl, C 2 -C 4 alkynyl, C3-C6 cycloalkyl, C1-C4 haolalkyl, C 2 -C4 haloalkenyl, C 2 -C haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO 2 , Cχ-04 alkoxy, C r C4 haloalkoxy, C r C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C 2 -C alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -C 6 frialkylsilyl; each R 5 is independently Cj-Cg haloalkyl, C 2 -C 6 haloalkenyl, C 2 -C 6 haloalkynyl, C 3 -C 6 halocycloalkyl, C r C 4 haloalkoxy, C r C alkylthio, C1-C4 alkylsulfϊnyl, C r C 4 alkylsulfonyl, C r C 4 haloalkylthio, C r C4 haloalkylsulfϊnyl, C r C 4 haloalkylsulfonyl, CN, NO 2 , C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 2 -C6 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, or C 3 -C 8 dialkylaminocarbonyl; or (R 5 ) 2 when attached to adjacent carbon atoms can be taken together as -OCF 2 O-, -CF 2 CF 2 O-, or -OCF 2 CF 2 O-; each R 6 is independently H, halogen, C^-Cg alkyl, C 2 -C 6 alkenyl, C 2 -Cg alkynyl, C 3 - Cg cycloalkyl, C1-C4 alkoxy; or each R 6 is independently phenyl, benzyl or phenoxy, each optionally substituted with C1-C4 alkyl, C 2 -C4 alkenyl, C 2 -C4 alkynyl, C 3 -Cg cycloalkyl, C1-C4 haolalkyl, C 2 -C4 haloalkenyl, C 2 -C4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C^- C alkylsulfonyl, C1-C4 alkylamino, C 2 -C dialkylamino, C -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C3~C 8 dialkylaminocarbonyl or C3- C 6 frialkylsilyl; each R 7 is independently H, C j -Cg alkyl, C 2 -C6 alkenyl, C 2 -C6 alkynyl, C3-C6 cycloalkyl, C j -Cg haloalkyl, C 2 -Cg haloalkenyl, C 2 -C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C j -C^ alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C r C4 haloalkylthio, C1-C4 haloalkylsulfϊnyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C3~C 6 cycloalkylamino, C 2 -Cg alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg aUcylaminocarbonyl, C3-C 8 dialkylaminocarbonyl, C 3 -Cβ frialkylsilyl; or each R 7 is independently phenyl, benzyl or phenoxy, each optionally substituted with C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 haloalkyl, G 2 -C4 haloalkenyl, C 2 -C4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, Cj- C 4 alkylsulfonyl C1-C4 alkoxycarbonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 3 -C 6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C 2 -C6 alkoxycarbonyl, C 2 -C6 aJJcylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -Cg frialkylsilyl. Also of note are methods for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidaUy effective amount of a compound of Formula III and insecticidal compositions thereof. Also of note are certain compounds of Formula IN rv wherein A and B are independently O or S; J is a phenyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 , or a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R 7 ; n is 1 to 4; R 1 is H; or C j -Cg alkyl, C 2 -C6 alkenyl, C 2 -C 6 alkynyl or C 3 -C 6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO 2 , hydroxy, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C 2 -C 4 alkoxycarbonyl, 0^4 alkylamino, C 2 -C 8 dialkylamino and C 3 -Cg cycloalkylamino; or R 1 is C 2 -C6 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl or C 3 -C 8 dialkylaminocarbonyl; R 2 is H, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 alkoxy, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 2 -C 6 alkoxycarbonyl or C 2 -C 6 alkylcarbonyl; R 3 is H; Cj-Cg alkyl, C 2 -Cg alkenyl, C 2 -C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO 2 , hydroxy, C1-C4 alkoxy, Cj-C4 alkylthio, C1-C4 alkylsulfϊnyl and C1-C4 alkylsulfonyl; C1-C4 alkoxy; C1-C4 alkylamino; C -C 8 dialkylamino; C3-C6 cycloalkylamino; C 2 -Cg alkoxycarbonyl or C 2 -Cg alkylcarbonyl; or R 2 and R 3 can be taken together with the nifrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nit ren ςnlfii nr ny σpn <?aiH ing may be optionally substituted with 1 to 4 substituents selected from the group consisting of C 1 -C 2 alkyl, halogen, CN, NO 2 and C r C 2 alkoxy; each R 4 is independently H, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C 6 haloalkyl, C 2 -C 6 haloalkenyl, C 2 -C 6 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C 4 alkoxy, C r C 4 haloalkoxy, C1-C4 alkylthio, -C4 alkylsulfmyl, C r C 4 alkylsulfonyl, C r C 4 haloalkylthio, C^C^ haloalkylsulfmyl, C r C haloalkylsulfonyl, C r C 4 alkylamino, C2-C 8 dialkylamino, C3-C6 cycloalkylamino, C2-C 6 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C3-C 8 dialkylaminocarbonyl, C 3 -C 6 frialkylsilyl; or each R 4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C Γ C4 alkyl, C 2 -C 4 alkenyl, Q2-C4 alkynyl, C 3 -C 6 cycloalkyl, C1-C4 haolalkyl, C 2 -C haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C r C4 haloalkoxy, -C4 alkylthio, 0^4 alkylsulfϊnyl, C j - C 4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -C alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C3- Cg frialkylsilyl; each R 5 is independently C^-Cg alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl, C3-C6 cycloalkyl, C j -Cg haloalkyl, C 2 -C ( 5 haloalkenyl, C 2 -C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C4 alkoxy, C j -C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, 0^04 haloalkylsulfϊnyl, 0^4 haloalkylsulfonyl, 0^04 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 2 -C 6 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C -Cg alkylaminocarbonyl, C 3 -C 8 diallcylaminocarbonyl, C 3 -C 6 frialkylsilyl; or (R 5 ) 2 when attached to adjacent carbon atoms can be taken together as -OCF 2 O-, -CF 2 CF 2 O-, or -OCF 2 CF 2 O-; each R 6 is independently H, halogen, Cj-Cg alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl, C 3 - C 6 cycloalkyl, C1-C4 alkoxy; or each R 6 is independently a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with 0^4 alkyl, C 2 -C4 alkenyl, C 2 -C4 alkynyl, C 3 -C 6 cycloalkyl, C^C^ haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, - C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C1-C4 aU ylamino, C 2 -C 8 dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C -C alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 -C6 niV /iα inr.rnrT-. r.Λ i r~.r~ i ^ ii^laminocarbonvl or C T C Λ trialkvlsilvl: each R 7 is independently H, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C 6 haloalkyl, C -C 6 haloalkenyl, C 2 -C 6 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C 4 aU oxy, C r C4 haloalkoxy, C r C alkylthio, C r C alkylsulfϊnyl, C r C alkylsulfonyl, C r C haloalkylthio, C r C 4 haloalkylsulfinyl, C r C haloalkylsulfonyl, C r C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 2 -C 6 alkylcarbonyl, C -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C3-C 8 dialkylaminocarbonyl, C 3 -C 6 frialkylsilyl; or each R 7 is independently a phenyl, benzyl, benzoyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with C1-C4 alkyl, C 2 -C4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C2-C4 haolaU yl, C 2 -C 4 haloalkenyl, C 2 -C haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C r C4 haloalkoxy, Cγ-C^ alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C r C 4 alkylamino, C 2 -C 8 dialkylamino, C3-C5 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C dialkylaminocarbonyl or C3-C6 frialkylsilyl; provided that when A and B are both O, R 2 is H or C1-C3 alkyl, R 3 is H or C1-C3 alkyl and R 4 is H, halogen, C^Cg alkyl, phenyl, hydroxy or C^Cg alkoxy, then one R 5 is other than halogen, Cj-Cg alkyl, hydroxy or Cj-Cg alkoxy. Also of note are methods for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidaUy effective amount of a compound of Formula IV and insecticidal compositions thereof. Preferred methods for reasons of better activity are: Preferred 1. Methods comprising compounds of Formula 1 wherein J is a phenyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 . Preferred 2. Methods of Preferred 1 wherein A and B are both O; n is 1 to 2; R 1 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R 2 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R 3 is C j -C 6 alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl or C 3 -Cg cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C1-C2 alkoxy, C j -C 2 alkylthio, C j -C 2 alkylsulfϊnyl and Cι-C 2 alkylsulfonyl; one of the R 4 groups is attached to the phenyl ring at the 2-position or 5-position, and ςaiH R4 j , c*-r. nlVvl Γ C A haloalkyl, halogen, CN, NO,, C,-G. alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C -C4 alkylsulfϊnyl, Cι~C 4 alkylsulfonyl, C j -C haloalkylthio, C 2 -C4 haloalkylsulfinyl or C 2 -C haloalkylsulfonyl; each R 5 is independently C1-C4 haloalkyl, CN, NO , C2-C4 haloalkoxy, C2-C4 alkylthio, C1-C4 alkylsulfϊnyl, C -C4 alkylsulfonyl, C2-C4 haloalkylthio, C2-C4 haloalkylsulfϊnyl, C r C haloalkylsulfonyl or C 2 - C4 alkoxycarbonyl; or (R 5 ) 2 when attached to adjacent carbon atoms can be taken together as -OCF 2 O-, -CF 2 CF 2 O- or -OCF 2 CF 2 O-; and each R 6 is independently H, halogen, C2-C4 alkyl, C2-Q2 alkoxy or C 2 -C4 alkoxycarbonyl, or each R 6 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with C -C4 alkyl, Q2-C4 alkenyl, C 2 -C4 alkynyl, C 3 -Cg cycloalkyl, C2-C4 haloalkyl, C2-C4 haloalkenyl, C 2 -C haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C2-C4 alkoxy, C2-C4 haloalkoxy, C2-C4 alkylthio, C2-C4 alkylsulfϊnyl, C2-C4 alkylsulfonyl, C -C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -Cg frialkylsilyl. Preferred 3. Methods of Preferred 2 wherein R 1 and R 2 are both H; R 3 is C2-C4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; each R 4 is independently H, CH 3 , CF 3i OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; each R 5 is independently CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 or S(O) p CF 2 CHF 2 ; each R 6 is independently H, halogen or methyl; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C2-C4 alkyl, C2-C4 haloalkyl, halogen or CN; and p is 0, 1 or 2. Preferred 4. Methods of Preferred 3 wherein R 3 is z-propyl or t-butyl. Preferred 5. Methods comprising compounds of Formula 1 wherein J is a 5- or 6- membered heteroaromatic ring optionally substituted with 1 to 4 R 7 . Preferred 6. Methods of Preferred 5 wherein J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J- 1, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R 7 J-l J-2 J-3 J-4 j-5 Q is O, S or NR 7 ; and W, X, Y and Z are independently N or CR 7 , provided that in J-4 and J-5 at least one of W, X, Y or Z is N. Preferred 7. Methods of Preferred 5 or Preferred 6 wherein A and B are O; n is 1 to 2; R 1 is H, C2-C4 alkyl, C2-C4 alkenyl, C 2 -C alkynyl, C2-C 6 alkylcarbonyl or C -C6 alkoxycarbonyl; R 2 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -C6 alkoxycarbonyl; R 3 is H; or C -C6 alkyl, C 2 -C6 alkenyl, C 2 -C6 alkynyl or C3-C 6 cycloaU yl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C2-C2 alkoxy, C2-C2 alkylthio, , C2-C2 alkylsulfϊnyl and C -C2 alkylsulfonyl; one of the R 4 groups is attached to the phenyl ring at the 2-position, and said R 4 is C2-C4 alkyl, C r C 4 haloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C -C4 haloalkoxy, C2-C4 alkylthio, C -C4 alkylsulfϊnyl, C2-C4 alkylsulfonyl, C -C4 haloalkylthio, C2-C4 haloalkylsulfinyl, or C2-C4 haloalkylsulfonyl; and each R 7 is independently H, C -C4 alkyl, C2-C4 haloalkyl, halogen, CN, NO 2 , C -C4 haloalkoxy, C -C4 alkylthio, C -C4 alkylsulfϊnyl, C2-C4 alkylsulfonyl, C2-C4 haloalkylthio, C2-C4 haloalkylsulfϊnyl, C2-C4 haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with Cι-C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C -C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkylthio, r,.r. n ii™i«nn i alkvlsulfonvL Cι-C„ alkvlamino. Co-Co dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloaUcylamino, C2-C4 alkylcarbonyl, C 2 -C6 alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C3-C 8 dialkylaminocarbonyl or C3-C6 frialkylsilyl. Preferred 8. Methods of Preferred 7 wherein J is selected from the group consisting of pyridine, pyrimidine, pyrazole, imidazole, friazole, thiophene, thiazole and oxazole, furan, isothiazole and isoxazole, each optionally substituted with 1 to 3 R 7 . Preferred 9. Methods of Preferred 8 wherein J is selected from the group consisting of pyridine, pyrimidine, pyrazole, thiophene and thiazole, each optionally substituted with 1 to 3 R 7 ; R 1 and R 2 are both H; R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; each R 4 is independently H, CH 3 , CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; each R 7 is independently H, halogen, CH 3 , CF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 , S(O) p CF 2 CHF 2 ; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C2-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkoxy, C2-C4 haloalkoxy, C2-C4 alkylthio, C2-C4 alkylsulfϊnyl, C -C4 alkylsulfonyl, halogen or CN; and p is 0, 1 or 2. Preferred 10. Methods of Preferred 9 wherein J is a pyridine optionally substituted with 1 to 3 R 7 . Preferred 11. Methods of Preferred 10 wherein one R 7 is a phenyl optionally substituted with C -C4 alkyl, C2-C4 haloalkyl, halogen or CN. Preferred 12. Methods of Preferred 10 wherein one R 7 is a pyrazole, imidazole, friazole, pyridine or pyrimidine, each ring optionally substituted with C2-C4 alkyl, C2-C4 haloalkyl, halogen or CN. Preferred 13. Methods of Preferred 9 wherein J is a pyrimidine optionally substituted with 1 to 3 R 7 . Preferred 14. Methods of Preferred 13 wherein one R 7 is a phenyl optionally substituted with C -C4 alkyl, C2-C4 haloalkyl, halogen or CN. Preferred 15. Methods of Preferred 13 wherein one R 7 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C -C4 alkyl, C2-C4 haloalkyl, halogen or CN. Preferred 16. Methods of Preferred 9 wherein J is a pyrazole optionally substituted with 1 to 3 R 7 . Preferred 17. Methods of Preferred 16 wherein one R 7 is a phenyl optionally substituted with C2-C4 alkyl, C -C4 haloalkyl, halogen or CN. Preferred 18. Methods of Preferred 16 wherein one R 7 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C2-C4 alkyl, C -C4 haloalkyl, halogen or CN. Preferred 19. Methods of Preferred 18 wherein R 7 is a pyridine optionally substituted with C2-C4 alkyl, C1-C4 haloalkyl, halogen or CN. Most preferred is the method comprising a compound of Formula 1 selected from the group consisting of: 3-methyl-N-(l-memylethyl)-2-[[4-(frifluoromethyl)benzoyl]amino]-benzamide, 2-methyl-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenyl]-4- (trifluoromethyl)benzamide, 2-methyl-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenyl]-6- (frifluoromethyl)-3-pyridinecarboxamide, 1 -ethyl-N-[2-methyl-6-[[(l -methylethyl)amino]carbonyl]phenyl]-3- (trifluoromethyl)- 1 H-pyrazole-5-carboxamide, 1 -(2-fluorophenyl)-N- [2-methyl-6-[[( 1 -methylethyl)amino)carbonyl]phenyl]-3 - (trifluoromethyl)-lH-pyrazole-5-carboxamide, l-(3-chloro-2-pyridinyl)-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenylJ3- (frifluoromemyl)-lH-pyrazole-5-carboxamide, N-[2-chloro-6-[[(l-methylethyl)amino]carbonyl]phenyl]-l-(3-chloro-2-pyridinyl)-3- (trifluoromethyl)-lH-pyrazole-5-carboxamide, 5-bromo- 1 -(2-chlorophenyl)-N- [2-methyl-6- [[( 1 - methylethyl)amino]carbonyl]phenyl]- lH-pyrazole-5-carboxamide, and 3-bromo-N-[2-chloro-6-[[(l-methylethyl)amino]carbonyl]phenyl]-l-(2- chlorophenyl)-lH-pyrazole-5-carboxamide. Preferred compounds for reasons of better activity and/or ease of synthesis are: Preferred A. Compounds of Formula 1 wherein J is a phenyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 . Preferred B. Compounds of Preferred A wherein A and B are both O; n is 1 to 2; R 1 is H, C2-C4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -C6 alkoxycarbonyl; R 2 is H, C2-C4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R 3 is C2-Cg alkyl, C 2 -C 6 aUcenyl, C 2 -C 6 alkynyl or C -Cg cycloalkyl each nntinnallv dn ς titntftrl x ή h one or more substituents selected from the group consisting of halogen, CN, C2~C alkoxy, C2~C 2 alkylthio, C2~C 2 alkylsulfϊnyl and C2-Q2 alkylsulfonyl; one of the R 4 groups is attached to the phenyl ring at the 2-position or 5- position, and said R 4 is C2-C4 alkyl, C2-C4 haloalkyl, halogen, CN, NO 2 , C 2 -C-4 alkoxy, C 2 -C 4 haloalkoxy, C -C 4 alkylthio, C 2 -C 4 alkylsulfmyl, C -C4 alkylsulfonyl, C2-C4 haloalkylthio, C -C4 haloalkylsulfϊnyl or C -C4 haloalkylsulfonyl; each R 5 is independently C2-C4 haloalkyl, CN, NO 2 , C2-C4 haloalkoxy, C2- C4 alkylthio, C2-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C2-C4 haloalkylthio, C2-C4 haloalkylsulfmyl, C2-C4 haloalkylsulfonyl or C 2 - C4 alkoxycarbonyl; or (R 5 ) 2 when attached to adjacent carbon atoms can be taken together as - OCF 2 O-, -CF 2 CF 2 O- or -OCF 2 CF 2 O-; and each R 6 is independently H, halogen, alkyl, C2-C2 alkoxy or C 2 -C4 ' alkoxycarbonyl, or each R 6 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with C -C4 alkyl, C 2 -C alkenyl, C2-C4 alkynyl, C 3 -C 6 cycloalkyl, C -C4 haloalkyl, C 2 -C4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -Ce halocycloalkyl, halogen, CN, NO 2 , C2-C4 alkoxy, C 2 -C4 haloalkoxy, C -C 4 alkylthio, C -C 4 alkylsulfϊnyl, C 2 -C 4 alkylsulfonyl, C2-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -Cg frialkylsilyl. Preferred C. Compounds of Preferred B wherein R 1 and R 2 are both H; R 3 is C!-C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; each R 4 is independently H, CH 3 , CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; each R5 is independently CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 or S(O) p CF 2 CHF 2 ; each R 6 is independently H, halogen or methyl; or phenyl, pyrazole, imidazole, friazole, pyridine or pyrimidine, each ring optionally substituted with C -C4 alkyl, C2-C4 haloalkyl, halogen or CN; and p is 0, 1 or 2. Preferred D. Compounds of Preferred C wherein R 3 is f-propyl or t-butyl. Preferred E. Compounds of Formula 1 wherein J is a 5- or 6-membered heteroaromatic rinp ontinnallv substituted with 1 to 4 R 7 . Preferred F. Compounds of Preferred E wherein J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R 7 J-l J-2 J-3 J-4 J-5 Q is O, S or NR 7 ; and W, X, Y and Z are independently N or CR 7 , provided that in J-4 and J-5 at least one of W, X, Y or Z is N. Preferred G. Compounds of Preferred E or Preferred F wherein A and B are O; n is 1 to 2; R 1 is H, C2-C4 alkyl, C -C alkenyl, C 2 -C 4 alkynyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R 2 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R 3 is H; or C2-C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or C -C 6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, Cj-C 2 alkoxy, C -C 2 alkylthio, C2~C 2 alkylsulfϊnyl and C2-C alkylsulfonyl; one of the R 4 groups is attached to the phenyl ring at the 2-position, and said R 4 is C r C 4 alkyl, C r C 4 haloalkyl, halogen, CN, NO 2 , C2-C 4 alkoxy, C -C4 haloalkoxy, C -C4 alkylthio, C2-C4 alkylsulfϊnyl, C2-C4 alkylsulfonyl, C -C4 haloalkylthio, C -C4 haloalkylsulfinyl or C -C4 haloalkylsulfonyl; and each R 7 is independently H, C2-C4 alkyl, C2-C 4 .haloalkyl, halogen, CN, NO 2 , C 2 -C4 haloalkoxy, C -C 4 alkylthio, C 2 -C alkylsulfinyl, C -C 4 alkylsulfonyl, C2-C4 haloalkylthio, C2-C4 haloalkylsulfinyl, C -C4 haloalkylsulfonyl or C 2 -C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with C2-C4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C2-C4 alkoxy, C -C4 haloalkoxy, C2-C4 alkylthio, C2-C4 alkylsulfmyl, C2-C4 alkylsulfonyl, C r C alkylamino, C -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 3 -C 6 (alkyl)cycloalkylamino, C 2 -C 4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -Cg frialkylsilyl. Preferred H. Compounds of Preferred G wherein J is selected from the group consisting of pyridine, pyrimidine, pyrazole, imidazole, triazole, thiophene, thiazole and oxazole, furan, isothiazole and isoxazole, each optionally substituted with 1 to 3 R 7 . Preferred I. Compounds of Preferred H wherein J is selected from the group consisting of pyridine, pyrimidine, . pyrazole, thiophene and thiazole, each optionally substituted with 1 to 3 R 7 ; R 1 and R 2 are both H; R 3 is C2-C4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; each R 4 is independently H, CH 3 , CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; each R 7 is independently H, halogen, CH 3 , CF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 , S(O) p CF 2 CHF 2 ; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C -C4 alkyl, C -C4 haloalkyl, C -C4 alkoxy, C -C4 haloalkoxy, C2-C4 alkylthio, C -C4 alkylsulfinyl, C2-C4 alkylsulfonyl, halogen or CN; and p is 0, 1 or 2. Preferred J. Compounds of Preferred I wherein J is a pyridine optionally substituted with 1 to 3 R 7 . Preferred K. Compounds of Preferred J wherein one R 7 is a plienyl optionally substituted with C -C4 alkyl, C2-C4 haloalkyl, halogen or CN. Preferred L. Compounds of Preferred J wherein one R 7 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C2-C4 alkyl, C -C4 haloalkyl, halogen or CN. Preferred M. Compounds of Preferred I wherein J is a pyrimidine optionally substituted Λvith 1 to 3 R 7 . Preferred N. Compounds of Preferred M wherein one R 7 is a phenyl optionally substituted with C2-C4 alkyl, C2-C4 haloalkyl, halogen or CN. Preferred O. Compounds of Preferred M wherein one R 7 is a pyrazole, imidazole, friazole, pyridine or pyrimidine, each ring optionally substituted with C 2 -C 4 alkyl, C 2 -C 4 haloalkyl, halogen or CN. Preferred P. Compounds of Preferred I wherein J is a pyrazole optionally substituted with 1 to 3 R 7 . Preferred Q. Compounds of Preferred P wherein one R 7 is a phenyl optionally substituted with C 2 -C4 alkyl, C -C4 haloalkyl, halogen or CN. Preferred R. Compounds of Preferred P wherein one R 7 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C 2 -C 4 alkyl, C 2 -C 4 haloalkyl, halogen or CN. Preferred S. Compounds of Preferred R wherein R 7 is a pyridine optionally substituted with C -C 4 alkyl, C -C 4 haloalkyl, halogen or CN. Most preferred is the compound of Formula 1 selected from the group consisting of: 3-methyl-N-(l-memylethyl)-2-[[4-(trifluoromethyl)benzoyl]amino]-benzamide, 2-methyI-N-[2-methyl-6-[[(l -methylethyl)amino]carbonyl]phenyl]-4- (trifluoromethyl)benzamide, 2-methyl-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenyl]-6- (trifluoromethyl)-3-pyridinecarboxamide, 1 -ethyl-N-[2-methyl-6-[[(l -methylethyl)amino]carbonyl]phenyl]-3- (frifluoromethyl)- lH-pyrazole-5-carboxamide, l-(2-fluorophenyl)-N-[2-methyl-6-[[(l-methylethyl)amino)carbonyl]phenyl]-3- (trifluoromethyl)-lH-pyrazole-5-carboxamide, l-(3-chloro-2-pyridinyl)-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenyl]3- (friιluoromethyl)-lH-pyrazole-5-carboxamide, N-[2-chloro-6-[[(l-methylethyl)amino]carbonyl]phenyl]-l-(3-chloro-2-pyridinyl)-3- (frifluoromethyl)-lH-pyrazole-5-carboxamide, 3-bromo-l-(2-chlorophenyl)-N-[2-methyl-6-[[(l- methylethyl)amino]carbonyl]phenyl]-lH-pyrazole-5-carboxamide, and 3 -bromo-N- [2-chloro-6- [[( 1 -methylethyl)amino]carbonyl]phenyl]- 1 -(2- chlorophenyl)-lH-pyrazole-5-carboxamide. Preferred compositions are those comprising compounds of formula 1 as preferred in Preferred 1 through 19, and the specifically preferred compounds above. As noted above, each J is independently a phenyl group or a naphthyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 ; or each J is independently a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R 7 . The term "optionally substituted" in connection with these J groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the arthropodicidal activity possessed by the unsubstituted analog. Note also that J-l through J-5 above denote 5- or 6-membered heteroaromatic rings. An example of phenyl substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 is the ring illustrated as J-6 in Exhibit 1, wherein m is an integer from 1-2 and q is an integer from 1 to 3. Note that at least one R 5 must be present in J-6. Although R 6 groups are shown in the structure J-6, it is noted that they do not need to be present since they are optional substituents. An example of a naphthyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 is J- 59 illustrated in Exhibit 1, wherein m is an integer from 1-2 and q is an integer from 1 to 3. Note that at least one R 5 must be present in J-59. Although R 6 groups are shown in the structure J-59, it is noted that they do not need to be present since they are optional substituents. Examples of 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R 7 include the rings J-7 through J-58 illustrated in Exhibit 1 wherein r is an integer from 1 to 4. Note that J-7 through J-26 are examples of J-l, J-27 through J-41 are examples of J-2, J-42 through J-44 are examples of J-3, J-46 through J-53 are examples of J-4 and J-54 through J-58 are examples of J-5. The nifrogen atoms that require substitution to fill their valence are substituted with R 7 . Note that some J groups can only be substituted with less than 4 R 7 groups (e.g. J-l 9, J-20, J-23 through J-26 and J-37 through J-40 can only be substituted with one R 7 ). Examples of aromatic 8-, 9- or 10-membered fused heterobicyclic ring systems optionally substituted with 1 to 4 R 7 include J-60 through J-90 illustrated in Exhibit 1 wherein r is an integer from 1 to 4. Although R 7 groups are shown in the structures J-7 through J-58 and J-60 through J-90, it is noted that they do not need to be present since they are optional substituents. Note that when R 5 , R6 and/or R 7 are H when attached to an atom, this is the same as if said atom is unsubstituted. Note that when the attachment point between (R 5 ) m , (R 6 ) q or (R 7 ) r and the J group is illustrated as floating, (R 5 ) m , (R 6 )q or (R 7 )r can 0Q attached to any available carbon atom of the J group. Note that when the attachment point on the J group is illustrated as floating, the J group can be attached to the remainder of Formula 1 through any available carbon of the J group by replacement of a hydrogen atom. Exhibit 1 J-6 J-10 J-l l J-12 J-13 J-14 J-15 J-16 J-17 J-18 J-21 J-22 J-36 J-37 J-38 J-39 J-40 J-41 J-46 J-47 J-48 J-49 J-50 J-51 J-52 J-53 J-54 J-59 J-60 J-61 J-62 J-63 J-64 J-65 J-66 J-67 6Z Li-£ 98-1 58-1 £/.-£ Wrf εz,-r ZL-i \L-i /I0Sfl/I3d 90/./I0 OΛV J-88 J-89 J-90 As noted above, G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O) 2 and optionally substituted with 1 to 4 substituents selected from the group consisting of C 2 -C 2 alkyl, halogen, CN, NO 2 and C -Q 2 alkoxy. The term "optionally substituted" in connection with these G groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the arthropodicidal activity possessed by the unsubstituted analog. Note that when the attachment point on the G group is illustrated as floating, the G group can be attached to the remainder of Formula 1 through any available carbon of the G group by replacement of a hydrogen atom. The optional substituents can be attached to any available carbon by replacing a hydrogen atom. Examples of 5- or 6-membered nonaromatic carbocyclic rings as G include the rings illustrated as G-1 through G-8 of Exhibit 2, wherein such rings are optionally substituted with 1 to 4 substituents selected from the group consisting of C ~C 2 alkyl, halogen, CN, NO 2 and Cχ-C 2 alkoxy. Examples of 5- or 6-membered nonaromatic heterocyclic rings as G include the rings illustrated as G-9 through G-48 of Exhibit 2, wherein such rings are optionally substituted with 1 to 4 substituents selected from the group consisting of C 2 -Q 2 alkyl, halogen, CN, NO 2 and C 2 -C 2 alkoxy. Note that when G comprises a ring selected from G-31 through G-34, G-37 and G-38, Q 1 is selected from O, S or N. Note that when G is G-11, G13, G-14, G16, G-23, G-24, G-30 through G-34, G-37 and G-38 and Q 1 is N, the nitrogen atom can complete its valence by substitution with either H or C 2 -C 2 alkyl. Exhibit 2 G-1 G-2 G-3 G-4 G-5 G-6 G-1 G-8 G-9 G-10 G-12 G-l l G-13 G-14 G-15 G-16 G-17 G-18 G-19 G-20 G-21 G-22 G-28 G-29 G-30 G-31 G-32 G-33 G-34 G-35 G-36 G-37 G-38 As noted above, each R 6 and each R 7 can be independently (among others) 5- or 6- membered heteroaromatic rings or aromatic 8-, 9- or 10-membered fused heterobicyclic ring systems, each ring optionally substituted with one to three substituents independently selected from the group consisting of C 2 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 4 haloalkyl, C 2 -C haloalkenyl, C 2 -C haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C 2 -C 4 alkoxy, C -C4 haloalkoxy, C2-C 4 alkylthio, C 2 -C 4 alkylsulfinyl, C 2 -C 4 alkylsulfonyl, C 2 -C 4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 3 -C 6 (alkyl)cycloalkylamino, C 2 -C 4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C dialkylaminocarbonyl or C 3 -Cg frialkylsilyl. Examples of such R 6 and R 7 groups include the rings or ring systems illustrated as rings J-7 through J-58 and J-60 through J-90 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents selected from the group consisting of C 2 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -Cg cycloalkyl, C -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C 2 -C 4 alkoxy, C -C 4 haloalkoxy, C -C 4 alkylthio, C -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C -C 4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 3 -Cβ (alkyl)cycloalkylamino, C 2 -C 4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -Cg frialkylsilyl rather than (R 7 ) r . Note that these substituents can be attached to any available carbon atom of the J group by replacement of a hydrogen atom. Note that when the attachment point on the J group is illustrated as floating, the J group can be attached to the remainder of Formula 1 through any available carbon of the J group by replacement of a hydrogen atom. One or more of the following methods and variations as described in Schemes 1-17 can be used to prepare the compounds of Formula 1. The definitions of A, B, J, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , m and n in the compounds of Formulae 1-34 below are as defined above in the Summary of the Invention. Compounds of Formulae la-c, 2a-b, 4a-g, 5a-b are various subsets of the compounds of Formula 1, 2, 4 and 5. Compounds of Formula 1 can be prepared by procedures outlined in Schemes 1-17. A typical procedure is detailed in Scheme 1 and involves coupling of an anthranilic amide of Formula 2 with an acid chloride of Formula 3 in the presence of an acid scavenger to provide the compound of Formula la. Typical acid scavengers include amine bases such as friethylamine, diisopropylethylamine and pyridine; other scavengers include hydroxides such as sodium and potassium hydroxide and carbonates such as sodium carbonate and potassium carbonate. In certain instances it is useful to use polymer-supported acid scavengers such as polymer-bound diisopropylethylamine and polymer-bound dimethylaminopyridine. In a subsequent step, amides of Formula la can be converted to thioamides of Formula lb using a variety of standard thip transfer reagents including phosphorus pentasulfide and Lawesson's reagent. Scheme 1 T sca a v c e i n d ger 2 la (A 5s O) lb (A is S) An alternate procedure for the preparation of compounds of Formula la involves coupling of an anthranilic amide of Formula 2 with an acid of Formula 4 in the presence of a dehydrating agent such as dicyclohexylcarbodiimide (DCC). Polymer supported reagents are again useful here, such as polymer-bound cyclohexylcarbodiimide. Synthetic procedures of Schemes 1 and 2 are only representative examples of useful methods for the preparation of Formula 1 compounds as the synthetic literature is extensive for this type of reaction. Scheme 2 dehydrative + V 1 coupling reagent OH la 4 One skilled in the art will also realize that acid chlorides of Formula 3 may be prepared from acids of Formula 4 by numerous well-known methods. Anthranilic amides of Formula 2a are typically available from the corresponding 2-nifrobenzamides of Formula 5 via catalytic hydrogenation of the nifro group. Typical procedures involve reduction with hydrogen in the presence of a metal catalyst such as palladium on carbon or platinum oxide and in hydroxylic solvents such as ethanol and isopropanol. These procedures are well documented in the chemical literature. R 1 substituents such as alkyl, substituted alkyl and the like can generally be introduced at this stage through known procedures including either direct alkylation or through the generally preferred method of reductive alkylation of the amine. A commonly employed procedure is to combine the aniline 2a with an aldehyde in the presence of a reducing agent such as sodium cyanoborohydride to produce the Formula 2b compounds where R 1 is alkyl, alkenyl, alkynyl or substituted derivatives thereof. Scheme 3 2a 2b (R 1 is other than H) The intermediate amides of Formula 5 a are readily prepared from commercially available 2-nifrobenzoic acids. Typical methods for amide formation can be applied here. These include direct dehydrative coupling of acids of Formula 6 with amines of Formula 7 using for example DCC, and conversion of the acids to an activated form such as the acid chlorides or anhydrides and subsequent coupling with amines to form amides of Formula 5a. We have found ethylchloroformate to be an especially useful reagent for this type of reaction involving activation of the acid. The chemical literature is extensive on this type of reaction. Amides of Formula 5a are readily converted to thioamides of Formula 5b by using commercially available thio transfer reagents such as phosphorus pentasulfϊde and Lawesson's reagent. Scheme 4 5b (B is S) Benzoic acids of Formula 4 (J is optionally substituted phenyl) are generally well known in the art as are procedures for. their preparation. One particularly useful subset of benzoic acids of this invention are 2-methyl-4-perfluoroalkyl benzoic acids of Formula 4a (R 5 equals e.g. CF 3 , C 2 F 5 , C 3 F 7 ). The synthesis for these compounds is outlined in Schemes 5-9. Benzoic acids of Formula 4a may be prepared from the benzonifriles of Formula 8 by hydrolysis. The conditions used may involve the use of a base such as an alkaline metal hydroxide or alkoxide (e.g. potassium or sodium hydroxide) in a solvent such as water, ethanol or ethylene glycol (e.g. J. Chem. Soc. 1948, 1025). Alternatively, the hydrolysis may be carried out using an acid such as sulfuric acid or phosphoric acid in a suitable solvent such as water (e.g. Org. Synth. 1955, Coll vol. 3, 557). The choice of the conditions is contingent on the stability of R 5 to the reaction conditions and elevated temperatures are usually employed to achieve this transformation. Scheme 5 Nifriles of Formula 8 may be prepared from anilines of Formula 9 by the classical sequence involving diazotization and treatment of the intermediate diazonium salt with a copper cyanide salt (e.g. J Amer. Chem. Soc. 1902, 24, 1035). Scheme 6 1) Diazotiazation 2) Copper Sulfide Anilines of Formula 9 may be prepared from compounds of Formula 10. This transformation may be achieved by a well-known procedure that employs Raney Nickel (Org. Synth. Coll. Vol VI, 581). Alternatively, the same fransformation may be effected by the use of a suitable catalyst such as palladium in the presence of hydrogen. The reaction is usually conducted at pressures of 10 2 to 10 5 kPa in a suitable organic solvent such as, but not limited to, toluene. Elevated temperatures of 80-110°C are usually required to achieve the fransformation. As one skilled in the art will realize, numerous chemical modifications of the thioether moiety are possible, and may be employed when necessary to facilitate this transformation. Scheme 7 10 Compounds of Formula 10 may be prepared from iminosulfuranes of Formula 11. The fransformation may be achieved in a protic solvent such as methanol or water, in a non-protic solvent such as dichloromethane or toluene in the presence of a suitable base such as triethylamine (e.g. Org. Synth. Coli. Vol. VI, 581) or sodium methoxide, or in a combination of a protic solvent, a protic solvent and a base. The temperature at which the reaction is conducted is usually in the range 40-110°C. As one skilled in the art will realize, suitable salts of compounds of Formula 11 such as, but not limited to a hydrochloride, a sulfate or a bisulfate may also be employed, provided that the appropriate amount of base is first used to generate the free base 11. This may be done as a separate step or as an integral part of the step involving the transformation of compounds of Formula 11 to compounds of Formula 10. Scheme 8 Compounds of Formula 11 may be prepared from anilines of Formula 12 by reaction with dimethyl sulfide and a suitable chlorinating agent such as, but not limited to N-chlorosuccinimide (e.g. Org. Synth. Coll. Vol. VI, 581), chlorine or N-chlorobenzotriazole. Alternatively, anilines of Formula 12 may be treated with dimethyl sulfoxide which has been "activated" by treatment with an agent such as acetic anhydride, trifluoroacetic, anhydride, frifluoromethanesulfonic anhydride, cyclohexylcarbodiimide, sulfur trioxide, or phosphorus pentoxide. The reaction is conducted in a suitable organic solvent such as dichloromethane or dimethyl sulfoxide. The reaction is conducted at a temperature of — 70°C to 25°C and is dependent on the solvent and reagent used. Scheme 9 Intermediate anthranilic amides of Formula 2a and 2b may also be prepared from isatoic anhydrides of Formula 13 and 14 (Scheme 10). Typical procedures involve combination of equimolar amounts of the amine 7 with the isatoic anhydride in polar aprotic solvents such as pyridine and dimethylformamide at temperatures ranging from room temperature to 100° C. R 1 substituents such as alkyl and substituted alkyl may be infroduced by the base catalyzed alkylation of isatoic anhydride 13 with known alkylating reagents R -Lg (wherein Lg is a leaving group such as halogen, alkyl or aryl suphonates or alkyl sulfates) to provide the alkyl substituted intermediates 14. Isatoic anhydrides of Formula 13 may be made by methods described in Coppola, Synthesis 505-36 (1980). Scheme 10 14 2 b (R 1 is other than H) An alternate procedure for the preparation of specific compounds of Formula 1 (where A is O, B is O and R 1 is H) involves reaction of an amine 7 with a benzoxazinone of Formula 15. Typical procedures involve combination of the amine with the benzoxazinone in solvents such as tefrahydrofuran or pyridine at temperatures ranging from room temperature to the reflux temperature of the solvent. Benzoxazinones are well documented in the chemical literature and are available via known methods that involve the coupling of either an anthranilic acid or an isatoic anhydride with an acid chloride. For references to the synthesis and chemistry of Benzoxazinones see Jakobsen et al, Biorganic and Medicinal Chemistry, 2000, 8, 2095-2103 and references cited within. See also Coppola, J. Heterocyclic Chemistry, 1999, 36, 563-588. Scheme 11 15 lc (A is O, B is O, R 1 is H) Heterocyclic acids 4, where J is equal to an optionally substituted heterocycle, can be prepared by procedures outlined in Schemes 12-17. Both general and specific references to a wide variety of heterocyclic acids including thiophenes, furans, pyridines, pyrimidines, friazoles, imidazoles, pyrazoles, thiazoles, oxazoles, isothiazoles, thiadiazoles, oxadiazoles, friazines, pyrazines, pyridazines, and isoxazoles can be found in the following compendia: Rodd's Chemistry of Chemistry of Carbon Compounds, Vol. IVa to IVL, S. Coffey editor, Elsevier Scientific Publishing, New York, 1973; Comprehensive Heterocyclic Chemistry, Vol. 1-7, A. R. Kafritzky and C. W. Rees editors, Pergamon Press, New York, 1984; Comprehensive Heterocyclic Chemistry II, Vol. 1-9, A. R. Kafritzky, C. W. Rees, and E. F. Scriven editors, Pergamon Press, NewYork, 1996; and the series, The Chemistry of Heterocyclic Compounds, E. C. Taylor, editor, Wiley, New York. Particularly useful heterocyclic acids of this invention include pyridine acids, pyrimidine acids and pyrazole acids. Procedures for the synthesis of representative examples of each are detailed in Schemes 12-17. A variety of heterocyclic acids and general methods for their synthesis may be found in World Patent Application WO 98/57397. The synthesis of representative pyridine acids (4b) is depicted in Scheme 12. This procedure involves the known synthesis of pyridines from β-ketoesters and 4- aminobutenones (19). Substituent groups R 7 (a) and R 7 (b) include e.g. alkyl and haloalkyl. Scheme 12 4b 20 The synthesis of representative pyrimidine acids (4c) is depicted in Scheme 13. This procedure involves the known synthesis of pyrimidines from vinylidene-β-ketoesters (22) and amidines. Substituent groups R 7 (a) and R 7 (b) include e.g. alkyl and haloalkyl. Scheme 13 4c 23 The synthesis of representative pyrazole acids (4d-4g) is depicted in Schemes 14-17. Pyrazoles 4d are described in Scheme 14. The synthesis of Scheme 14 involves as the key step introduction of the R 7 (b) substituent via alkylation of the pyrazole. The alkylating agent R 7 (b)-Lg (wherein Lg is a leaving group such as Cl, Br, I, sulfonates such as p- toluenesulfonate or methanesulfonate or sulfates such as -SO 2 OR 7 (b)) includes R 7 (b) groups such as C2-C 6 alkyl, C -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C -C 6 haloalkyl, C 2 - Cg haloalkenyl, C 2 -C 6 haloalkynyl, C 3 -C 6 halocycloalkyl, C 2 -C 6 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 3 -C 8 diaUcylaminocarbonyl, C3-C6 trialkylsilyl; or phenyl, benzyl, benzoyl, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring or ring system optionally substituted. Oxidation of the methyl group affords the pyrazole carboxylic acid. Some of the more preferred R 7 (a) groups include haloalkyl. Scheme 14 Lg is a leaving group 4d Pyrazoles 4e are described in Scheme 15. These pyrazole acids may be prepared via metallation and carboxylation of pyrazoles of formula 28 as the key step. The R 7 (b) group is infroduced in a manner similar to that of Scheme 14, i.e. via alkylation with a R 7 (b) alkylating agent. Representative R 7 (a) groups include e.g. cyano, and haloalkyl. Scheme 15 1) LDA 2) C0 2 Lg is a leaving group Pyrazoles 4f are described in Scheme 16. These can be prepared via reaction of an optionally substituted phenyl hydrazine 29 with a pyruvate 30 to yield pyrazole esters 31. Hydrolysis of the ester affords the pyrazole acids 4f. This procedure is particularly useful for the preparation of compounds where R 7 (b) is optionally substituted phenyl and R 7 (a) is haloalkyl. Scheme 16 R 7 (b) Pyrazoles acids of Formula 4g are described in Scheme 17. These can be prepared via 3+2 cycloaddition of an appropriately substituted nifrilimine with either substituted propiolates (33) or acrylates (36). Cycloaddition with acrylates requires additional oxidation of the intermediate pyrazoline to the pyrazole. Hydrolysis of the ester affords the pyrazole acids 4g. Preferred iminohalides for this reaction include the trifluoromethyl iminochloride (38) and the iminodibromide (39). Compounds such as 38 are known (J. Heterocycl Chem. 1985, 22(2), 565-8). Compounds such as 39 are available by known methods (Tetrahedron Letters 1999, 40, 2605). These procedures are particularly useful for the preparation of compounds where R 7 (b) is optionally substituted phenyl and R 7 (a) is haloalkyl or bromo. Scheme 17 35 Xι_ is halogen 38 39 It is recognized that some reagents and reaction conditions described above for preparing compounds of Formula 1 may not be compatible with certain functionalities present in the intermediates. In these instances, the incorporation of protection/deprotection sequences or functional group interconversions into the synthesis will aid in obtaining the desired products. The use and choice of the protecting groups will be apparent to one skilled in chemical synthesis (see, for example, Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 2nd ed.; Wiley: New York, 1991). One skilled in the art will recognize that, in some cases, after the introduction of a given reagent as it is depicted in any individual scheme, it may be necessary to perform additional routine synthetic steps not described in detail to complete the synthesis of compounds of Formula 1. One skilled in the art will also recognize that it may be necessary to perform a combination of the steps illustrated in the above schemes in an order other than that implied by the particular sequence presented to prepare the compounds of Formula 1. One skilled in the art will also recognize that compounds of Formula 1 and the intermediates described herein can be subjected to various electrophilic, nucleophilic, radical, organometallic, oxidation, and reduction reactions to add substituents or modify existing substituents. Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. The following Examples are, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Percentages are by weight except for chromatographic solvent mixtures or where otherwise indicated. Parts and percentages for chromatographic solvent mixtures are by volume unless otherwise indicated. } H NMR specfra are reported in ppm downfield from teframethylsilane; s is singlet, d is doublet, t is triplet, q is quartet, m is multiplet, dd is doublet of doublets, dt is doublet of triplets, br s is broad singlet. EXAMPLE 1 Step A: Preparation of 3 -methyl-N-C 1 -methylethyl)-2-nitrobenzamide A solution of 3-methyl-2-nifrobenzoic acid (2.00 g, 11.0 mmol) and triethylamine (1.22 g, 12.1 mmol) in 25 mL of methylene chloride was cooled to 10°C. Ethyl chloroformate was carefully added and a solid precipitate formed. After stirring for 30 minutes isopropylamine (0.94 g, 16.0 mmol) was added and a homogeneous solution resulted. The reaction was stirred for an additional hour, poured into water and extracted with ethyl acetate. The organic extracts were washed with water, dried over magnesium sulfate and evaporated under reduced pressure to afford 1.96 g of the desired intermediate as a white solid melting at 126-128 °C. *H ΝMR (CDC1 3 ) δ 1.24 (d,6H), 2.38 (s,3H), 4.22 (m,lH), 5.80 (br s,lH), 7.4 (m,3H). Step B: Preparation of 2-amino-3-methyl-N-( -methylethvDbenzamide The 2-nitrobenzamide of Step A (1.70 g, 7.6 mmol) was hydrogenated over 5% Pd/C in 40 mL of ethanol at 50 psi. When the uptake of hydrogen ceased the reaction was filtered through celite and the celite was washed with ether. The filtrate was evaporated under reduced pressure to afford 1.41 g of the title compound as a solid melting at 149-151 °C. 1HΝMR (CDCI 3 ) δ 1.24 (dd,6H), 2.16 (s,3H), 4.25 (m,lH), 5.54 (br s,2H), 5.85 (br s,lH), 6.59 (t,lH), 7.13 (d,lH), 7.17 (d,lH). Step C: Preparation of 3-methyl-N-q-methylethyl>2-IT4- ffrifluoromethoxy)benzoyl]aminolbenzamide 4-(frifluoromethoxy)benzoyl chloride (0.29 g, 1.3 mmol) was added dropwise to a mixture of the aniline from Step B (0.25 g, 1.3 mmol) and triethylamine (0.13 g, 1.3 mmol) in 5 mL of methylene chloride at room temperature. After stirring for one hour the reaction was poured into water and extracted with ethyl acetate. The combined extracts were dried over magnesium sulfate and evaporated under reduced pressure. The resulting solids were washed with hexane/ether and filtered to afford 0.41 g of the title compound, a compound of the present invention, as a solid melting at 207-209°C. iH NMR (CDCI3) δ 1.19 (d, 6H), 2.33 (s, 3H), 4.15 (m, 1H), 5.97 (br d, 1H), 7.2-7.4 (m, 6H), 8.04 (d, 1H), 10.11 (br s, 1H). EXAMPLE 2 Step A: Preparation of l-Ethyl-3-frifluoromethylpyrazol-5-yl Carboxylic acid To a mixture of 3-trifluoromethylpyrazole (5 g, 37 mmol) and powdered potassium carbonate (10 g, 72 mmol) stirring in 30 mL of NN-dimethylformamide, iodoethane (8 g, 51 mmol) was added dropwise. After a mild exotherm, the reaction was stirred overnight at room temperature. The reaction mixture was partitioned between 100 mL of diethyl ether and 100 mL of water. The ether layer was separated, washed with water (3X) and brine, and dried over magnesium sulfate. Evaporation of solvent in vacuo gave 4 g of oil. To 3.8 g of this oil stirring in 40 mL of tetrahydrofuran under nitrogen in a dry ice/acetone bath, 17 mL of a 2.5 M solution of rø-butyl lithium in tetrahydrofuran (43 mmol) was added dropwise and the solution stirred for 20 minutes at -78°C. An excess of gaseous carbon dioxide was bubbled into the stirred solution at a moderate rate for 10 minutes. After addition of carbon dioxide, the reaction was allowed to slowly reach room temperature and stirred overnight. The reaction mixture was partitioned between diethyl ether (100 mL) and 0.5 Ν aqueous sodium hydroxide (100 mL). The basic layer was separated and acidified with concentrated hydrochloric acid to a pH of 2-3. The aqueous mixture was exfracted with ethyl acetate (100 mL) and the organic extract washed with water and brine and dried over magnesium sulfate. The oily residue, which remained after evaporating the solvent in vacuo, was triturated to a solid from a small amount of rø-butyl chloride. After filtering and drying, a slightly impure, sample of l-ethyl~3-frifluoromethyl-pyrazol-5-yl carboxylic acid (1.4 g) was obtained as a broad-melting solid. 1H ΝMR (CDCI 3 ): 9.85 (br s,lH), 7.23 (s,lH), 4.68 (q,2H), 1.51 (t,3H) ppm. Step B: Preparation of 2-| " l-Ethyl-3-frifluoromethylpyrazol-5-yl carbamoyll-3- methyl-N-( 1 -methylethvDbenzamide To a solution of l-ethyl-3-frifluoromethyl-pyrazol-5-yl carboxylic acid (0.5 g, 2.4 mmol) stirring in 20 mL of methylene chloride, oxalyl chloride (1.2 mL, 14 mmol) was added. Upon addition of 2 drops of NN-dimethylformamide, foaming and bubbling occurred. The reaction mixture was heated at reflux for 1 hr as a yellow solution. After cooling, the solvent was removed in vacuo and the resulting residue dissolved in 20 mL of tetrahydrofuran. To the stirred solution, 2-amino-3-methyl-N-(l-methylethyl)benzamide (0.7 g, 3.6 mmol) was added followed by the dropwise addition of N,N- diisopropylethylamine (3 mL, 17 mmol). After stirring at room temperature overnight, the reaction mixture was partitioned between ethyl acetate (100 mL) and IN aqueous hydrochloric acid (75 mL). The separated organic layer was washed with water and brine and dried over magnesium sulfate. Evaporating in vacuo gave a white solid residue, which on purification by flash column chromatography on silica gel (2:1 hexanes/ethyl acetate) afforded 0.5 g of the title compound, a compound of the present invention, melting at 223-226°C. 1HNMR (DMSO-D 6 ): 10.15 (s,lH), 8.05 (d,lH), 7.45 (s,lH), 7.43-7.25 (m,3H), 4.58 (q,2H), 3.97 (m,lH), 2.45 (s,3H), 1.36 (t,3H), 1.06 (d,6H) ppm. EXAMPLE 3 Step A: Preparation of S.S-dimethyl-N- 4-(frifluoromethyl phenyllsulfilimine A solution of N-chlorosuccinimide (12-43 g, 93.1 mmol) in -170 mL of dichloromethane was added to a mixture of 4-(trifluoromethyl) aniline (15 g, 93.1 mmol) and dimethyl sulfide (6.35 g, 102 mmol) in 230 mL of dichloromethane at-5-0°C. After the addition was complete, the mixture was stirred at 0-5°C for lh, and N-chlorosuccinimide (0.02 g, 4.64 mmol) was added. After a further 30 minutes, the mixture was washed with 500 mL of IN sodium hydroxide. The organic phase was dried and evaporated to give the product as a solid 19-72 g melting at 101-103 °C (after crystallization from ethyl acetate/hexanes). IR (Νujol) 1603, 1562, 1532, 1502, 1428, 1402, 1335, 1300, 1270, 1185, 1150, 1103, 1067, 1000, 972, 940, 906, 837, 817 cm "1 . 1H NMR (CDC1 3 ) δ 7.35 (d, J=8.8 Hz, 2 H), 6.84 (d, J=8.8 Hz, 2 H), 2.67 (5, 3 H). Step B: 2-| " (methylthio ' )methyll-4-(trifluoromethyl)benzenamine . Sodium methoxide in methanol (1.95 g, 9.02 mmol, 25%) was added to S,S- dimethyl-N-[4-(trifluoromethyl)phenyl]sulfilimine from Step A (2 g, 9.04 mmol) in 15 mL of toluene. The mixture was warmed to ~80°C for ~1 h. The mixture was allowed to cool to 25°C and was poured into 100 mL of water. The mixture was exfracted with 2x100 mL of ethyl acetate and the combined extracts were dried and evaporated to give 1.8 g of the product as a solid melting at 65.5-67.5°C (after crystallization from hexanes). IR (nujol) 3419, 3333, 1629, 1584, 1512, 1440, 1334, 1302, 1235, 1193, 1139, 1098, 1078, 979, 904, 832 cm -1 . 1H ΝMR (CDC1 3 ) δ 7.35 (dd, J=l .5 Hz x 8.2 Hz, 1H) 6.72 (d, J=8.4 Hz) 4.39 (br.5, 2 H, 3.69 (5, 2 H), 1.99 (5, 3 H). Step C: Preparation of 2-methyl-4-ftrifluoromethyl benzenamine Activated Raney nickel (500 g wet paste, ~50μ) was added portionwise to a solution of 2-[(methyltMo)methyl]-4-(frifluoromethyl)benzenamine (55.3 g, 0.25 mole) in 1 L of ethanol over 30 minutes at 25-30° C. The heterogeneous mixture was stirred vigorously for 30 minutes after the addition. The stirring was stopped, and the solids were allowed to settle over one hour. The liquid was decanted from the solids and poured through filter paper. The filtrate was evaporated under reduced pressure, and the residue was taken up in dichloromethane. The organic phase was separated from a small volume of water, dried over magnesium sulfate and evaporated under reduced pressure to afford 37.6g of the title compound as amber oil. 1H NMR (CDC1 3 ) δ 7.28 (m,2H), 6.68 (d,lH), 3.87 (br s,2H), 2.19 (s,3H). Step D: Preparation of 2-methyl-4-(trifluoromethyl benzonitrile Concentrated hydrochloric acid (16 mL) was added dropwise at a moderate rate to a heterogeneous mixture of 2-methyl-4-(frifluoromethyl)benzenamine (14 g, 80 mmol) and 120 mL of water while stirring vigorously. A thick suspension resulted which was stirred for 20 minutes, diluted with 280 mL of water and cooled to 5° C. A solution of sodium nifrite (5.5 g, 80 mmol) and 25 mL of water was added slowly to the reaction suspension. After stirring for 30 minutes at 5° C a solution resulted which was stirred cold for 30 more minutes and then neutralized with potassium carbonate. This diazonium salt solution was then added portionwise via cannula to a stirred, 95 ° C mixture of potassium cyanide (22 g, 0.34 mole), copper sulfate pentahydrate (20 g, 80 mmol) and 140 mL of water. After the addition the mixture was stirred for 30 minutes at 95° C and then allowed to cool to room temperature. Ether was added and the heterogeneous mixture was filtered through celite. The solids were washed with ether, and the filtrate was partitioned. The aqueous phase was exfracted with ether, and the combined organic extracts were dried over magnesium sulfate and concentrated under reduced pressure to afford 13.1 g of the title compound as brown oil. 1H NMR (CDC1 3 ) δ 7.74 (d,lH), 7.60 (s,lH), 7.55 (d,lH), 2.64 (s,3H). Step E: Preparation of 2-methyl-4-frifluoromethyl benzoic acid Potassium hydroxide (15.7 g, 0.28 mole) and 15 mL of water were added as a solution to a stirred, heterogeneous mixture of 2-mefhyl-4-(trifluoromethyl)benzonitrile (13 g, 70 mmol) and 135 mL of ethylene glycol. The reaction mixture was heated at 120-130° C for 20 hours and allowed to cool to room temperature. The dark solution was poured into 800 mL of water and filtered through celite. The filtrate was washed with ether and then the aqueous was acidified v/ith concentrated hydrochloric acid. This aqueous phase was exfracted three times with ethyl acetate, the organic extracts were combined, dried over magnesium sulfate and evaporated under reduced pressure to afford the title compound as a tan solid. 1H NMR (CDC1 3 ) δ 7.98 (d,lH), 7.70 (s,lH), 7.65 (d,lH), 2.60 (s,3H). Step F: Preparation of 2-methyl-4-(trifluoromethoxy benzoyl chloride Thionyl chloride (0.42 g, 3.5 mmol) was added to a solution of the benzoic acid from Step E (0.50 g, 2.4 mmol) in 10 mL of toluene at room temperature. The reaction was refluxed for three hours then cooled to room temperature. The solvent was evaporated under reduced pressure and excess thionyl chloride was removed by azeotroping with toluene. The benzoyl chloride obtained was used directly in Step G. Step G: Preparation of 2-methyl-N-r2-methyl-6-rr( ' l-methylethyl amino1- carbonyl]phenyl]-4-(trifluoromethyl)benzamide The benzoyl cliloride of Step F (0.29 g, 1.3 mmol) was added to a mixture of the aniline from Example 1, Step B (0.36 g, 1.9 mmol) and diisopropylethylamine (0.26 g, 2.0 mmol) in 10 mL of chloroform at room temperature. The reaction was allowed to stir overnight. The solid precipitate was filtered and dried to afford 0.38 g of the title compound, a compound of the present invention, as a solid melting at 247-248 °C. !H ΝMR (CDC1 3 ) α 1.24 (d,6H), 2.41 (s,3H), 2.58 (s,3H), 4.20 (m,lH), 5.94 (br d,lH), 7.2-7.3 (m,2H), 7.40 (d,lH), 7.52 (s,lH), 7.53 (d,lH), 7.70 (d,lH), 9.36 (br s,lH). EXAMPLE 4 Step A: Preparation of 2-Methyl-6-(trifluoromethyl -3-pyridinecarbonyl chloride Thionyl chloride (4.35 g, 36.5 mmol) was added to a mixture of 2-methyl-6- trifluoromethyl nicotinic acid (5.00 g, 24.4 mmol) in 75 mL of toluene and the mixture was heated at reflux for 3 hours. The reaction was cooled to room temperature and the solvent was removed under reduced pressure. Excess thionyl chloride was removed by azeotrope with toluene. The resultant acid chloride was used as is in Example 4, Step B. Step B: Preparation of S-Methyl^-p-methyl-ό-CtrifluoromethvD-S-pyridinyll^H- 3.1-benzoxazine A mixture of the 6-methyl isatoic anhydride (3.92 g, 22.1 mmol) and the acid chloride from Step A (5.45 g, 24.3 mmol) was heated at reflux in pyridine for 16 hours. The dark brown solution was cooled to room temperature and the solvent was removed under reduced pressure. Excess pyridine was removed by azeofrope with toluene. Ether was added and the resulting brown solid was removed by filtration. The solid was taken up in a mixture of aqueous sodium bicarbonate and chloroform, the chloroform extracts were dried over magnesium sulfate and evaporated. Excess pyridine was again removed by azeofrope with toluene to afford 5.1 g of the title compound as a brown solid. Η ΝMR (CDC1 3 ) d 2.65 (s,3H), 3.11 (s,3H), 7.49 (t,lH) 7.40 (m,lH), 7.68-7.73 (m,2H), 1.11 (d,lH), 8.58 (d,lH). Step C: Preparation of 2-Methyl-N-r2-methyl-6-rr(T - methylethvDaminolcarbonyllphenyl -ό- frifluoromethvD-S-pyridine Isopropylamine (7.37 g, 0.125 mmol) was added to a mixture of the benzoxazinone of Step B (4.00 g, 12.5 mmol) in 30 mL of tetrahydrofuran. A homogeneous solution formed. The mixture was heated briefly after which a thick white precipitate formed. The solvent was removed under reduced pressure and the resultant solid was washed with ether and filtered to afford 4.48 g of the title compound as a solid melting at 247-248 C. ! H ΝMR (CDC1 3 ) d 1.24 (d,6H), 2.41 (s,3H), 2.77 (s,3H), 4.17 (m,lH), 5.96 (bd,lH), 7.21 (m,2H) 7.40 (m,lH), 7.53 (d,lH), 7.97 (d,lH), 9.80 (bs,lH). EXAMPLE 5 Step A: Preparation of 4-Methyl-N-r2-methyl-6-[rd- methylethyl amino]carbonyl1phenyl]-2-(frifluoromethyl -5- pyrimidinecarboxamide To a solution 0.8 g (4 mmol) of 4-methyl-2-trifluoromethylpyrimidine-5-carboxylic acid [made by the method of Palanki et al, J. Med. Chem. 2000, 43, 3995] stirring in 15 mL of methylene chloride, oxalyl chloride (2 mL, 23 mmol) was added. Upon addition of 2 drops of NN-dimethylformamide, foaming and bubbling occurred. The reaction mixture was heated at reflux for 1 hr as a yellow solution. After cooling, the solvent was removed in vacuo and the resulting residue dissolved in 20 mL of tetrahydrofuran. To the stirred solution, 2-amino-3-methyl-N-(l-methylethyl)benzamide (1 g, 5 mmol) was added followed by the dropwise addition of NN-diisopropylethylamine (3 ml, 17 mmol). After stirring at room temperature overnight, the reaction mixture was partitioned between ethyl acetate (200 mL) and IN aqueous hydrochloric acid (75 mL). The separated organic layer was washed with water and brine and dried over magnesium sulfate. Evaporating in vacuo gave a white solid, which was suspended in a small amount of ethyl acetate and filtered to afford (after drying) 650 mg of the title compound, a compound of the present invention, melting at 248-25 FC. 1H ΝMR (DMSO-D 6 ): 10.3 (s,NH), 9.07 (s,lH), 8.25 (d,NH), 7.43-7.25 (m,3H), 4.03 (m,lH), 2.73 (s,3H), 2.32 (s,3H), 1.12 (d,6H) ppm. EXAMPLE 6 Step A: Preparation of 2-Methyl-l-phenyl-4- trifluoromethyl -lH-pyrazole A solution of 1,1,1 -frifluoropentane-2,4-dione (20.0 g, 0.130 mole) in glacial acetic acid (60 mL) was cooled to 7°C using an ice/water bath. Phenylhydrazine (14.1 g, 0.130 mole) was added dropwise over a period of 60 minutes. The reaction mass temperature increased to 15°C during the addition. The resulting orange solution was held under ambient conditions for 60 minutes. The bulk of the acetic acid was removed by stripping on a rotary evaporator at a bath temperature of 65°C. The residue was dissolved in methylene chloride (150 mL). The solution was washed with aqueous sodium bicarbonate (3 g in 50 mL water). The purple-red organic layer was separated, treated with activated charcoal (2 g) and MgSO 4 , then filtered. Volatiles were removed on a rotary evaporator. The crude product consisted of 28.0 g of a rose-colored oil, which contained ~89% the desired product and 11% l-phenyl-5-(frifluoromethyl)-3-methylpyrazole. 1HNMR (DMSO-D 6 ) δ 2.35 (s,3H), 6.76 (s,lH), 7.6-7.5 (m,5H). Step B: Preparation of l-Phenyl-3-(frifluoromethyl)-liJ-pyrazole-5-carboxylic acid A sample of crude l-phenyl-3-(frifluoromethyl)-5-methylpyrazole (-89%, 50.0 g, 0.221 mole) was mixed with water (400 mL) and cetyltrimethylammonium chloride (4.00 g, 0.011 mole). The mixture was heated to 95°C. Potassium permanganate was added in 10 equal portions, spaced at ~8 minute intervals. The reaction mass was maintained at 95-100°C during this period. After the last portion was added, the mixture was held for ~15 minutes at 95-100°C, whereupon the purple, permanganate color had been discharged. The reaction mass was filtered while hot (~75°C ) through a 1 cm thick bed of Celite ® on a 150 ml, coarse, glass frit. The filter cake was washed with warm (~50°C) water (3xlO0mL). The combined filtrate and washings were extracted with ether (2x100 mL) to remove a small amount of yellow, water-insoluble material. The aqueous layer was purged with nitrogen to remove residual ether. The clear, colorless alkaline solution was acidified by adding concentrated hydrochloric acid dropwise until the pH reached ~1.3 (28 g, 0.28 mole). Gas evolution was vigorous during the first two-thirds of the addition. The product was collected via filtration, washed with water (3x40 mL), then dried overnight at 55°C in vacuo. The product consisted of 11.7 g of a white, crystalline powder, which was essentially pure based upon 1H NMR. 1HNMR (CDC1 3 ) δ 7.33 (s,lH), 7.4-7.5 (m,5H). Step C: Preparation of l-Phenyl-3-ffrifluoromethyl)-lH-pyrazole-5-carbonyl chloride A sample of crude l-phenyl-3-(trifluoromethyl)pyrazole-5 -carboxylic acid (4.13 g, 16.1 mmol) was dissolved in methylene chloride (45 mL). The solution was treated with oxalyl chloride (1.80 mL, 20.6 mmol), followed by NN-dimethylformamide (0.010 mL, 0.13 mmol). Off-gassing began shortly after adding the NN-dimethylfortnamide catalyst. The reaction mixture was stirred for ~20 minutes under ambient conditions, then was heated to reflux for a period of 35 minutes. Volatiles were removed by stripping the reaction mixture on a rotary evaporator at a bath temperature of 55°C. The product consisted of 4.43 g of a light-yellow oil. The only impurity observed by ! H ΝMR was NN-dimethylformamide. 1HΝMR (CDC1 3 ) δ 7.40 (m,lH), 7.42 (s,lH), 7.50-7.53 (m,4H). Step D: Preparation of N-r2-Methyl-6-rf i-methylethvπamino]carbonyl]phenyl]-l- phenyl-3-(trifluoromethylVlH-pyrazole-5-carboxamide A sample of 3-methylisatoic anhydride (0.30 g, 1.7 mmol) partially dissolved in pyridine (4.0 mL) was treated with l-phenyl-3-(frifluoromethylpyrazole)-5-carboxyl chloride (0.55 g, 1.9 mmol). The mixture was heated to ~95°C for a period of 2 hours. The resulting orange solution was cooled to 29°C, then was treated with isopropylamine (1.00 g, 16.9 mmol). The reaction mass self-heated to 39°C. It was further heated to 55°C for a period of 30 minutes, whereupon much precipitate formed. The reaction mass was dissolved in methylene chloride (150 mL). The solution was washed with aqueous acid (5 mL cone. HC1 in 45 mL water), then with aqueous base (2 g sodium carbonate in 50 mL water). The organic layer was dried over MgSO 4 , filtered, then concenfrated on a rotary evaporator. Upon reduction to ~4 mL, product crystals had formed. The slurry was diluted with ~10 mL of ether, whereupon more product precipitated. The product was isolated by filtration, washed with ether (2x10 mL), then washed with water (2x50 mL). The wet cake was dried for 30 minutes at 70°C in vacuo. The product consisted of 0.52 g of an off-white powder melting at 260-262°C. 1H NMR (DMSO-D 6 ) δ 1.07 (d,6H), 2.21 (s,3H), 4.02 (octetlH), 7.2-7.4 (m,3H), 7.45-7.6 (m,6H), 8.10 (d,lH), 10.31 (s,lH). EXAMPLE 7 Step A: Preparation of 3 -Trifluoromethyl-2- [3 -(trifluoromethyl)- 1 H-pyrazol- 1 - yllpyridine A mixture of 2-chloro-3-trifluoromethylpyridine (3.62 g., 21 mmol), 3- trifluoromethylpyrazole (2.7 g., 20 mmol ), and potassium carbonate (6.0 g., 43 mmol ) were heated at 100 ° C for 18 h. The cooled reaction mixture was added to ice/water (100 mL). The mixture was extracted twice with ether (100 mL) and the combined ether extracts were washed twice with water (100 mL). The organic layer was dried with magnesium sulfate and concentrated to an oil. Chromatography on silica gel with hexanes:ethyl acetate 8:1 to 4:1 as eluent gave the title compound (3.5 g) as an oil. 1HNMR (CDC1 3 ) δ 6.75 (m,lH), 7.5 (m,lH), 8.2 (m,2H), 8.7 (m,lH). Step B: Preparation of 3-( y Trifluoromethyl -l-r3- trifluoromethyl -2-pyridinyl]-lH ' - pyrazole-5-carboxylic acid A mixture of the title compound of Example 5, Step A (3.4 g, 13 mmol) was dissolved in tetrahydrofuran (30 mL) and cooled to - 70 °C. Lithium diisopropylamide ( 2N in heptane/tetrahydrofuran, (Aldrich) 9.5 mL, 19 mmol) was added and the resulting dark mixture was stirred for 10 minutes. Dry carbon dioxide was bubbled through the mixture for 15 minutes. The mixture was allowed to warm to 23 °C and treated with water (50 mL) and 1 N sodium hydroxide (10 mL). The aqueous mixture was extracted with ether (100 mL) and then ethyl acetate (100 mL). The aqueous layer was acidified with 6N hydrochloric acid to pH 1-2 and extracted twice with dichloromethane. The organic layer was dried with magnesium sulfate and concenfrated to give the title compound (1.5 g). 1H MR (CDC1 3 ) δ 7.6 (m,lH), 7.95 (m,lH), 8.56 (m,lH), 8.9 (m,lH), 14.2 (br,lH) Step C: Preparation of N-( " 2-Methyl-6-f( " π-methyiethyl)amino1carbonyl]phenyl]-3- ( trifluoromethyl)- 1 - [3 -(trifluoromethyl -2-pyridinyl]- 1 H-pyrazole-5- carboxamide A mixture of the title compound of Example 5, Step B (0.54 g, 1.1 mmol), the title compound from Example 1, Step B (0.44 g, 2.4 mmol) and bop chloride (bis(2-oxo- oxazolidinyl)phosphinyl chloride, 0.54 g, 2.1 mmol) in acetonitrile (13 mL) was treated with triethylamine (0.9 mL). The mixture was shaken in a closed scintillation vial for 18 h. The reaction was partitioned between ethyl acetate (100 mL) and IN hydrochloric acid. The ethyl acetate layer was washed successively with IN hydrochloric acid (50 mL), IN sodium hydroxide (50 mL) and saturated sodium chloride solution (50 mL). The organic layer was dried over magnesium sulfate and concentrated. The residue was subjected to column chromatography on silica gel with hexanes/ethyl acetate (5:1 to 3:1) as eluent. The title compound (0.43 g) was isolated as a white solid, m.p. 227 -230 °C. 1H ΝMR (CDC1 3 ) δ 1.2 (m, 6H), 4.15 (m, 1H), 5.9 (br d,lH), 7.1 (m,lH), 7.2 (m,2H), 7.4 (s,lH), 7.6 (m,lH), 8.15 (m,lH), 8.74 (m,lH), 10.4 (br,lH). By the procedures described herein together with methods known in the art, the following compounds of Tables 1 to 17 can be prepared. The following abbreviations are used in the Tables: t is tertiary, s is secondary, n is normal, i is iso, c is cyclo, Me is methyl, Et is ethyl, Pr is propyl, ' -Pr is isopropyl, t-Bu is tert butyl, Ph is phenyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is ethylthio, CΝ is cyano, ΝO 2 is nifro, TMS is frimethylsilyl, S(O)Me is methylsulfinyl, and S(O) 2 Me is methylsulfonyl. Table 1 R 4 R 5 and/or R 6 R 4 R 5 and/or R 6 R 4 R 5 and/or R 6 Me 2-CF 3 Me 3-CF3 Me 4-CF 3 Me 2-OCF 3 Me 3-OCF3 Me 4-OCF 3 Me 2-OCF 2 H Me 3-OCF 2 H Me 4-OCF 2 H Me 2-OCF 2 CF 2 H Me 3-OCF 2 CF 2 H Me 4-OCF 2 CF 2 H Me 2-OCH 2 CF 3 Me 3-OCH 2 CF 3 Me 4-OCH 2 CF 3 Me 2-SCF 3 Me 3-SCF 3 Me 4-SCF3 Me 2-SOCF3 Me 3-SOCF 3 Me 4-SOCF3 Me 2-S0 2 CF 3 Me 3-S0 2 CF 3 Me 4-S0 2 CF 3 Me 2-SCF 2 H Me 3-SCF 2 H Me 4-SCF 2 H Me 2-SOCF 2 H Me 3-SOCF 2 H Me 4-SOCF 2 H Me 2-S0 2 CF 2 H . Me 3-S0 2 CF 2 H Me 4-S0 2 CF 2 H OMe OMe OMe OMe OMe OMe OMe OMe OMe OMe OMe CF 3 CF 3 CF 3 CF 3 CF 3 CF 3 CF 3 CF 3 CF 3 CF 3 CF 3 OCF 2 H OCF 2 H OCF 2 H OCF 2 H OCF 2 H OCF 2 H OCF 2 H OCF 2 H OCF 2 H 2-SCF 2 H 0CF 2 H 3-SCF 2 H OCF 2 H 4-SCF 2 H OCF 2 H 2-SOCF 2 H 0CF 2 H 3-S0CF 2 H OCF 2 H 4-SOCF 2 H OCF 2 H 2-S0 2 CF 2 H OCF 2 H 3-S0 2 CF 2 H OCF 2 H 4-S0 2 CF 2 H Me 2-Me-4-CF 3 F 2-Me-4-CF 3 Cl 2-Me-4-CF 3 Me 2-Me-4-OCF 3 F 2-Me-4-0CF 3 Cl 2-Me-4-0CF 3 Me 2-Me-4-OCF H F 2-Me-4-0CF 2 H Cl 2-Me-4-0CF 2 H Me 2-Me-4-OCH 2 CF 3 F 2-Me-4-OCH 2 CF 3 Cl 2-Me-4-OCH 2 CF 3 Me 2-Me-4-SCF 3 F 2-Me-4-SCF 3 Cl 2-Me-4-SCF 3 Me 2-Me-4-SOCF 3 F 2-Me-4-S0CF 3 Cl 2-Me-4-S0CF 3 Me 2-Me-4-S0 2 CF 3 F 2-Me-4-S0 2 CF 3 Cl 2-Me-4-S0 2 CF 3 Me 2-Me-4-SCF 2 H F 2-Me-4-SCF 2 H Cl 2-Me-4-SCF 2 H Me 2-Me-4-SOCF 2 H F 2-Me-4-S0CF 2 H Cl 2-Me-4-S0CF 2 H Me 2-Me-4-S0 2 CF 2 H F 2-Me-4-S0 2 CF 2 H Cl 2-Me-4-S0 2 CF 2 H Br 2-Me-4-CF 3 2-Me-4-CF 3 OMe 2-Me-4-CF 3 Br 2-Me-4-OCF 3 2-Me-4-0CF 3 OMe 2-Me-4-0CF 3 Br 2-Me-4-OCF 2 H 2-Me-4-0CF 2 H OMe 2-Me-4-0CF 2 H Br 2-Me-4-OCH 2 CF 3 2-Me-4-0CH 2 CF 3 OMe 2-Me-4-OCH 2 CF 3 Br 2-Me-4-SCF 3 2-Me-4-SCF 3 OMe 2-Me-4-SCF 3 Br 2-Me-4-SOCF 3 2-Me-4-S0CF 3 OMe 2-Me-4-SOCF 3 Br 2-Me-4-S0 2 CF 3 2-Me-4-S0 2 CF 3 OMe 2-Me-4-S0 2 CF 3 Br 2-Me-4-SCF 2 H 2-Me-4-SCF 2 H OMe 2-Me-4-SCF 2 H Br 2-Me-4-S0CF 2 H 2-Me-4-SOCF 2 H OMe 2-Me-4-SOCF 2 H Br 2-Me-4-S0 2 CF 2 H 2-Me-4-S0 2 CF 2 H OMe 2-Me-4-S0 2 CF 2 H CF 3 2-Me-4-CF 3 N0 2 2-Me-4-CF 3 SMe 2-Me-4-CF 3 CF 3 2-Me-4-0CF 3 N0 2 2-Me-4-OCF 3 SMe 2-Me-4-OCF 3 CF 3 2-Me-4-OCF 2 H N0 2 2-Me-4-OCF 2 H SMe 2-Me-4-OCF 2 H CF 3 2-Me-4-OCH 2 CF 3 N0 2 2-Me-4-OCH 2 CF 3 SMe 2-Me-4-OCH 2 CF 3 CF 3 2-Me-4-SCF 3 N0 2 2-Me-4-SCF 3 SMe 2-Me-4-SCF 3 CF 3 2-Me-4-SOCF 3 N0 2 2-Me-4-SOCF 3 SMe 2-Me-4-SOCF 3 CF 3 2-Me-4-S0 2 CF 3 N0 2 2-Me-4-S0 2 CF 3 SMe 2-Me-4-S0 2 CF 3 CF 3 2-Me-4-SCF 2 H N0 2 2-Me-4-SCF 2 H SMe 2-Me-4-SCF 2 H CF 3 2-Me-4-SOCF 2 H N0 2 2-Me-4-SOCF 2 H SMe 2-Me-4-S0CF 2 H CF 3 2-Me-4-S0 2 CF 2 H N0 2 2-Me-4-S0 2 CF 2 H SMe 2-Me-4-S0 2 CF 2 H Table 2 R 4 R 5 and/or R 6 R 4 R 5 and/or R 6 R 4 R 5 and/or R 6 Me 2-CF 3 Me 3-CF3 Me 4-CF3 Me 2-OCF3 Me 3-OCF3 Me 4-OCF3 Me 2-OCF 2 H Me 3-OCF 2 H Me 4-OCF 2 H • Me • 2-OCF CF 2 H Me 3-OCF 2 CF 2 H Me 4-OCF 2 CF 2 H Me 2-OCH 2 CF 3 Me 3-OCH 2 CF 3 Me 4-OCH 2 CF 3 Me 2-SCF 3 Me 3-SCF3 Me 4-SCF3 Me 2-SOCF3 Me 3-SOCF3 Me 4-SOCF3 Me 2-S0 2 CF 3 Me 3-S0 2 CF 3 Me 4-S0 2 CF 3 Me 2-SCF 2 H Me 3-SCF 2 H • Me 4-SCF 2 H Me 2-SOCF 2 H Me 3-SOCF 2 H Me 4-SOCF 2 H Me 2-S0 2 CF 2 H Me 3-S0 2 CF H Me 4-S0 2 CF 2 H Cl 2-CF 3 Cl 3-CF3 Cl 4-CF3 Cl 2-0CF 3 Cl 3-OCF3 Cl 4-OCF 3 Cl 2-OCF 2 H Cl 3-OCF 2 H Cl 4-OCF 2 H . Cl 2-OCF 2 CF 2 H Cl 3-OCF 2 CF 2 H Cl 4-OCF 2 CF 2 H Cl 2-OCH 2 CF 3 Cl 3-OCH 2 CF 3 Cl 4-OCH 2 CF 3 Cl 2-SCF3 Cl 3-SCF3 Cl 4-SCF 3 Cl 2-SOCF3 Cl 3-SOCF3 Cl 4-SOCF 3 Cl 2~S0 2 CF 3 Cl 3-S0 2 CF 3 Cl 4-S0 CF 3 Cl 2-SCF 2 H Cl 3-SCF 2 H Cl 4-SCF 2 H Cl 2-SOCF 2 H Cl 3-SOCF 2 H Cl 4-SOCF 2 H Cl 2-S0 2 CF 2 H Cl 3-S0 2 CF 2 H Cl 4-S0 2 CF 2 H F 2-CF3 F 3-CF 3 F 4-CF 3 F 2-OCF3 F 3-0CF 3 F 4-OCF 3 F 2-OCF 2 H F 3-0CF 2 H F 4-OCF 2 H ' F 2-OCF 2 CF 2 H F 3-OCF 2 CF 2 H F 4-OCF 2 CF 2 H F F F . F F F F Br Br Br Br Br Br Br Br Br Br Br OMe OMe OMe OMe OMe OMe OMe OMe OMe 2-SCF 2 H OMe 3-SCF 2 H OMe 4-SCF 2 H OMe 2-SOCF 2 H OMe 3-SOCF 2 H OMe 4-SOCF 2 H OMe 2-S0 2 CF 2 H OMe 3-S0 2 CF 2 H OMe 4-S0 2 CF 2 H CF 3 2-CF 3 CF 3 3-CF 3 CF 3 4-CF 3 CF 3 2-OCF 3 CF 3 3-OCF 3 CF 3 4-OCF 3 CF 3 2-OCF 2 H CF 3 3-OCF 2 H CF 3 4-OCF 2 H CF 3 2-OCF 2 CF 2 H CF 3 3-OCF 2 CF 2 H CF 3 4-OCF 2 CF 2 H CF 3 2-OCH 2 CF 3 CF 3 3-OCH 2 CF 3 CF 3 4-OCH 2 CF 3 CF 2-SCF3 CF 3 3-SCF 3 ■ CF 3 4-SCF3 CF 3 2-SOCF3 CF 3 3-SOCF 3 CF 3 4-SOCF3 CF 3 2-S0 2 CF 3 CF 3 3-S0 2 CF 3 CF 3 4-S0 2 CF 3 CF 3 2-SCF 2 H CF 3 3-SCF 2 H CF 3 4-SCF 2 H CF 3 2-S0CF 2 H CF 3 3-SOCF 2 H CF 3 4-SOCF 2 H CF 3 2-S0 2 CF 2 H CF 3 3-S0 2 CF 2 H CF 3 4-S0 2 CF 2 H OCF 2 H 2-CF3 OCF 2 H 3-CF 3 OCF 2 H 4-CF3 OCF 2 H 2-OCF3 OCF 2 H 3-OCF3 OCF 2 H 4-OCF3 OCF 2 H 2-OCF 2 H OCF 2 H 3-0CF 2 H OCF 2 H 4-OCF 2 H OCF 2 H 2-OCF 2 CF 2 H OCF 2 H 3-OCF 2 CF 2 H OCF 2 H 4-OCF 2 CF 2 H OCF 2 H 2-OCH 2 CF 3 OCF 2 H . 3-0CH 2 CF 3 OCF 2 H 4-OCH 2 CF 3 OCF 2 H 2-SCF3 OCF 2 H 3-SCF 3 OCF 2 H 4-SCF3 OCF 2 H 2-SOCF3 OCF 2 H 3-SOCF3 OCF 2 H 4-SOCF3 OCF 2 H 2-S0 2 CF 3 OCF 2 H 3-S0 2 CF 3 OCF 2 H 4-S0 2 CF 3 OCF 2 H 2-SCF 2 H OCF 2 H 3-SCF 2 H OCF 2 H 4-SCF 2 H OCF 2 H 2-SOCF 2 H OCF 2 H 3-SOCF 2 H OCF 2 H 4-SOCF 2 H OCF 2 H 2-S0 2 CF 2 H OCF 2 H 3-S0 2 CF 2 H OCF 2 H 4-S0 2 CF 2 H Me 2-Me-4-CF 3 F 2-Me-4-CF 3 Cl 2-Me-4-CF 3 Me 2-Me-4-0CF 3 F 2-Me-4-OCF 3 Cl 2-Me-4-0CF 3 Me 2-Me-4-OCF 2 H F 2-Me-4-OCF 2 H Cl 2-Me-4-0CF 2 H Me 2-Me-4-OCH 2 CF 3 F 2-Me-4-OCH 2 CF 3 Cl 2-Me-4-0CH 2 CF 3 Me 2-Me-4-SCF 3 F 2-Me-4-SCF 3 Cl 2-Me-4-SCF 3 Me 2-Me-4-SOCF 3 F 2-Me-4-SOCF 3 Cl 2-Me-4-S0CF 3 Me 2-Me-4-S0 2 CF 3 F 2-Me-4-S0 2 CF 3 Cl 2-Me-4-S0 2 CF 3 Me 2-Me-4-SCF 2 H F 2-Me-4-SCF 2 H Cl 2-Me-4-SCF 2 H Me 2-Me-4-S0CF 2 H F 2-Me-4-SOCF 2 H Cl 2-Me-4-SOCF 2 H Me 2-Me-4-S0 2 CF 2 H F 2-Me-4-S0 2 CF 2 H Cl 2-Me-4-S0 2 CF 2 H Br 2-Me-4-CF 3 I 2-Me-4-CF 3 OMe 2-Me-4-CF 3 Br 2-Me-4-OCF 3 I 2-Me-4-0CF 3 OMe 2-Me-4-0CF 3 Br 2-Me-4-OCF 2 H 2-Me-4-OCF 2 H OMe 2-Me-4-OCF 2 H Br 2-Me-4-OCH 2 CF 3 2-Me-4-OCH 2 CF 3 " OMe 2-Me-4-OCH 2 CF 3 Br 2-Me-4-SCF 3 2-Me-4-SCF 3 OMe 2-Me-4-SCF 3 Br 2-Me-4-SOCF 3 2-Me-4-SOCF 3 OMe 2-Me-4-SOCF 3 Br 2-Me-4-S0 2 CF 3 2-Me-4-S0 2 CF 3 OMe 2-Me-4-S0 2 CF 3 Br 2-Me-4-SCF 2 H 2-Me-4-SCF 2 H OMe 2-Me-4-SCF 2 H Br 2-Me-4-SOCF 2 H 2-Me-4-SOCF 2 H OMe 2-Me-4-SOCF 2 H Br 2-Me-4-S0 2 CF 2 H 2-Me-4-S0 2 CF 2 H OMe 2-Me-4-S0 2 CF 2 H CF 3 2-Me-4-CF 3 N0 2 2-Me-4-CF 3 SMe 2-Me-4-CF 3 CF 3 2-Me-4-OCF 3 N0 2 2-Me-4-OCF 3 SMe 2-Me-4-OCF 3 CF 3 2-Me-4-OCF 2 H N0 2 2-Me-4-OCF 2 H SMe 2-Me-4-OCF 2 H CF 3 2-Me-4-OCH 2 CF 3 N0 2 2-Me-4-OCH 2 CF 3 SMe 2-Me-4-OCH 2 CF 3 CF 3 2-Me-4-SCF 3 N0 2 2-Me-4-SCF 3 SMe 2-Me-4-SCF 3 CF 3 2-Me-4-SOCF 3 N0 2 2-Me-4-SOCF 3 SMe 2-Me-4-SOCF 3 CF 3 2-Me-4-S0 2 CF 3 N0 2 2-Me-4-S0 2 CF 3 SMe 2-Me-4-S0 2 CF 3 CF 3 2-Me-4-SCF 2 H N0 2 2-Me-4-SCF 2 H SMe 2-Me-4-SCF 2 H CF 3 2-Me-4-S0CF 2 H N0 2 2-Me-4-SOCF 2 H SMe 2-Me-4-SOCF 2 H CF 3 2-Me-4-S0 2 CF 2 H N0 2 2-Me-4-S0 2 CF 2 H SMe 2-Me-4-S0 2 CF 2 H Table 3 R4 R 5 and or R 6 R 4 R 5 and/or R 6 R 4 R 5 and/or R 6 Me 2-CF3 Me . 3-CF3 Me 4-CF3 Me 2-OCF3 Me 3-OCF3 Me 4-OCF3 Me 2-OCF 2 H Me 3-OCF 2 H Me 4-OCF 2 H Me 2-0CF 2 CF 2 H Me 3-OCF 2 CF 2 H Me 4-OCF 2 CF 2 H Me 2-OCH 2 CF 3 Me 3-OCH 2 CF 3 Me 4-OCH 2 CF 3 Me 2-SCF3 Me 3-SCF3 Me 4-SCF3 Me 2-SOCF3 Me 3-SOCF3 Me 4-SOCF3 O TJ O O O O O O Q OCF 2 H 2-OCH 2 CF 3 OCF 2 H 3-0CH 2 CF 3 OCF 2 H 4-OCH 2 CF 3 OCF 2 H 2-SCF3 OCF 2 H 3-SCF3 OCF 2 H 4-SCF 3 OCF 2 H 2-SOCF3 OCF 2 H 3-SOCF3 OCF 2 H 4-SOCF 3 OCF 2 H 2-S0 2 CF 3 OCF 2 H 3-S0 2 CF 3 OCF 2 H 4-S0 2 CF 3 OCF 2 H 2-SCF 2 H OCF 2 H 3-SCF 2 H OCF 2 H 4-SCF 2 H OCF 2 H 2-SOCF 2 H OCF 2 H 3-S0CF 2 H OCF 2 H 4-SOCF 2 H OCF 2 H 2-S0 2 CF 2 H OCF 2 H 3-S0 2 CF 2 H OCF 2 H 4-S0 2 CF 2 H Me 2-Me-4-CF 3 F 2-Me-4-CF 3 Cl 2-Me-4-CF 3 Me 2-Me-4-OCF 3 F 2-Me-4-OCF 3 Cl 2-Me-4-0CF 3 Me 2-Me-4-OCF 2 H F 2-Me-4-OCF 2 H Cl 2-Me-4-0CF 2 H Me 2-Me-4-OCH 2 CF 3 F 2-Me-4-OCH 2 CF 3 Cl 2-Me-4-OCH 2 CF 3 Me 2-Me-4-SCF 3 F 2-Me-4-SCF 3 Cl 2-Me-4-SCF 3 Me 2-Me-4-SOCF 3 F 2-Me-4-SOCF 3 Cl 2-Me-4-S0CF 3 Me 2-Me-4-S0 2 CF 3 F 2-Me-4-S0 2 CF 3 Cl 2-Me-4-S0 2 CF 3 Me 2-Me-4-SCF 2 H F 2-Me-4-SCF 2 H Cl 2-Me-4-SCF 2 H Me 2-Me-4-SOCF 2 H F 2-Me-4-SOCF 2 H Cl 2-Me-4-S0CF 2 H Me 2-Me-4-S0 2 CF 2 H F 2-Me-4-S0 2 CF 2 H Cl 2-Me-4-S0 2 CF 2 H Br 2-Me-4-CF 3 2-Me-4-CF 3 OMe 2-Me-4-CF 3 Br 2-Me-4-0CF 3 2-Me-4-0CF 3 OMe 2-Me-4-0CF 3 Br 2-Me-4-OCF 2 H 2-Me-4-OCF 2 H OMe 2-Me-4-0CF 2 H Br 2-Me-4-OCH 2 CF 3 2-Me-4-OCH 2 CF 3 OMe 2-Me-4-OCH 2 CF 3 Br 2-Me-4-SCF 3 2-Me-4-SCF 3 OMe 2-Me-4-SCF 3 Br 2-Me-4-SOCF 3 2-Me-4-SOCF 3 OMe 2-Me-4-SOCF 3 Br 2-Me-4-S0 2 CF 3 2-Me-4-S0 2 CF 3 OMe 2-Me-4-S0 2 CF 3 Br 2-Me-4-SCF 2 H 2-Me-4-SCF 2 H OMe 2-Me-4-SCF 2 H Br 2-Me-4-SOCF 2 H 2-Me-4-SOCF 2 H OMe 2-Me-4-SOCF 2 H Br 2-Me-4-S0 2 CF 2 H 2-Me-4-S0 2 CF 2 H OMe 2-Me-4-S0 2 CF 2 H CF 3 2-Me-4-CF 3 N0 2 2-Me-4-CF 3 SMe 2-Me-4-CF 3 CF 3 2-Me-4-OCF 3 N0 2 2-Me-4-OCF 3 SMe 2-Me-4-OCF 3 CF 3 2-Me-4-OCF 2 H N0 2 2-Me-4-OCF 2 H SMe 2-Me-4-OCF 2 H CF 3 2-Me-4-OCH 2 CF 3 N0 2 2-Me-4-OCH 2 CF 3 SMe 2-Me-4-OCH 2 CF 3 CF 3 2-Me-4-SCF 3 N0 2 2-Me-4-SCF 3 SMe 2-Me-4-SCF 3 CF 3 2-Me-4-SOCF 3 N0 2 2-Me-4-SOCF 3 SMe 2-Me-4-SOCF 3 CF 3 2-Me-4-S0 2 CF 3 N0 2 2-Me-4-S0 2 CF 3 SMe 2-Me-4-S0 2 CF 3 CF 3 2-Me-4-SCF 2 H N0 2 2-Me-4-SCF 2 H SMe 2-Me-4-SCF 2 H CF 3 2-Me-4-SOCF 2 H N0 2 2-Me-4-SOCF 2 H SMe 2-Me-4-SOCF 2 H CF 3 2-Me-4-S0 2 CF 2 H N0 2 2-Me-4-S0 2 CF 2 H SMe 2-Me-4-S0 2 CF 2 H Table 4 R 4 R 5 and/or R 6 R 4 R 5 and/or R 6 R 4 R 5 and/or R 6 Me 2-CF3 Me 3-CF3 Me 4-CF3 Me 2-OCF3 Me 3-OCF3 Me 4-OCF3 Me 2-OCF 2 H Me 3-OCF 2 H Me 4-OCF 2 H Me 2-OCF 2 CF 2 H Me 3-OCF 2 CF 2 H Me 4-OCF 2 CF 2 H Me 2-OCH 2 CF 3 Me 3-OCH 2 CF 3 Me 4-OCH 2 CF 3 Me 2-SCF3 Me 3-SCF3 Me 4-SCF 3 Me 2-SOCF3 Me 3-SOCF3 Me 4-SOCF 3 Me 2-S0 2 CF 3 Me 3-S0 2 CF 3 Me 4-S0 2 CF 3 Me 2-SCF 2 H Me 3-SCF 2 H ' Me 4-SCF 2 H Me 2-SOCF 2 H Me 3-SOCF 2 H Me 4-SOCF 2 H Me 2-S0 2 CF 2 H Me 3-S0 2 CF 2 H Me 4-S0 2 CF 2 H Cl 2-CF3 Cl 3-CF3 Cl 4-CF3 Cl 2-OCF3 Cl 3-OCF3 Cl 4-OCF3 Cl 2-OCF 2 H Cl 3-OCF 2 H Cl 4-0CF 2 H Cl 2-OCF 2 CF 2 H Cl 3-OCF 2 CF 2 H Cl 4-0CF 2 CF 2 H Cl 2-OCH 2 CF 3 Cl 3-OCH 2 CF 3 Cl 4-0CH 2 CF 3 Cl 2-SCF3 Cl 3-SCF3 Cl 4-SCF3 Cl 2-SOCF3 Cl 3-SOCF3 Cl 4-SOCF3 Cl 2-S0 2 CF 3 Cl . 3-S0 2 CF 3 Cl 4-S0 2 CF 3 Cl 2-SCF 2 H Cl 3-SCF 2 H Cl 4-SCF 2 H Cl 2-SOCF 2 H Cl 3-SOCF 2 H Cl 4-SOCF 2 H Cl 2-S0 2 CF 2 H Cl 3-S0 2 CF 2 H Cl 4-S0 2 CF 2 H F 2-CF3 F 3-CF3 F 4-CF 3 F 2-OCF3 F 3-OCF3 F 4-OCF 3 F 2-OCF 2 H F 3-OCF 2 H F 4-OCF 2 H ' F , 2-OCF 2 CF 2 H F 3-OCF 2 CF 2 H F 4-OCF 2 CF 2 H F F F F F F F Br Br Br Br Br Br Br Br Br Br Br OMe OMe OMe OMe OMe OMe OMe OMe l-H TJ TJ TJ . TJ J TJ TJ TJ o o o o o o o o o o o o o o o o o o o o π o o o o o TJ o TJ o TJ o TJ o TJ o TJ o TJ o TJ o TJ T oJ oj oTJ oTJ oTJ oTJ oTj o i TJ Tj oTj oTJ oTj o*τj o o o f o to to to to t t to t to to t a a a a a a a a a a a Br 2-Me-4-OCF 2 H 2-Me-4-OCF 2 H OMe 2-Me-4-OCF 2 H Br 2-Me-4-OCH 2 CF 3 2-Me-4-OCH 2 CF 3 OMe 2-Me-4-OCH 2 CF 3 Br 2-Me-4-SCF 3 2-Me-4-SCF 3 OMe 2-Me-4-SCF 3 Br 2-Me-4-SOCF 3 2-Me-4-SOCF 3 OMe 2-Me-4-SOCF 3 Br 2-Me-4-S0 2 CF 3 2-Me-4-S0 2 CF 3 OMe 2-Me-4-S0 2 CF 3 Br 2-Me-4-SCF 2 H 2-Me-4-SCF 2 H OMe 2-Me-4-SCF 2 H Br 2-Me-4-SOCF 2 H 2-Me-4-SOCF 2 H OMe 2-Me-4-SOCF 2 H Br 2-Me-4-S0 2 CF 2 H 2-Me-4-S0 2 CF 2 H OMe 2-Me-4-S0 2 CF 2 H CF 3 2-Me-4-CF 3 N0 2 2-Me-4-CF 3 SMe 2-Me-4-CF 3 CF 3 2-Me-4-OCF 3 N0 2 2-Me-4-OCF 3 SMe 2-Me-4-0CF 3 CF 3 2-Me-4-OCF 2 H N0 2 2-Me-4-OCF 2 H SMe 2-Me-4-0CF 2 H CF 3 2-Me-4-OCH CF 3 N0 2 2-Me-4-OCH 2 CF 3 SMe 2-Me-4-0CH 2 CF 3 CF 3 2-Me-4-SCF 3 N0 2 2-Me-4-SCF 3 SMe 2-Me-4-SCF 3 CF 3 2-Me-4-SOCF 3 N0 2 2-Me-4-SOCF 3 SMe 2-Me-4-SOCF 3 CF 3 2-Me-4-S0 2 CF 3 N0 2 2-Me-4-S0 2 CF 3 SMe 2-Me-4-S0 2 CF 3 CF 3 2-Me-4-SCF 2 H N0 2 2-Me-4-SCF 2 H SMe 2-Me-4-SCF 2 H CF 3 2-Me-4-S0CF 2 H N0 2 2-Me-4-SOCF 2 H SMe 2-Me-4-SOCF 2 H CF 3 2-Me-4-S0 2 CF 2 H N0 2 2-Me-4-S0 2 CF 2 H SMe 2-Me-4-S0 2 CF 2 H Table 5 R 3 R 4 R7 W X Y z-Pr Me CF 3 . CMe N CH CH • z-Pr Cl CF 3 CMe N CH CH z ' -Pr Br CF 3 CMe N CH CH j-Pr I CF 3 CMe N CH CH /-Pr F CF 3 CMe N CH CH /-Pr H CF 3 CMe N CH CH t-Pr Et CF 3 CMe N . CH CH we t « ω to to co co co w c ω « CO CO CO t- e f= t- c s c f- Co s- f= s= t≤ e TJ TJ τj TJ TJ *τJ Tj *T3 TJ TJ TJ Ω ϋ S a T i HM ω o ^ bo nj J ω o w a J o w a Tj H Co o Sl M jn ^ M co o O O O O O O O O O O O O O O O Q O O O O O O O O O O O O Q O O O O O O O O O Q O O O Q O O Q ^ iHj ^ S-J si ^ ^ ^ ' ^ ^ sS izi ^ iz: Q O O O O Q Q Q Q O O O O O a a a a a a a a a a a a a a O3 C.J ► _, ►--, ,_, '>--/ ►_< ι_ι i-j tJ o(.J o(.J o{. J o(.J o(.J o(,J oI _ ■ oU ol, o(.J oU oI J oIJ oI. J ol J o(. J o(. J o!. J ol J oI J i-i w ► i- a: 2. Oa Oa aO aO aO Oa Oa Qa Oa Oa Oa aO aQ Qa 2Z ^ 2Z 2 2 2 > 2£ 2Z 2Z 2£ 2Z 2 O o o o o o r-Bu Br CF 3 CMe CH CH N t-Bu I CF 3 CMe CH CH N t-Bu F CF 3 CMe CH CH N t-Bu H CF 3 CMe CH CH N t-Bu Et CF 3 CMe CH CH N /-Pr Me OCF 3 CMe N ' CH CH /-Pr Cl OCF3 CMe N CH CH /-Pr Br OCF3 CMe N CH CH /-Pr I OCF3 CMe N CH CH -Pr F OCF3 CMe N CH CH /-Pr H OCF3 CMe N CH CH -Pr Et OCF3 CMe N CH CH /-Pr Me CF 3 CH N CH CH /-Pr Cl CF 3 CH N CH CH /-Pr Br CF 3 CH N CH CH /-Pr I CF 3 CH N CH CH /-Pr F CF 3 CH N CH CH -Pr H CF 3 CH N CH CH /-Pr Et CF 3 CH N CH CH /-Pr Me Cl CMe CH CH N /-Pr Cl Cl CMe CH CH N /-Pr Br Cl CMe CH CH N /-Pr I Cl CMe CH CH N -Pr F Cl CMe CH CH N /-Pr H Cl CMe CH CH N /-Pr Et Cl CMe CH CH N Table 6 \ J J? TJ TJ TJ J J 2P J TJ TJ TJ W CO CO to co co to cd ώ co to ώ co "-« >-ι •-« ! -ι (3 C C £ ^ « Ω £ ^ -» S TJ ^ Ω ^ S a ^ " S? Ω ^ 5? a τι >-< ω o O l o o o o o -o. o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o g ^ S ^ S ^ S K a a a a a a ^ S S S S ^ S S ^ ^ S ^ ^ ^ S S S ^ S S! O O O O O Q Q Q O O O O O O O Q O O O i→ i→ h ^. i→ i→ i- O O O O O a a a a a a a a a a a a a a a a a a a a a z :z; :z; :z; !z; :z: 2: a a a a a a ^ ^ ' ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ' ' ^ '^ '^ 'Z '^ ' 'Z ' Table 7 R 3 R 4 X /-Pr Me S CCF 3 CH CH /-Pr Cl S CCF 3 CH CH /-Pr Br s CCF 3 CH CH -Pr I s CCF 3 CH CH z ' -Pr F s CCF 3 CH CH /-Pr H s CCF 3 CH CH /-Pr Et s CCF 3 CH CH /-Pr Me s CCF 3 CMe CH /-Pr Cl s CCF 3 CMe CH z ' -Pr Br s CCF 3 CMe CH /-Pr I s CCF 3 CMe CH z ' -Pr F s CCF 3 CMe CH z ' -Pr H s CCF 3 CMe CH /-Pr Et s CCF 3 CMe CH t-Bu Me s CCF 3 CMe CH t-Bu Cl s CCF 3 CMe CH t-Bu Br s CCF 3 CMe CH t-Bu I s CCF 3 CMe CH t-Bu F s CCF 3 CMe CH t-Bu H s CCF 3 CMe CH t-Bu Et s CCF 3 CMe CH z-Pr Me s CCF 3 CMe •N /-Pr Cl s CCF 3 CMe N z ' -Pr Br s CCF 3 CMe N z ' -Pr I s CCF 3 CMe N z ' -Pr F s CCF 3 CMe N z ' -Pr H s CCF 3 CMe N » TJ TJ S? s Tl TJ TJ J J 5* TJ J TJ TJ TJ TJ TJ W K TJ i - S? o £ w a > fl '-< ω o § w κ ^ ι - ι 5 ) o £ w a τj ι→ ω o to a ι M ω o S g O O O O O O O oo oo oo oo co oo oo oo oo CΛ oo oo oo O O O O O O o o o o o o o o o o o O O O O O O O o o oo oo oo oo oo o o_ ^ ^ izi ^ izi z ≥l ^ ^ ^ ^ izi ^ z; ^ O o O o o Q O O o O Tl Tl j TJ TJ TJ TJ Ω Ω Ω Ω Ω Ω Ω .a .a a .a a a o a TJ to 3 τ S 5 t to t to to to t to t to t to to 0 O O O Tl TJ TJ Tj TJ 0 TJ O Q O O O O O O Q Q Q Q O Q s o o o o o o o o o o o o o o o o o o o o o o G o o o o o o o o o o o o o ^- j 1 .^ .Tl .Tl .OJ .OTj Tj .OTi .TJ .QTl .Tl .TJ .OTJ .QTl .QTJ ^ i 2' 2"^; ^ i 2; !^zl ≥^: ≥^; 2-^! 2^l a ≥i ^ zi ^ ≥j ^ ≥; *: !?: : ^ ^ ^ OJ OJ OJ J OJ OJ TJ TJ '"ϋ •TJ *i5 ^"ϋ "ϋ *τd *τ3 ^ ►*ϋ ^ *τ3 »-ø S a TJ H ω o £? a τι -→ W Ω £ w a τι I-. ω o g w TJ w o ≥j izi ≥i oo oo o oo o o o oo o o o o o o o o o o o o o o o o o ■ rj cj o ^r ol o * j oτj ^ ( o *τj o ^rj o ^rj o ^rj ocj coij orj o *τj oτj o rrj orj or oτ o rrj o rij oτj o ■ < T~J> t to 1 OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ TJ J TJ 2 2 2? TJ TJ TJ J TJ a? 5? TJ TJ -IJ TJ J J TJ J TJ OJ S S a T j M tO O ^ W iij i ^ ύ O g W tll ^ o O O O O O Q Q 0 0 0 0 0 0 0 0 O O O O O O O O O O O O Ω O O O O a a a X M a W W " C " C5 «D " CD ^CD ^CD ^D a W a'^ a^' a" ^ ^ CD CD CO CD CD CD CD 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 ' 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 P O O O O -O Q P P P P P P G O O O O O O O G Q Q G Q G G Ω O O O O O Ω & a a a a a a a ^ N CD ^CD ^CD ^CD ^ ^ & a a a a a a a ^ CD ^CD ^CD &CD. ^ & & a a a a a a a CH CH CH CH z ' -Pr Br Cl Me CH CH CH CH r-Bu Br Cl Me CH CH CH CH z ' -Pr Me Br Me CH CH CH CH t-Bu Me Br Me CH CH ' CH CH z ' -Pr Cl Br Me CH CH CH CH t-Bu Cl Br Me CH CH CH CH z'-Pr Br Br Me CH CH CH CH t-Bu Br Br Me CH CH CH CH z'-Pr Me CN Me CH CH CH CH t-Bu Me CN Me CH CH CH CH z ' -Pr Cl CN Me CH CH CH CH t-Bu Cl CN Me CH CH CH CH z ' -Pr Br CN Me CH CH CH CH . t-Bu Br CN Me CH CH CH CH z-Pr Me CF 3 F CH CH CH CH t-Bu Me CF 3 F CH CH CH CH z'-Pr Cl CF 3 F CH CH CH CH t-Bu Cl CF 3 F CH CH CH CH z'-Pr Br CF 3 F CH CH CH CH t-Bu Br CF 3 F CH CH CH CH z'-Pr Me ' Cl F CH CH CH CH t-Bu Me Cl F CH CH CH CH z ' -Pr Cl Cl F CH CH CH CH t-Bu Cl Cl F CH CH CH CH z ' -Pr Br Cl F CH CH CH CH t-Bu Br Cl F CH CH CH CH z-Pr Me Br F CH CH CH CH t-Bu Me Br F CH CH CH CH z ' -Pr Cl Br F CH CH CH CH t-Bu Cl Br F CH CH CH CH z'-Pr Br Br F CH CH CH CH t-Bu Br Br F CH CH CH CH z'-Pr Me CN F CH CH CH CH t-Bu Me CN F CH CH CH CH -Pr Cl CN F CH CH CH CH t-Bu Cl CN F CH CH CH CH z ' -Pr Br CN F CH CH CH CH t-Bu Br CN F CH CH CH CH z'-Pr Me CF 3 Cl CH CH CH CH t-Bu Me CF 3 Cl CH CH CH CH z'-Pr Cl CF 3 Cl CH CH CH CH t-Bu Cl CF 3 Cl CH CH CH CH z ' -Pr Br CF 3 Cl CH CH CH CH t-Bu Br CF 3 Cl CH CH CH CH z ' -Pr Me Cl Cl CH CH CH CH t-Bu Me Cl Cl CH CH CH CH z'-Pr Cl Cl Cl CH CH CH CH t- u Cl Cl Cl CH CH CH CH z'-Pr Br Cl Cl CH CH CH CH t-Bu Br Cl Cl CH CH CH CH z'-Pr Me Br Cl CH CH CH CH t-Bu Me Br Cl CH CH CH CH z'-Pr Cl Br Cl CH CH CH CH t-Bu Cl Br Cl CH CH CH CH z'-Pr Br Br Cl CH CH CH CH t-Bu Br Br Cl CH CH CH CH z'-Pr Me CN Cl CH CH CH CH t-Bu Me ' CN Cl CH CH CH CH z ' -Pr Cl CN Cl CH CH CH CH t-Bu Cl CN Cl CH CH CH CH z ' -Pr Br CN Cl CH CH CH CH t-Bu Br CN Cl CH CH CH CH z'-Pr Me CF 3 Br CH CH CH CH t-Bu Me CF 3 Br CH CH CH CH z'-Pr Cl CF 3 Br CH CH CH CH t-Bu Cl CF 3 Br CH CH CH CH z'-Pr Br CF 3 Br CH CH CH CH t-Bu Br CF 3 Br CH CH CH CH z'-Pr Me Cl . Br CH CH CH CH t-Bu Me Cl Br CH CH CH CH z ' -Pr Cl Cl Br CH CH CH CH - t-Bu Cl Cl Br CH CH CH CH z ' -Pr Br Cl Br ' CH CH CH CH t-Bu Br Cl Br Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω O O Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω O O O O O O O a w a w ffi ffi a a a a a a a a a a a a a a a a a a a a a a O Ω Ω Ω Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a a a a a a a a a a a a a a a ffi ffi ffi W ffi ffi hH HH HH MH o o o o o o o o o o o 2 Ωa Ωa Ωa Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω O O O O a a a a a w a K ffi K a H ffi ffi Pi Pi ffi ffi K pH H K H ffi a TJ o 3 CO TJ O 5* ω O T3 CO TJ CO TJ TJ O TJ DO J CO CO TJ CO (3 > 3-!* to TJ ω 3 c S >-* 3 CO S3 ff w S $3 t? CO TJ C S3 S .ω ω o Ω ^ g « ω o Ω g ^ » Ω g g w co o o ; g ω ^ Ω g ; ω ω Ω θ g; g Ω Ω Ω Ω Ω Ω Ω CO CO CO OO CO CO Ω Ω Ω Ω Ω O O Ω Ω Ω Ω O O Ω Q O Ω Q CO pO GO CO CO CO ω T'I Z 2 i ι 2 -^ Λ 2, .--24 2 Η '"' ^ "* * * * * -' '- , -' ^ - -' , - T JI O T JI O T JI O T JJ O T JI OJJ ^^ 2^ ^ 2^ 2^ 2^ ^ ^ ^ ^ ^ Ω Ω Ω Ω Q Q Ω Q O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω CO CO CO CO CO CO CO CO CO CO tO CO 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 "* ^ ^ ^ ^ ^ ^ '"' "* CH CH CH N t-Bu Me CF 3 ' Me CH CH CH N z ' -Pr Cl CF 3 Me CH CH CH N t-Bu Cl CF 3 Me CH CH CH N z-Pr Br CF 3 Me CH CH CH N t-Bu Br CF 3 Me CH CH CH N z'-Pr Me Cl Me CH CH CH N t-Bu Me Cl Me CH CH CH N z'-Pr Cl Cl Me CH CH CH N t-Bu Cl Cl Me CH CH CH N z-Pr Br Cl Me CH CH CH N t-Bu Br ci Me CH CH CH N z ' -Pr Me Br Me CH CH CH N t-Bu Me Br Me CH CH CH N z-Pr Cl Br Me CH CH CH N t-Bu Cl Br Me CH CH CH N /-Pr Br Br Me CH CH CH N t-Bu Br Br Me CH CH CH N z'-Pr Me CN Me CH CH CH N t-Bu " Me CN Me CH CH CH N z'-Pr Cl CN Me CH CH CH N t-Bu Cl CN Me CH CH CH N z-Pr Br CN Me CH CH CH N t-Bu Br CN Me CH CH CH N z'-Pr Me CF 3 F CH CH CH N t-Bu Me CF 3 F CH CH CH N z'-Pr Cl CF 3 F CH CH CH N t-Bu Cl CF 3 F CH CH CH N z'-Pr Br CF 3 F CH CH CH N t-Bu Br CF 3 F CH CH CH N z-Pr Me Cl F CH CH CH N t-Bu Me Cl F CH CH CH N z ' -Pr Cl Cl F CH CH CH N t-Bu Cl Cl F CH CH CH N z'-Pr Br Cl F CH CH CH N t-Bu Br Cl F CH CH CH N z'-Pr Me Br F ' CH CH CH N t-Bu Me Br F 19 CH CH CH N z-Pr Cl Br F CH CH CH N t-Bu Cl Br F CH CH CH N z ' -Pr Br Br F CH CH CH N t-Bu Br Br F CH CH CH N /-Pr Me CN F CH CH CH N t-Bu Me CN F CH CH CH N z ' -Pr Cl CN F CH CH CH N t-Bu Cl CN F CH CH CH N z ' -Pr Br CN F CH CH CH N t-Bu Br CN F CH CH CH N z ' -Pr Me CF 3 Cl CH CH CH N t-Bu Me CF 3 Cl CH CH CH N /-Pr Cl CF 3 Cl CH CH CH N t-Bu Cl CF 3 Cl CH CH CH N z'-Pr Br CF 3 Cl CH CH CH N t-Bu Br CF 3 Cl CH CH CH N z ' -Pr Me Cl Cl CH CH CH N t-Bu Me Cl Cl CH CH CH N z'-Pr Cl Cl Cl CH CH CH N t-Bu Cl Cl Cl CH CH CH N z ' -Pr Br Cl Cl CH CH CH N t-Bu Br Cl Cl CH CH CH N z ' -Pr Me Br Cl CH CH CH N t-Bu Me Br Cl CH CH CH N z ' -Pr Cl Br Cl CH CH CH N t-Bu Cl Br Cl CH CH CH N z ' -Pr Br Br Cl CH CH CH N t-Bu Br Br Cl CH CH CH N z'-Pr Me CN Cl CH CH CH N t-Bu Me CN Cl CH CH CH N z ' -Pr Cl CN Cl CH CH CH N t-Bu Cl CN Cl CH CH CH N z ' -Pr Br CN Cl CH CH CH N t-Bu Br CN Cl CH CH CH N z ' -Pr Me CF 3 Br CH CH CH N t-Bu Me CF 3 Br CH CH CH N z ' -Pr Cl CF 3 Br Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a Ωa Ωa Ωa Ωa Ωa Ωa Oa Oa Ωa aΩ aΩ Ωa Ωa Ωa aΩ aΩ Ωa Ωa Ωa Ωa Ωa Oa aO Ωa aΩ aΩ aΩ aΩ Ωa Oa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Q Ω Ω Ω Ω Ω Ω Ω Ω O Ω O Ω Ω Ω Ω Ω Ω Ω a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω g g S , Ω Ω S £ £? Ω Ω g £ Ω Ω g g Ω Ω §: g S J ^ Ω Ω g £ S ) ∞ Ω W CO CO CO O O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω tO tO CO CO CO CO O O O Ω Ω Ω Ω Ω Ω ,-, ► , -, -, „ „ ^ ^ -. ι - l - rj τj τj τi τ τj 2 2 2 2 2 "' "* ^ ^ ^ ^ i - — ,- .- ^ .--. .^ ^ ^ ≥ Ω! Ωz 2Ω zΩ Ω2 Ω Ω Ω Ω Ω2 Ω2 Ω2 2Ω 2Ω Ω Ω C"o ! w ! c"o t to ! a i w ! c k, o w"' rø" ! rø" 1 a w a td a a a co a a a CH CH CH N z ' -Pr Br Br CN CH CH CH N t-Bu Br Br CN CH CH CH N z ' -Pr Me CN CN CH CH CH N t-Bu Me CN CN CH CH CH N -Pr Cl CN CN CH CH CH N t-Bu Cl CN CN CH CH CH N z ' -Pr Br CN CN CH CH CH N t-Bu Br CN CN CH CH CH CH Me Me CF 3 F CH CH CH CH Et Me CF 3 F CH CH CH CH CH(CH 3 )CH 2 OCH 3 Me CF 3 F CH CH CH CH CH(CH 3 )CH 2 SCH 3 Me CF 3 F CH CH CH CH propargyl Me CF 3 F CH CH CH CH Me Me CF 3 Cl CH CH CH CH Et Me CF 3 Cl CH CH CH CH CH(CH 3 )CH 2 OCH 3 Me CF 3 Cl CH CH CH CH CH(CH 3 )CH 2 SCH 3 Me CF 3 Cl CH CH CH CH propargyl Me CF 3 Cl CH CH CH CH Me Me Br F CH CH CH CH Et Me Br F CH CH CH CH CH(CH 3 )CH 2 OCH 3 Me Br F CH CH CH CH CH(CH 3 )CH 2 SCH 3 Me Br F CH CH CH CH propargyl Me Br F CH CH CH CH Me Me Br Cl CH CH CH CH Et Me Br Cl CH CH CH CH CH(CH 3 )CH 2 OCH 3 Me Br Cl CH CH CH CH CH(CH 3 )CH 2 SCH 3 Me Br Cl CH CH CH CH propargyl Me Br Cl CH CH CH CH Me Cl CF 3 F CH CH CH CH Et Cl CF 3 F CH CH CH CH CH(CH 3 )CH 2 OCH 3 Cl CF 3 F CH CH CH CH CH(CH 3 )CH 2 SCH 3 Cl CF.3 F CH CH CH CH propargyl Cl CF 3 F CH CH CH CH Me Cl CF 3 Cl CH CH CH CH Et Cl CF 3 Cl CH CH CH CH CH(CH 3 )CH 2 OCH 3 Cl CF 3 Cl CH CH CH CH CH(CH 3 )CH 2 SCH 3 Cl CF 3 Cl CH CH CH CH propargyl Cl CF 3 Cl CH CH CH CH Me Cl Br F CH CH CH CH Et Cl Br F CH CH CH CH CH(CH 3 )CH 2 OCH 3 Cl Br F CH CH CH CH CH(CH 3 )CH 2 SCH 3 Cl Br F CH CH CH CH propargyl Cl Br F CH CH CH CH Me Cl Br Cl CH CH CH CH Et Cl Br Cl CH CH CH CH CH(CH 3 )CH 2 OCH 3 Cl Br Cl CH CH CH CH CH(CH 3 )CH 2 SCH 3 Cl Br Cl CH CH CH CH propargyl Cl Br Cl CH CH CH N Me Me CF 3 F CH CH CH N Et Me CF 3 F CH CH CH N CH(CH 3 )CH 2 OCH 3 Me CF 3 F CH CH CH N CH(CH 3 )CH 2 SCH 3 Me CF 3 F CH CH CH N propargyl Me CF 3 F CH CH CH N Me Me CF 3 Cl CH CH CH N Et Me CF 3 Cl CH CH CH N CH(CH 3 )CH 2 OCH 3 Me CF 3 Cl CH CH CH N CH(CH 3 )CH 2 SCH 3 Me CF 3 Cl CH CH CH N propargyl Me CF 3 Cl CH CH CH ' N Me Me Br F CH CH CH N Et Me Br F CH CH CH N CH(CH 3 )CH 2 OCH 3 Me Br F CH CH CH N CH(CH 3 )CH 2 SCH 3 Me Br F CH CH CH N propargyl Me Br F CH CH CH N Me Me Br Cl CH CH CH N Et Me Br Cl CH CH CH N CH(CH 3 )CH 2 OCH 3 Me Br Cl CH CH CH N CH(CH 3 )CH 2 SCH 3 Me Br Cl CH CH CH N propargyl Me Br Cl CH CH CH N Me Cl CF 3 F CH CH CH N Et Cl CF 3 F CH CH CH N CH(CH 3 )CH 2 OCH 3 Cl CF 3 F CH CH CH N CH(CH 3 )CH 2 SCH 3 Cl CF 3 F CH CH CH N propargyl Cl CF 3 F ' CH CH CH N Me Cl CF 3 Cl Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω a τj o a a τj Q a a a >τi a a τι ό a a a j ό B a a a a a a a a a a a 2 2 2 Ω Q O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 2 2 2 2 2 2 2 2 2 2 2 a a a a a Ω Ό τι π n J t? s TJ 2 J J J 5 J • 3 Ω o a B a s Θ TS n n — \ a a o a /* a— \ 5 Ω o Ω Ω P? O n ^ a a 2§ a a rW a a Ω Ω o n Ω IO a t a t a t a to a ιo a CΛ Ω CΛ O CΛ Ω O o a n a a π a ϋ a Cl a £ § S Ω G Ω Ω £ £ £ £ £ Ω Ω Ω Ω Ω £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ΩT TΩ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a a a a a a a a a a a a a a a a a a a a a ff ■ I ff wT wT iι'j όI iTi ffiT Ω i ffi τ) ή i a iTj a a 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a a a a a a a a a a a Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O O Ω Ω O O O O O O O O O O O O O O Ω Ω O a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 fccJ fcrJ *ϋ £ £ Ω Ω Ω £ £ £ G Ω Ω §; £ £ Ω Ω Ω £ £ £ Ω Ω Ω Ω £ £ £ S £ Ω Ω Ω Ω Ω £ £ o Ω CO CO CO CO tO O O Ω Ω Ω Ω Ω Tl Tl a a a a W W Ω Ω Ω Ω Ω Ω Ω 2 TJ Ωj ΩTl ΩTl ΩTl Ω i H - I ^ j W W W CO OJ J OJ J OJ OJ OJ OJ OJ OJ OJ OJ J £ K Ω £ W Ω £ S Ω £ W Ω £ K Ω £ W Ω £ a Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω O O O Ω Ω Ω O O O Ω O O O O O Ω O O O O O O O O O O O O O Q O O O O O O O 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc H HH pH fc fc H HH hH 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 i-l i-t -t i-t -l -l i-S ^ i-i H i-l i-l i-l i - -l i-t i-l i-t i-ϊ i-l j j j -. p -j pJ i-j j - ς j j -j j - j-. p j β j -; OO ON £ £ £ Ω Ω Ω £ £ £ Ω Ω Ω £ £ £ Ω Ω Ω £ £ £ Ω Ω Ω £ £ £ Ω Ω Ω £ £ £ Ω Ω Ω £ Ω w Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω TJ ΩT! ΩTl w | -ι a i -l a | -i | -i 'a-ι w h ι Ω w a ω o Ω Ω 2 ^ ^ ^ ^ ^ j i -, H ►, a -i a H a -j o 2 , g ≥ , Ω :z , Ω2 2 Ωτ| ΩH3 Ω'τ ) Ωτι Ω g a Ω g a Ω g a Ω g a Ω g Ω g a Q g Ω g Ω a Ω g a Ω g Ω g a Ω Ω g g g Ω Ω Ω Ω Tj TJ Tl Tl OJ OJ J OJ a a co CO £ CD Ω £CD CD CD Ω a Ω a Ωa Ga Ωa Ω a Ω a Ω a Ω a a Ω a Ω a Ω a Ω Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a a Ω Ω a a Ω Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω Ω Ω Ω Ω Ω Ω Ω O O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω S ffi ffi ffi S K ffi ffi w H W W H H H Ω a Ωa aΩ Ga Ωa Ωa aΩ a Ω a Ω a Ω a Ω a Ω Ωa a Ω Ωa Ωa Ωa Ωa Ωa Ω ^ Ω a Ω a Ω a Ω a Ga Ωa Ω a Ω a Ωa Ga Ω a Ω a Ω a Ω a Ω a Ω a Ω a ^ ^ ^ ^. ^. ^ • ^ ^ ^ ^i ^ O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O O Ω Ω O Ω Ω 2 2 2 2 2 2 2 2 2 ffi K ffi W > I j W W K > I i > ι 1 a a a a a a a a a a -ij g a3 -!j t5 aS3 -!j g a3 τ i "!j a aS3 τ-1 S $a3 3 a g CD gCD gCD gCD CgD gCD gCD CgD gCD gCD gCD O»— i Ωf— Ωi— i Ωι— Ωι—" Ωi—. Ωι— • O»— Ωι—' Ωi— Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω £ £ Ω TJ Ω TJ Ωj TΩj Ω TJ ' TΩJ TΩJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω Tj ΩJ Ω TJ TΩJ Ω TJ Ω Tj Ω TJ Ω Tj Ω Tj Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω Tj Ω TJ ΩJ Ω TJ Ω TJ Ω Tj Ω Tj Ω TJ Ω TJ ΩJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ Tj j T T T Cp a CO Ω Ω Ωss CH CH CH N t-Bu Me CF 3 F CH CH CH N Et Me CF 3 Me CH CH CH N z-Pr Me CF 3 Me CH CH CH N t-Bu Me CF 3 Me CH CH CH N Et Me CF 3 CF 3 CH CH CH N z-Pr Me CF 3 CF 3 CH CH CH N t-Bu Me CF 3 CF 3 CH CH CH N Et Me CF 3 OMe CH CH CH N z ' -Pr Me CF 3 OMe CH CH CH N t-Bu Me CF 3 OMe CH CH CH N Et Me CF 3 CN CH CH CH N /-Pr Me CF 3 CN CH CH CH N t-Bu Me CF 3 CN CH CH CH N Et Cl CF 3 Cl CH CH CH N z ' -Pr Cl CF 3 Cl CH CH CH N t-Bu Cl CF 3 Cl CH CH CH N Et Cl CF 3 Br CH CH CH N z-Pr Cl CF 3 Br CH CH CH N t-Bu Cl CF 3 Br CH CH CH N Et Cl CF 3 I CH CH CH N z ' -Pr Cl CF 3 I CH CH CH N t-Bu Cl CF 3 I CH CH CH N Et Cl CF 3 F CH CH CH N z-Pr Cl CF 3 F CH CH CH N t-Bu Cl CF 3 F CH CH CH N Et Cl CF 3 Me CH CH CH N /-Pr Cl CF 3 Me CH CH CH N t-Bu Cl CF 3 Me CH CH CH N Et Cl CF 3 CF 3 CH CH CH N z'-Pr Cl CF 3 CF 3 CH CH CH N t-Bu Cl CF 3 CF 3 CH CH CH N Et Cl CF 3 OMe CH CH CH N z'-Pr Cl CF 3 OMe CH CH CH N t-Bu Cl CF 3 OMe CH CH CH N Et Cl CF 3 CN CH CH CH N z ' -Pr Cl CF 3 CN CH CH CH N t-Bu Cl CF 3 CN CH CH N CH Et Me CF 3 Cl CH CH N CH z'-Pr Me CF 3 Cl CH CH N CH t-Bu Me CF 3 Cl CH CH N CH Et Me ' CF 3 Br CH CH N CH z'-Pr Me CF 3 Br CH CH N CH t-Bu Me CF 3 Br CH CH N CH Et Me CF 3 I CH CH N CH z-Pr Me CF 3 I CH CH N CH t-Bu Me CF 3 I CH CH N CH Et Me CF 3 F CH CH N CH z ' -Pr Me CF 3 F CH CH N CH t-Bu Me CF 3 F CH CH N CH Et Me CF 3 Me CH CH N CH /-Pr Me CF 3 Me CH CH N CH t-Bu Me CF 3 Me CH CH N CH Et Me CF 3 CF 3 CH CH N CH z'-Pr Me CF 3 CF 3 CH CH N CH t-Bu Me CF 3 CF 3 CH CH N CH Et Me CF 3 OMe CH CH N CH z'-Pr Me CF 3 OMe CH CH N CH t-Bu Me CF 3 OMe CH CH N CH Et Me CF 3 CN CH CH N CH z'-Pr Me CF 3 CN CH CH N CH t-Bu Me CF 3 CN CH CH N CH Et Cl CF 3 Cl CH CH N CH z ' -Pr Cl CF 3 Cl CH CH N CH t-Bu Cl CF 3 Cl CH CH N CH Et Cl CF 3 Br CH CH N CH /-Pr Cl CF 3 Br CH CH N CH t-Bu Cl CF 3 Br CH CH N CH Et Cl CF 3 I CH CH N CH z ' -Pr Cl CF 3 I CH CH N CH t-Bu Cl CF 3 I CH CH N CH Et Cl CF 3 F CH CH N CH z'-Pr Cl CF 3 F CH CH N CH t-Bu Cl CF 3 ' F CH CH N CH Et Cl CF 3 Me Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω O Ω O Ω Ω O O Ω fc fc fc fc fc fc fc fc fc fc fc O O O O O O O O O O O O O O O O O Q O Q O O O O O fc fc fc fc fc fc HH ifc fc pH fc fc fc K fc ffi fc fc 2 2 2 2 2 2 2 2 2 2 2 Ω a aΩ aΩ aΩ aΩ Ω a ' a a O aΩ Ωa Ωa Ωa aΩ Ωa Ωa Ωa a Ω Ωa Ωa aΩ Ωa Ωa Ωa Ωa a Ωa aΩ Ωa Ωa a Ω a Ω Ω a a Ω Ω a Ω a Ω a Ω a J a a S3 3 a a T (3 -!J a a S3 g a £ a TJ S S co a a 3 a 3 a a TJ P S3 a a J a a a O O g g g g g g g g g g g g g g g. g g g g g g g g g Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ΩJ TΩJ Ω TJ Ω TJ Ω Tj Ω Tj Ω Tj Ω Tj Ω Tj Ω Tj Ω TJ TΩj Ω Tj Ω Tj Ωj Ω Tj Ω TJ Ω TJ Ω TJ Ω Tj Ω Tj Ω Tj Ω TJ ΩJ ΩJ Ω TJ Ω TJ ΩJ Ωj O Tj O Tj Ω Tj Ω Tj Ω Tj Ω Tj Ω Tj Ω TJ O O O O o Ω Ω § § £ £ g 3 g g g H ? S ϊ Q Q Q s § § I I I S S .9 s s CH N CH CH t-Bu • Cl CF 3 Cl CH N- CH CH Et Cl CF 3 Br CH N CH CH z ' -Pr Cl CF 3 Br CH N CH CH t-Bu Cl CF 3 Br CH N CH CH Et Cl CF 3 I CH N CH CH z'-Pr Cl CF 3 I CH N CH CH t-Bu Cl CF 3 I CH N CH CH Et Cl CF 3 F CH N CH CH z ' -Pr Cl CF 3 F CH N CH CH t-Bu Cl CF 3 F CH N CH CH Et Cl CF 3 Me CH N CH CH z ' -Pr Cl CF 3 Me CH N CH CH t-Bu Cl CF 3 Me CH N CH CH Et Cl CF 3 CF 3 CH N CH CH z ' -Pr Cl CF 3 CF 3 CH N CH CH t-Bu Cl CF 3 CF 3 CH N CH CH Et Cl CF 3 OMe CH N CH CH /-Pr Cl CF 3 OMe CH N CH CH t-Bu Cl CF 3 OMe CH N CH CH Et Cl CF 3 CN CH N CH CH z ' -Pr Cl CF 3 CN CH N CH CH t-Bu Cl CF 3 CN N CH CH CH Et . Me CF 3 Cl N CH CH CH z'-Pr Me CF 3 Cl N CH CH CH t-Bu Me CF 3 Cl N CH CH CH Et Me CF 3 Br N CH CH CH z'-Pr Me CF 3 Br N CH CH CH t-Bu Me CF 3 Br N CH CH CH Et Me CF 3 I N CH CH CH Z-Pr Me CF 3 I N CH CH CH t-Bu Me CF 3 I N CH CH CH Et Me CF 3 F N CH CH CH z ' -Pr Me CF 3 F N CH CH CH t-Bu Me CF 3 F N CH CH CH Et Me CF 3 Me N CH CH CH /-Pr Me CF 3 Me N CH CH CH t-Bu Me CF 3 Me O Ω Ω Ω - a a a a 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 i- T --'ι i.ι T --'ι i---ι ΩT ΩT OT ΩT ΩT ΩT ΩT ΩT ΩT ΩT ΩT ΩT ΩT ΩT ΩT ΩT ΩT OT ΩT ΩT TO OT OT ΩT ΩT OT OT ΩT ΩT TΩ TΩ ΩT TΩ a O aO Ωa aΩ aΩ aΩ aO aO aΩ aΩ aΩ aΩ Ωa aΩ aΩ Ωa aΩ aΩ aΩ aΩ Ωa a Ω O a Ω a Ω a Ω a a Ω Ω a a Ω a Ω Ω a Ω a Ω a Ω a Ω a a Ω Ω a 2 2 2 i »→ ΩWH ΩWH ' ΩWH ΩHH ΩHH WΩH ΩWH ΩWH WΩH ΩWH ΩWH ΩWH ΩWH ΩWH WΩH Ω Ω WH OH ΩWH WH ΩH WΩH Ω WH ΩH Ω HH WΩH Ω ΩWH ΩWH ΩWH ΩWH 7- T . S a TJ a a TJ S co TJ g w B » Ξ? a 51 M 03 TJ S3 -i a CO 5 CO 5 w O J S? co a g g g g Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω g g g g g g g g g T Ω1 *Ωι] iΩι| Ω , τj TΩ] -ΩTj Ωιl Ωiτ] , Ωτ] , Ωτ] ΩT] Ωiϊ| iΩιJ TΩ| a Ω Ω Ω Ω 2Ω Ω 2 S S S S Ω ,!Ω? -^ s Tl Tj Tj l— l W 2 Ω ■ 8 * s g a a a Ω Ω Ω § ^ § ^ § ^ i m i o ' i co ω 9 "Θ ωQ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω-Ω Ω Ω Ω Ω. g g g g g g g g g g g g g g g g g g g g' O O O O O ' O O O O O O O O O O O O O O Q O O O Q O O O O O O O O O O O TJ TJ Tf TJ TJ TJ Tj Tj Tj Tj Tj i ^ Tl Tl l i ^ l j i T^ j Tl l Tl Tl Tl Tj Tj T^ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω B B B Ω B Ω Ω B Ω B B Ω Ω B B Ω B Ω ΩB ΩB GB ΩB Ω B Ω B B Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω O Ω O O O Ω Ω Ω O O Ω O O O O O O Ω Ω Ω Ω Ω O a a B K B B B B B B a ffi B B B B B B B B B B B K B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω ' Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω O O O O Ω Ω Ω Ω Ω O O O O O O O O O O O O O O O O O O O O O O 2 2 2 2 2 2 2 a 7\ V- J S a a a e ι-rJ S? a c i-iJ a a TJ a a j S ^ M B 2P B ώ 5? a TJ a a a? a a TJ S a O l fl iOfl Oifl ^O ^O 'O^ ^ OT| Q^ ^Q Ofl O^ O^ O^ ^Q ^O ^O Q" ^Q O^ O^ O >I 5 O f ι1 1 O'I OTJ Oι| OiιJ O , τJ TO| Ori iOτl iOι| Oiϊi iOfl OT1 O^ Oι] ϋ ύ g -Ii -1i ύ-Ii Ω Ω Ω Ω Ω Ω P- o 2 2 2 2 2 TJ ToJ oJ OJ OJ J C £O £G £ TJ Tj Tj i—l CD i—i a a ω Ω Ω o Ω Ω Ω o o o o CO C ■ —D ^CD 2 2 2 £ ( £ j I (I £(I O Ω O O O Ω Ω Ω O O O O Ω Ω Ω Ω Q O O O Ω Ω Ω O O O Ω O O Ω O Ω O O Ω O O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc O O O O O ' O Q O O O O O O O O O O Ω Ω Ω Ω O O Ω Ω Ω O O Ω Ω Ω 4 4 43 43 43 43 43 43 43 43 43 43 43 4 43 4 4j 43 Ω Q Ω Ω Ω TJ Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω O O Ω Ω S a S ^ a w S ώ ^ g a ^ S ώ ^ w a ^ S ^ S a ^ S 7a- v^- S Σa Tg- g a g S a S S3 i -l 3 i -ι S3 1 -! S i -1 S3 -! S3 -! (3 -f (3 -1 S -! (3 -1 S3 -1 S3 -t a Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω OJ T ΩJ Ωj Ω Ω Ω Ω TJ TJ TJ T TJ O Tj O Ω Ω Ω Tl Ω Ω Ω Ω Ω Ω Ω Ω Ω Tl Tl Tj TJ Tl Tl Tl TJ Tj Ω Ω Ω Ω 3 43 3 4 4 3 4 Tj Tj Ω Ω Ω Ω Ω Ω Ω OJ OJ OJ OJ OJ OJ OJ Tl Tl Tl Tl Tl TJ Tj J OJ OJ J OJ OJ OJ OJ Q ϊ* Ω Tj ' T ΩJ Ω Tj j j T H-i a a o o Tj J Tj i—< 1—I t? OJ OJ OJ £ g £ — 2 2 2 g* & g* OJ OJ OJ CD « a Ω Ω Ω Ω Ω Ω <^ Q Q Q O Q O O O O O O O O O O O O O O O O O O O O O O O O Ω B ΩB ΩB BΩ ΩB ΩB ΏB Ωa Ωa τΩi TΩj Ωτj Qτj Qτj τOj TΩj Qτj iOi τΩj τΩj τOj τOj Oτj τOj TOj Oτι τOι Oτj τOj τOj τOj τOj τOj τΩι τΩι τΩι τOj £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω O O Ω O O Ω Ω Ω O O Ω O O Ω Ω £ £ £ £ £ >-' ω ω ω Ω Ω 0 Ω Ω Ω Ω Ω Ω Ω Ω Tj £ £ £ TJ « » « Ω Ω Ω § § § | | Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω O O Ω Ω Ω Ω O O Ω Ω Ω Ω O O Ω Ω Ω Ω O O Ω O O O Ω B ΩB ΩI-M Ω B ΩB Ω B GB B Ω Ω B ΩB Ω B Ω B Ω B ΩB Ω B Ω B ΩB Ω B Ω B B Ω Ω B Ω B O B Ω B Ω B Ω B Ω B Ω B Ω B Ω B B Ω B Ω B O B Ω B Ω B B Ω O Q Ω O Ω O Ω Ω Ω Ω Ω Ω Ω O O Ω O O O O O O O O O O O O O O O O O Ω O Ω O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω B ΩB B Ω B Ω GB B Ω ' B Ω Ω B B Ω ΩB B Ω Ω B Ω B B Ω B Ω B Ω GB B Ω B Ω B Ω B Ω B Ω Ω B Ω B B Ω B Ω B Ω Ω B B Ω B Ω ΩB B Ω BΩ ΩB Ω B B Ω B Ω o o 7" ~- ? • S? a P T"1J g a1-3 a a a S a S3 i -lJ 5? δ(3 s 5 ύ a 7 f. a ι-d S3 -! a a J ^ ώ g S a J S a J g a g w Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ to Ω toΩ toΩ toΩ to toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ tΩ toΩ toΩ tΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ TJ TJ TJ Tj TJ TJ TJ TJ Tl Tl Tj TJ Tl J TJ TJ TJ TJ TJ TJ TJ TJ TJ Tj TJ TJ TJ TJ TJ Tj TJ Tl Tl Tl TJ TJ Tj 0n 0rt 0 lΛ 0ft t-n 0ft Ul lΛ 0Λ Uι O 0ft υι rt lΛ υι 0Λ 0rt >l 0ft lΛ 0 <-Λ 0 0h 0ft C* Cl l-Λ Ul 0rt 0h 0»l l-»> lΛ n O ' O O n o O § £ £ 333 £ £ £ Tj J !? « » G Ω Ω 9 g g £ £ Q Q ζι £ £ £ Tl TJ CH CH CH CH z'-Pr Me CF 3 CN CH CH CH CH f-Bu Me CF 3 CN CH CH CH CH Et Cl CF 3 Cl CH CH CH CH z ' -Pr Cl CF 3 Cl CH CH CH CH t-Bu Cl CF 3 Cl CH CH CH CH Et Cl CF 3 Br CH CH CH CH z ' -Pr Cl CF 3 Br CH CH CH CH t-Bu Cl CF 3 Br CH CH CH CH Et Cl CF 3 I CH CH CH CH z ' -Pr Cl CF 3 I CH CH CH CH t-Bu Cl CF 3 I CH CH CH CH Et Cl CF 3 F CH CH CH CH /-Pr Cl CF 3 F CH CH CH CH t-Bu Cl CF 3 F CH CH CH CH Et Cl CF 3 Me CH CH CH CH z ' -Pr Cl CF 3 Me CH CH CH CH t-Bu Cl CF 3 Me CH CH CH CH Et Cl CF 3 CF 3 CH CH CH CH z ' -Pr Cl CF 3 CF 3 CH CH CH CH t-Bu Cl CF 3 CF 3 CH CH CH CH Et Cl CF 3 OMe CH CH CH CH z ' -Pr Cl CF 3 OMe CH CH CH CH t-Bu Cl CF 3 OMe CH CH CH CH Et Cl CF 3 CN CH CH CH CH z ' -Pr Cl CF 3 CN CH CH CH CH t-Bu Cl CF 3 CN CH CH CH N Et Me CF 3 Cl CH CH CH N z'-Pr Me CF 3 Cl CH CH CH N t-Bu Me CF 3 Cl CH CH CH N Et Me CF 3 Br CH CH CH N z'-Pr Me CF 3 Br CH CH CH N t-Bu Me CF 3 Br CH CH CH N Et Me CF 3 I CH CH CH N z-Pr Me CF 3 I CH CH CH N t-Bu Me CF 3 I CH CH CH N Et Me CF 3 F CH CH CH N Z-Pr Me CF 3 F Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B ΩH ΩfH Ω Ω Ω WH WH HΩH Ω HH HΩH ΩHH WH OWH OWH WΩH WΩH WΩH ΩWH T T Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B a B B B B B B B B B B B B B B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 o a S P a s? a a a a 5 a a (3 5 8 a P a S a3 a a TJ a a J a a a a a (3 T1J 5 rt ? a (3 T nJ a. a Ω Ω O O O O Ω Ω Ω Ω Ω O Ω Ω Ω O O Ω O O Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω O Q -Ω Ω Ω Ω Ω Ω Q Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω TJ TJ TJ TJ TJ TJ TJ τι τι τι TJ TJ TJ TJ TJ TJ TJ TJ TJ TJ TJ TJ TJ TJ TJ TJ τ τι TJ TJ TJ TJ a a a a a OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ £ Tj TJ TJ a a a o n o Ω o o o o o Q 43 O 4 O " " £ £ £ 3 43 CO CD CD a O O Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω O O Ω O Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω . Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω B Ω B Ω B Ω B Ω B Ω B ' Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B B Ω Ω B Ω B Ω B Ω B Ω B B Ω ΩB ΩB ΩT ΩB ΩB τT ΩB ΩB ΩB ΩB B Ω B Ω GB Ω B Ω B ® $ S a a a S3 a w a S3 a B S a3 *ϊ S? a a a a $3 a 5? a 5? a £ a a a a TJ W B ^ a Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω'Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B Ω B B Ω Ω B Ω B Ω B Ω B Ω B QB ΩB Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B B Ω B Ω Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B T T T B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω I^ K IV- I^ ^ IV I-V I^ ^ ^ B B B B B B B B B B B B B B B B B B B B B B B B B B ^ ^ ^ 2 ' 2 ' 2 ' 2 ' 2 ' 2 ' 2 ' 2 ' Ω B Ω B Ω B B Ω Ω B Ω B Ω B ΩB GB ΩB ΩB Ω B ΩB Ω B ΩB Ω B Ω B Ω B O B Ω B Ω B B Ω B Ω Ω B B Ω Ω B Ω B Ω B Ω B Ω B Ω B B Ω Ω B Ω B Ω B Ω B Ω B O O £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω TJ Ω Tj Ω TJ Ω Tj Ω Tj Ω Tj Ω TJ Ω TJ TΩl Ω Tl TΩl Ω Tl Ω Tl Ω Tl Ω Tl TΩj TΩJ Ωj Ω TJ Ωj Ω TJ ΩJ Ω TJ Ω Tj Ω TJ ΩJ TΩJ TΩJ Ω TJ Ω Tj Ω TJ Ω TJ Ω TJ TΩj TΩJ TΩj Ω Tj J UJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ UJ OJ OJ OJ OJ OJ Ω Ω Ω Ω G 9 9 9 Ω Ω Ω o y y y s g u TJ J TJ T T a a ? a £ £ £ -1 a-I -I o o G g g g O Q Q § co co CD 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω B Ω B Ω B O B O B Ω B Ω B Ω B QB O B QB Ω B Ω B ΩB GB Ω B Ω B ΩB ΩB ΩB ΩB Ω B B Ω Ω B ΩB ΩB GB Ω B Ω B Ω B Ω B ΩB Ω B Ω B Ω B Ω B Ω B Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B o OS j g ώ j to ώ g a 7 7 a J a ώ a a ϊ? a S a P S a % a a- 7' S3 a 5? a S3 £ B a S3 a s a S3 S P a £ £ £ £ £ £ £ £ £ ■ £ £ £ £ £ £ o o Ω Ω Ω Ω O O Ω Ω Ω Ω O O Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω -Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Ω Ω Ω Ω Q Ω Ω Ω Q Q O Ω a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a 9 Ω ^ fe a a a a a a Ω Ω Ω 8 S S fi £ f £ £ a Ωa Ω i a £ £ £ a a a a a a o O O Ω Ω B B B B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O fc fc fc fc fc fc fc fc fc fc fc fc ffi fc fc fc fc fc fc pH o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o fc fc W fc fc fc fc fc fc fc fc fc fc fc ffi fc fc fc fc 2 2 2 2 g s O O O O Ω Ω O Ω Ω Ω Q Q O Ω O O Ω O O Ω O Ω Ω O O O O O Ω O O O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B a a ^ S a ^ S ^ a a S3 S a S Pa a a (3 a? S a a c (3σ T-IJ S a P a a T S3 5 a a S3 a £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ O TJ Q TJ Ω TJ Ω TJ Ω TJ ΩJ Ω TJ Ω TJ Ω TJ Ω TJ TΩJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ Ω TJ ΩJ Ω TJ Ω TJ Ω Ω a Ω a Ω a Ω a aΩ Ω a Ω a Ω a TΩJ Ω TJ a Ω Ω y M Ω y ^ S £ £ Q £ £ S £ Ω a aΩ t a &- &i?' &^ TJ TJ TJ t— ! I— I ~ a a w Q Ω Ω g g g g ! ! Q Ω Q ^ co £ CD CD CD CD Ω c WH Ω f fcH 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω WH ΩWH ΩHH ΩHH ΩWH ΩWH ΩWH ΩWH OWH ΩWH ΩWH ΩWH ΩWH ΩWH ΩWH OWH ΩWH ΩHrt ΩH ΩWH ΩWH ΩWH ΩWH ΩWH OHH ΩH ΩWH ΩWH O Ω WH ΩWH ΩηH ΌWH WH ΩWH WH OWH 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 S ώp g*-t H c. ϊ 1 *-*; Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ CD £ CD Ω Ω Ωa Ωa Ω Ω O Ω Ω Ω Ω Ω ° Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a Ωa a a Ωa Ωa Ωa Ωa a a a a a a a a a j Ω Tj T Ωj Ω Tj Ω a T Ω 43 43 4 3 43 3 43 43 43 Ω Ω Ω OJ OJ J OJ a a a a . Ωa . Ωa £ s? £ sr £ ?r TJ TJ TJ 1— 1 i— 1 T a a a o o 0 Ω Ω Ω Ω 9 0 θ Ω Ω - 2 2 2 £ £ £ -^ -^ -^ 1 TJ TJ a a a Ω Ω Ω Ω O . Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc B B B B 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O- O Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω B O Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω O O Ω Ω Ω O O Ω O O O O Ω Ω O Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 2 2 2 2 2 2 2 o so δ a δ a T" 7- a ^ S a ^ g ώ ^ a (3 a 7* s a 7- S3 s P 5? a a 5? a a 7* a S3 δ P a S a a w a t? a a S a P Ω Ω Ω Ω o o £ £ £ £ £ £ £ £ £ £ £. £ £ £ £ £ £ £ £ £ £ Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 43 3 43 3 3 43 4 3 43 43 43 43 3 43 3 3 4 43 4 4 43 3 3 4 43 3 43 43 4 3 43 43 a a Ω B Ω B Ω B Ω B Ω B Ω B B Ω Ω B Ω B Ω B Ω B B Ω Ω B Ω B ΩB GB GB ΩB GB GB Ω B BΩ B Ω ΩB ΩB GB ΩB B Ω Ω B B Ω Ω B Ω B B Ω B Ω Ω B Ω B Ω B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q O Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc fc fc fc fc HH fc fc B O o Ω Ω Ω Ω Ω Ω O O O 0 0 Ω Ω 43 Ω3 Ω Ω Ω Ω 0 0 0 0 0 0 0 0 0 0 0 0 0 4 43 4 43 a a a a a a a a a a a a a Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 0 Ω Ω Ω Ω Ω Ω Ω £ 7- S ap gJ S aP a 1 "^ S a C ^ 1 "* S ώP ^ 1 "! a a P ^ 1 "! S P a 1 -* W a ^"1 S a1 "! S a P 1 "! ^ P a ^ 1 -! S ώp ^f* S ^p S 1- ! - £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ωa aΩ Ωa Ωa Ωa 'Ωa Ωa aΩ Ωa Ωa Ωa Ωa Ωa Ωa aΩ Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa aΩ Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa CH CH CH CF z-Pr Me CF 3 OMe CH CH CH CF t-Bu Me CF 3 OMe CH CH CH CF Et Me CF 3 CN CH CH CH CF z ' -Pr Me CF 3 CN CH CH CH CF r-Bu Me CF 3 CN CH CH CH CF Et Cl CF 3 Cl CH CH CH CF Z-Pr Cl CF 3 Cl CH CH CH CF t-Bu Cl CF 3 Cl CH CH CH CF Et Cl CF 3 Br CH CH CH CF Z-Pr Cl CF 3 Br CH CH CH CF t-Bu Cl CF 3 Br CH CH CH CF Et Cl CF 3 I CH CH CH CF Z-Pr Cl CF 3 I CH CH CH CF t-Bu Cl CF 3 I CH CH CH CF z ' -Pr Cl CF 3 F CH CH CH CF t-Bu Cl CF 3 F CH CH CH CF Et Cl CF 3 Me CH CH CH CF Z-Pr Cl CF 3 Me CH CH CH CF t-Bu Cl CF 3 Me CH CH CH CF Et Cl CF 3 CF 3 CH CH CH CF z ' -Pr Cl CF 3 CF 3 CH CH CH CF t-Bu Cl CF 3 CF 3 CH CH CH CF Et Cl CF 3 OMe CH CH CH CF z'-Pr Cl CF 3 OMe CH CH CH CF t-Bu Cl CF 3 OMe CH CH CH CF Et Cl CF 3 CN CH CH CH CF Z-Pr Cl CF 3 CN CH CH CH CF t-Bu Cl CF 3 CN CH CH CH CH Et Me C 2 F 5 Cl CH CH • CH CH Z-Pr Me C 2 F 5 Cl CH CH CH CH t-Bu Me C 2 F 5 Cl CH CH CH CH Et Me C 2 F 5 Br CH CH CH CH z'-Pr Me C 2 F 5 Br CH CH CH CH t-Bu Me C 2 F 5 Br CH CH CH CH Et Me C 2 F 5 I CH CH CH CH z'-Pr Me C 2 F 5 I CH CH CH CH t-Bu Me C F 5 I Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O O O Ω ° Ω ^ ^ ^ O O fc fc f c f c fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc f c O WH OWH OHfH OWH OWH OWH OWH OWH WOH OWH OWH OWH ^r^ OWH W O H O WH QWH OWH O WH OWH OWH WH ^WH W^H W WH W -i T T T T T T H T T l-H I-H T I-H t-H T ^H ^ ^H ^WH ^WH ΩWH W 0 H WH WH WH W μ^ lH |H I-J ^H 1 ^WH ^WH |^ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q O O Ω Ω Ω fc f c f c f c f c fc fc fc fc fc fc fc f c fc fc fc fc fc fc fc fc fc fc fc fc fc o o o o o o'θ θ θ θ θ θ Ω Ω Ω Ω Ω o Ω Ω Ω Ω Ω ° ^ Ω Ω Ω Ω ( ^ i ^ o o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ O toO toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toO toΩ toΩ toΩ toΩ toΩ toΩ toO toO toΩ toΩ toΩ toΩ toΩ wtoO toΩ toO tO tO toΩ Tj Tj Tj a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a 9 l i i Q Q S £ £ a a a a a a o o Π Ω Ω Ω 9 9 9 Ω Ω Ω Ω ^ ^ y £ a ^ ^ £ £ £ TJ Tj TJ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω -Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω O Ω Ω O Ω Ω Ω Ω Ω Ω Ω O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B Q B O B O B O B Ω B B Ω Ω B Q B ΩB B Ω Ω B ΩB ΩB Ω B Ω B ΩB Ω B Ω B Ω B Ω B Ω B ' T ' T ' I T ' I T ' V ' I T ' I^' I^' T ' T ' Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 2 2 2 2 , 2 2 2 2 2 2 2 w ffi K > ι H tι < B B B B B B B B B B B B B B B B B B B B B £ £ £• £ £ £ £ £ £ £ £ Ω Ω Ω O Ω Ω. Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω C £D T ΩJ O TJ O TJ TΩJ O TJ -Ω TJ Q TJ Ω TJ TΩj Q Tl Ω TJ Ω Tj O Tj O TJ Q TJ O Tj Ω TJ Q TJ Ωj Ω Tj Ω Tl Ω HJ Ω Tl Ω TJ O TJ O TJ O TJ TΩJ O TJ O TJ Ω TJ Ωj Q TOJ ΩJ Ω Tl OJ a a ' τ τ τ a a Ω Ω Ω g g g g g g Q Q C £D £CD £CD a a ■ >_< a a a Ω Ω Ω § g Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O O Ω Ω O O Ω O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω O O Ω Ω Ω Ω Ω O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 p g"t tfl άpϊ tJ S p T>tJ S a (3 S a P 2 S Pa a a Sa3 a a S3 a a $ 2 $ a TJ a Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ Ω TJ Ω Tj Ω TJ Ω TJ Ω Tj 'Ω Tj TΩj Ω TJ Ω TJ Ω Tj Ωj TΩJ Ω TJ Ω Tj ΩJ Ω Tj Ω Tj Ω TJ Ω TJ Ω TJ Ω TJ Ω Tj Ωj Ω Tj Ωj Ω TJ Ω Tj Ω TJ Ω TJ Ωj ΩJ Ω TJ ΩJ Ω Tj Ω Tj Ωj O Tj Q Ω Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Q Ω Q Q Q O Ω O O O O O O O O O O Ω Ω Ω Ω O Ω o o o B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B a a a Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω *^ CD £ £ £ £ £ £ £ £ £co £ £ £ £ £ £ £ £ £ £ £ £ £ £ T ΩJ T ΩJ T ΩJ T ΩJ T ΩJ • TΩj TΩJ TΩj ΩTj Ωj 0 TJ TΩj ΩTj ΩTj 0 TJ ΩTJ ΩTj 0 J 0 TJ T 0 j T 0 J ΩJ T 0 j °j TΩJ TΩJ Ωj TΩj ΩJ Ωj Ωj TΩJ ΩTJ ΩTJ ΩJ ΩTj Ωj OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω O O O O O O Ω O B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω B B B B B B B B B B B B B K B B B B B B B B B B B B B B B B B B B B B B B ►ϋ ώ % g to j 0 a ^ S ώ iτJ S ώ % . cc % w £ώ %- £ (i ζ w Ω o £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ ■ £ £ £ £ £ £ £ O O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω -Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 0 0 0 0 0 0 0 0 0 0 0 0 0 Ω Ω Ω Ω Ω Ω 4 43 4 43 43 4 43 43 4 43 43 43 -43 43 43 4 43 43 43 43 43 43 43 43 43 43 43 43 43 Ω a a a a a a a Q Q ' s s a l l gj^.θ β B s ∞ w o o g g g g g g o Q CD CD CD θ £ £ CH N CH CH t-Bu Cl CF 3 Cl CH N CH CH Et Cl CF 3 Br CH N CH CH z ' -Pr Cl CF 3 Br CH N CH CH t-Bu Cl CF 3 Br CH N CH CH Et Cl CF 3 I CH N CH CH z'-Pr Cl CF 3 I CH N CH CH t-Bu Cl CF 3 I CH N CH CH Et Cl CF 3 F CH N CH CH z'-Pr Cl CF 3 F CH N CH CH t-Bu Cl CF 3 F CH N CH CH Et Cl CF 3 Me CH N CH CH z ' -Pr Cl CF 3 Me CH N CH CH t-Bu Cl CF 3 Me CH N CH CH Et Cl CF 3 CF 3 CH N CH CH z ' -Pr Cl CF 3 CF 3 CH N CH CH t-Bu Cl CF 3 CF 3 CH N CH CH Et Cl CF 3 OMe CH N CH CH Z-Pr Cl CF 3 OMe CH N CH CH t-Bu Cl CF 3 OMe CH N CH CH Et Cl CF 3 CN CH N CH CH Z-Pr Cl CF 3 CN CH N CH CH t-Bu Cl CF 3 CN N CH CH CH Et Me CF 3 Cl N CH CH CH z'-Pr Me CF 3 Cl N CH CH CH t-Bu Me CF 3 Cl N CH CH CH Et Me CF 3 Br N CH CH CH Z-Pr Me CF 3 Br N CH CH CH t-Bu Me CF 3 Br N CH CH CH Et Me CF 3 I N CH CH CH Z-Pr Me CF 3 I N CH CH CH t-Bu Me CF 3 I N CH CH CH Et Me CF 3 F N CH CH CH Z-Pr Me CF 3 F N CH CH CH t-Bu Me CF 3 F N CH CH CH Et Me CF 3 Me N CH CH CH Z-Pr Me CF 3 Me N CH CH CH t-Bu Me CF 3 Me ϋ t iu ω fi Qj cij aj O ! ι ,— t _- < _ ω jj ω a o o u o u y y o u o o u o o u y u y o o υ s § s s ss 3 S3 w a w a ¬ -4 Λ w pi a ω PH a ω ω * <? 3 * - pp « m f « w f? a W a w £ a w ** a S ffi fc fc fc fc fc fc fc fc ffi fc HH HM fc fc K o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o u o y o u υ o u y y y o y y y o u o y o y o υ u y y υ y y o ,^: ' '^ , ^ '^ © t~~ 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 g 3 y y Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Q Ω Ω Ω C I Ω O J Ω C I Ω Ω C I C J Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 t o Ω -Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω Ώ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a a a a a a a a a a a a a a a a a a a a a a a a a a a a a TJ TJ TJ TJ J TJ TJ TJ KΩ Ω ' T* ΩWH ΩH ΩWH ΩWH WΩH ΩWH ΩWH ΩWH ΩH WΩH WΩH ΩWH ΩH ΩfH ΩHH OWH OWH ΩWH ΩWH ΩWH WΩH ΩHW ΩWH ΩWH ΩWH Ω ΩWH OWH OWH OWH OWH WΩH WΩH ΩWH ΩWH I^ HH HM hH T H^ I^ I- T I^ I^ I^ I-M I-H lJi HM I^ HH I^ HH HlH )^ B Ω BΩ BΩ BΩ BΩ BΩ BΩ BΩ BΩ Ω O BΩ BΩ BΩ ΩB BΩ BΩ BΩ ΩB BΩ BΩ BΩ Ω BΩ BΩ BΩ ΩB BΩ BΩ BΩ O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω O O O Ω Ω Ω Ω Ω O O O O O O O O Ω O O O O O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B a B B B O O O O Ω O O O O O Ω O O O O O O O Ω O Ω O Ω O O O O O O O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω O Ω Ω Ω Ω 2 2 2 2 2 2 2 ώ fi ^ 0^ afi ζH S fi H 0 fia a^ S fia ^H 0 7. - £, 7" fi >-t 0 afi τ~J S fia a>~t a afi iHfl fi '-t fi * i t C >^ fi o o o o o £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω O O Ω Ω O Ω Ω Ω Ω Ω Ω Ω TJ Tj TJ TJ Tj Tj Tl Tj Ω Tl ΩTl QTJ OTj ΩlTj ΩTJ ΩTJ ΩTJ ΩTJ ΩTJ ΩTJ ΩTj ΩTJ ΩTJ ΩTJ ΩTj ΩTj ΩTJ a Ω Ωa Ωa aΩ Ωa aΩ Ωa Ωa Ωa Ωa Ωa Ω fc Ω ffi Ω H Ωfc Ωfc Ω fc Ωfc Ωfc Ω fc Ωfc Ωfc Ωffi Ω fc Gfc Ω fc Ωffi Ω fc Gfc Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O O O O O O O Ω Ω Ω 0 Ω 0 0 0 ^ ° ^ 0 ( ^ ^ ^ ^ 1 ^ 1 ^ 1 Q O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω O Ω O O Ω Ω Ω O Ω O O O Ω O Ω O O Q O Q Ω Q Ω ' Ω O Ω Ω O Ω Ω O O O O O O O Ω O O O Ω 4 43 4 43 43 43 4 3 Ω 4J Ω43 Ω O4 43 4Ω 4O Ω43 O4 O Ω O Ω a Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω S ω a a S r a a t fi a a -I S a £ a a P a a a 5? a P a a ω a a a a . s £ £ £ £ £ £ £ £ £ £ £ £ £ £ ■ £ £ £ £ £ O Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Q O Ω Ω Ω -Ω Ω Ω Ω Ω Q O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a 9 5? Ω TJ Ω TJ Ω TJ I I I Tj TJ TJ l a-l a -1 a l-l o Ω Ω t-5 Ω Ω y Q y Q G 9 9 9 y £ « TJ . Ω Q TJ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ( ^ Ω Ω Ω Ω Ω Ω ( ^ ^ ^ ^ ^ 1 0 ( ^ ^ 1 ( ^ ^ ϊ ^ ^ o o o o o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω s Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B Ω B ΩB ΩB QB ΩB ΩB ' ΩB ΩB ΩB Ωa Oa Oa Oa Ωa Ωa Ωa Ωa Ωa Oa aO Oa Oa Oa Oa Oa aO aO Oa Ωa Ωa Ωa Oa Oa Ωa Oa Oa Oa i ES J S? a J 5? fc a a fc a. a fc . a fc a a a a c a a a a fc , a fc S a £ £ £ £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ Ω toΩ toΩ toΩ toΩ -toΩ toΩ toΩ toΩ o o s-! o !•-! Ω Ω Ω Ω Ω Ω Ω Ω Ω TJ ΩTj ΩTJ Ωl ΩTl ΩTj ΩTJ ΩTJ ΩTj ΩTj ΩTj ΩHcj Ωj Oj Ωj ΩJ ΩTJ ? ? ? U^ <-? ? <J? LΛ 3 CΛ 3 W" W ω W~ "-° ω" tΛ>" ω~ W" > ° i" W" W W °° UJ" W" OJ~ " ω" °° " ω ω ω ω t? fir ff Ω Ω Ω S 8 S | | |55J? τ j HH τ τ τ a a o Ω Ω g Ω g Cj g Ω HfcH Ω f cWH ΩWfcH o o o o o o o q o o o o o o o o o o o o o o o o o o o o o o o o o o o o o fc fc fc HM fc fc fc fc H fc HM fc fc fc o o o o o o o o o n o ^ O Ω ^ n Ω n o ^ ( ^ Ω 0 ^ ^ ^ ^ ^ o o o Ω Ω Ω Ω Ω Ω ' Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc HH HH fc fc fc fc fc fc fc fc fc fc fc wH fc to •^ 5 a a a a a ffl e τi-ii S sci ζ-i tS Bcj τi-tJ S Bέ τ-i) S a a a a S a P a a a fi a a a a a Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω. Ω O Ω O θ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ to Ω toΩ toΩ toΩ toΩ to Ω toΩ toΩ toΩ Ωo toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ toΩ a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a G Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω O Ω O B ΩB B B ΩB ΩB ΩB Ω B Ω B Ω B Ω B Ω B Ω B ΩB Ω Ω Ω Ω O Ω Ω Ω B ΩB Ω B fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 2 2 2 2 2 2 2 2 2 2 2 Ω O O Ω O O O O Q O Ω Ω Ω Ω Q O O Ω Ω Ω Ω Ω Ω O O Ω B B B B B B B T pH B a B B a ffi B B B B B B B B 7. 7- a a a £ f 2 ® tϊ a ώ fc^ a ^ fc ^ S a a a a -I 5? a 3 a fc 3 e a a & a a a a £ £ £ £ £ £ £ £ £ £ £ Ω O Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω O £ £ Ω Ω Ω Ω Ω -Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Tj a J TJ TJ TJ TJ Tj TJ TJ TJ TJ TJ TJ TJ TJ TJ TJ TJ J Tj TJ TJ TJ TJ TJ TJ TJ TJ TJ Tj a a a a « ω Ω Ω Ω 9 Ω | | | Q Q Q £ £ £ H « a Q o § § Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc cf fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω O Ω O O Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω O θ £ £ £ £ £ £ £ £ £ £ CD C £D Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a a a a a a a a a a a a Tj a a a a a a a a a a a a a a a a Ω a a a Ωa Ωa Ωa Ωa Ωa s § § I I 133 a Ω £ £ £ a a !? ff * Ω Ω Ω § § S | | ! S u 9 . Ωa £ CD £CD a Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω ' Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Ω Ω Q O Ω Ω Ω Ω Ω Q Ω Ω O Ω Ω Ω Ω Ω Ω a g 2. 7- e a - a ai a a 5? S a a a a a fc B a 2- 7- a 31 7- I— i a a 5? - P S a P a a a a a a a ω a a Ω Ω Ω-Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £. £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ωa Ωa Ωa Ωa Ωa • Ωa Ωa Ωa Ωa Ωa Ωa aΩ Ωa Ωa Ωa aΩ aΩ Ωa aΩ aΩ aΩ aΩ aΩ aΩ aΩ aΩ aΩ aΩ aΩ aΩ Ωa aΩ aΩ aΩ Ωa Ωa Ωa TJ TJ TJ T a a a Ω Ω Ω § g § Q | | Q £ Q a Ω a Q £ £ £ TJ TJ a a a a o o o ΩB ΩB ΩB B Ω GB B Ω B Ω B Ω B Ω ΩHIH Ω B Ω B B Ω Ω B B Ω B Ω B Ω B Ω Ω B B Ω B Ω B Ω B Ω B Ω B B Ω Ω B Ω B Ω B Ω B Ω B B Ω Ω B B Ω Ω B Ω B Ω B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω n B ΩB GB GB ΩB B Ω QB B Ω B Ω B Ω 2 2 2 2 2 2 2 2 2 2 2 Ω B GB GB B Ω GB Ω B Ω B B Ω Ω B Ω B B Ω B Ω Ω B B Ω B Ω B Ω B Ω B Ω Ω B ΩB BG BΩ B Ω B Ω Ω B Ω B B Ω Ω B B Ω O B B Ω Ω B Ω B B Ω Ω B Ω B Ω B a ώ ^ S ^ S fc g ^ a a fi a 3 ώ fc ' S a a a a a a a TJ 5? a fc 5? to P Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω T ΩJ Ω TJ ΩJ TQJ ΩJ TΩJ Ω TJ TΩJ Ω Tj ΩTj ΩTj ΩTj ΩTj ΩTj ΩTj ΩTj ΩTj ΩTj Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ω a Ω a Ω a Ω Ω 9 9 9 l l i .9.8.9 § § §: ■ * S E? G Ω Ω y Ωy Ω^ S g g Ωa aΩ Ω g^ ^:? 90 . n m f O fQ M M M tI< 1XH !J;< l 2 T F U 1) σι U ffl m m a M T T fi, fi, PL, © s s s o o i >l2 &i G ft O _ζ o o o s s s H o ro m c ci m co o co co co co ci m cj cn cn cn cn cπ cn c ci c cn ci cπ c c^ co c ri cn cn ci α. UoH pon Poi Poi Poi Poi Poi Poi Poi oPi Poi Poi Pπ Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi o o o o o o o o o o o o o o o o o o o o. O O O O O , , _< — , t — --* ι > ι i i , — — , ι θ ι3j L) ω () (ij α> ) ω > ι o (ij <-> o υ υ o o o o o o o o o o o o o o o o o s S S JS ^ S ^ S ^ S ^ S S S S o o o o o o o o o o o o o o o o o υ o o o o o o o o o o o o.o o o o o o H 4H HH WH WH WH WH r^^ ^T^ H> ■( ^ WH WH WH WH f^i WH HH WH H WH WH WH WH WH WH WH HH WH WH WH WH WH WH WH o υ o o o o o o o o o o o o o o o υ o o o υ o υ o o o o o o o o o o o o o 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 g g g g g g g g g g g θ θ S θ B B B B B B B B B B B B B B B B B B B B B B i7 i7 >7 i7 i r i7 iτ i7 i7 i7 i7 i 7 - ι-7 H i7 υ o υ o o o o o o o o o o o o o o o , ^ '^ '^ '^ , ^ '^ , ^ '^ '^ '^ ^' ^ , ^ ι '^ , , ^ Ω Ω Ω Ω B B B B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 O O O O O O O Q O O O O O O O O O O O O O O O O O Q Q O O O O O O O O O O fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc 2 2 2 >V Ω HH Ω K Ω ■ ■ ■ Ω ._ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ O fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc ) £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω i Ω— Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ Ω TJ Ω Tj Ω Tl Ωj Ωj Ωj Ω TJ Ω Tj ΩJ Ω TJ ΩJ Ω Tj Ωj Ωj Ωj ΩJ Ω TJ Ω Tj Ω Tl TΩl Ωj TΩl TΩj TΩj Ω TJ Ω TJ Ω Tj ΩJ Ω TJ ΩJ ΩJ TΩJ Ω Tj Ωj TΩj TΩl Ω Tj Go oG ΩΩ ^ G^ ^G i i £ ^S G £ £ I Tl Tj Tj T - ω a co Ω Ω Ω g g g O g O g O y oJ Ω CO CD C? " ω a Ω B GB ΩB Ω B ΩB ΩB B Ω 9B GB GB ΩB ΩB GB ΩB GB ΩB ΩB ΩB B Ω B Ω S Ω B Ω B Ω ΩB B Ω Ω B B Ω B Ω BΩ Ω B Ω B Ω B B Ω B Ω BG B Ω 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 a 3 a fc a fc 3 fc Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω • Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 43 4 3 43 3 43 4 4 43 43 43 3 43 43 43 3 4 4 43 43 43 4 43 4 43 43 43 W UJ -< > L^ C L^ J J L w ^ U- ω UJ W U^ a a a a a a a a O Ω Ω Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B τ τ τ Ωτ τ Ωa O Ωτ Ω τΩ τ Ωτ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω O Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω O Ω Ω Ω O O O O Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω O Ω Ω Ω Ω O Ω O O 2 2 2 2 2 2 2 O Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj a a a a a a a a a a a a a a a a a a a a a a a a a a a OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ « « ^ Ω £ Ω 43 43 43 HH I-, G H- Ω - ^- 9 z; 2; 92; £ &, ^, ^, O9J J tJ 9J i θ7 CD - S? S? a Ω 22 § § s 11 I 5 CH CH CH CC1 Et Cl CF 3 I CH CH CH CC1 z'-Pr Cl CF 3 ϊ CH CH CH CC1 t-Bu Cl CF 3 I CH CH CH CC1 Et Cl CF 3 F CH CH CH CC1 z ' -Pr Cl CF 3 F CH CH CH CC1 t-Bu Cl CF 3 F CH CH CH CC1 Et Cl CF 3 Me CH CH CH CC1 z ' -Pr Cl CF 3 Me CH CH CH CC1 t-Bu Cl CF 3 Me CH CH CH CC1 Et Cl CF 3 CF 3 CH CH CH CC1 z ' -Pr Cl CF 3 CF 3 CH CH CH CC1 t-Bu Cl CF 3 CF 3 CH CH CH CC1 Et Cl CF 3 OMe CH CH CH CC1 z ' -Pr Cl CF 3 OMe CH CH CH CC1 t-Bu Cl CF 3 OMe CH CH CH CC1 Et Cl CF 3 CN CH CH CH CC1 z ' -Pr Cl CF 3 CN CH CH CH CC1 t-Bu Cl CF 3 CN CH CH CH CF Et Me CF 3 Cl CH CH CH CF z ' -Pr Me CF 3 Cl CH CH CH CF t-Bu Me CF 3 Cl CH CH CH CF Et Me CF 3 Br CH CH CH CF z ' -Pr Me CF 3 Br CH CH CH CF t-Bu Me CF 3 Br CH CH CH CF Et Me CF 3 I CH CH CH CF z ' -Pr Me CF 3 I CH CH CH CF t-Bu Me CF 3 I CH CH CH CF Et Me CF 3 F CH CH CH CF z-Pr Me CF 3 F CH CH CH CF t-Bu Me CF 3 F CH CH CH CF . Et Me CF 3 Me CH CH CH CF z ' -Pr Me CF 3 Me CH CH CH CF t-Bu Me CF 3 Me CH CH CH CF Et Me CF 3 CF 3 CH CH CH CF z-Pr Me . CF 3 CF 3 CH CH CH CF t-Bu Me CF 3 CF 3 CH CH CH CF Et Me CF 3 OMe O Q Q O O O O O O O O O O O O O O O Ω f c fc fc fc fc fc fc f c fc fc fc K f c fc fc fc fc fc Ω O Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω O Ω O B B B B B B B B B B B B B B B B B B B Ω Q Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω HH HH HH T HH I^ HH HH HH HIH HH HH HH T HH HIH HH I^ HH HH T I^ HH T Ω B BΩ ΩB ΩB ΩB ΩB ΩB ΩB ΩB Ωa Ωa Ωa Ωa Oa Ωa Ωa Ωa Qa Ωa Oa Ωa Ωa Ωa Ωa Oa Oa Oa Oa Ωa Oa Oa Oa Oa Oa Oa Ωa Ωa fi a t? 3 a fc a a a 3 ό? a a a fc 3 a 3 " ap % i -l £ CD £CD £CD £CD £CD £CD £CD £CD £CD Oi—t Ω— Ωf- Ωf— Ωi—i Ωf-i Ωπ— ΩH-. Ω Ω Ω Ω Ω -Ω Ω Ω Ω n o to to to to to to to to to U W Tj Tj Tj j Tj Tj Ti Ti . . Ωa Ωa aΩ Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa aΩ Ωa Ωa Ωa on on on on on on on on on « ** δΉ? «-I Ω— Ωi— i Ωn-. 9Z; 9Z; 9Z; |&, ^£ £P», 0 9 J -' 9 J - , 9 J ' !D £co £CD a « « ^ Ω Ω Ω § § § £ CD £CD Ω fc Ωfc Ofc Qfc Ofc Ωfc Ofc Ofc Ofc Ofc Ofc Ofc Ofc Qfc Ofc Ωfc Ofc Ωfc Ofc Ωfc Ωfc Ωfc Ωfc Ωfc Ωfc Ωfc Qfc Ofc Ofc Ωfc Ofc Ωfc Ofc Ωfc Ofc Ofc Ofc Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B a B B B a a B a a a a B B B B B a a a a B B B a B a B a B B B B a B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B Ω B ΩB ΩB Ω B Ω B Ω B Ω B Ω B B B O Ω B Ω B O Ω O O O O O Ω Ω O O O O O O Ω O Ω O Ω Ω O O O O Ω Ω Ω O Ω O Ω O O O O O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B 3 a a a a a a 3 fc i i a 3 fc i| 3 C a fc s a a 5 P a " a a 5? P *wj w ώP fc" P fc *-t 5? a a Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω O Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to o an oan oan oan oai oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan O an o an o an o an o an ai o an o an o an o an o an o TnJ o TnJ o TnJ O TnJ o TnJ 2 9 £ g £ g £ Ω a Ω a Ω a £ £ £ J J a 5* 5 s Ω Ω Ω 2 G G 29 iS Si &i 9 9a .9 £ £ £ TJ j a en oPi O O O O O O O O O O S S u o o o o o o o o o o o o o o o o o o o o o o o P-t 4 s fi S3 « J 3 $ « w a .i-i i" 1 ^ . , JH 3 3 ._. .. 3 δ 5 ffl (2 U f? w 5 ffl δ 5 t? S a a f a w i p p s f p ? a f o e B B B B B B B B B B B B B B B B B B B B B B B B B B i7 i7'' i7 i7 >7 i7 i7 i7 v- i7 ' θ υ θ O O O O O O O O O O O O O O O O O O O O O O ' £< ^ , , ^ ' ώ , ^' ^' , ^' '^ , ' i ' , ^ , ' ,i ' u u α u o u u o u u α o u u o α o o u o u u u u u o u u u o o o o cj u fc fc fc fc fc fc f c f c fc fc f c fc f c f c f c f c f c f c f c fc f c f c f c f c f c f c f c f c f c fc fc o o o υ υ o υ o υ o o o o o o υ o o υ υ o υ o o o o o υ o o υ υ υ o υ o υ © t- fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc u o α o u o u o u u u u o u u u u o u u u u α α o u u u u o α α o u o u o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω cf fc fc fc fc fc fc fc cf fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc O O O O O O O O Q Q O O O O Q O O Q O Q O O Q O O O O O O O O O O O O O O fc fc fc fc fc ffi fc fc fc fc ffi fc ffi fc fc fc fc fc fc fc 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 -1 -i -i Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω-Ω Ω Ω Ω Ω. Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ a Ω Ωa Ωa Ωa Ωa Ώa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ω 2 Ω 2 ' Ω 2 9 £ 9 £ 9 £ -Ω^ • -Ω^ -G^ £- £- £^ a a « » » 9 Ω Ω 9 2 92 92 | £ I 1 £ .9 9 .9 | a CH CH N CH Et Me CF 3 Cl CH CH N CH z ' -Pr Me CF 3 Cl CH CH N CH t-Bu Me CF 3 Cl CH CH N CH Et Me CF 3 Br CH CH N CH z ' -Pr Me CF 3 Br CH CH N CH t-Bu Me CF 3 Br CH CH N CH Et Me CF 3 I CH CH N CH z ' -Pr Me CF 3 I CH CH N CH t-Bu Me CF 3 I CH CH N CH Et Me CF 3 F CH CH N CH z'-Pr Me CF 3 F CH CH N CH t-Bu Me CF 3 F CH CH N CH Et Me CF 3 Me CH CH N CH z'-Pr Me CF 3 Me CH CH N CH t-Bu Me CF 3 Me CH CH N CH Et Me CF 3 CF 3 CH CH N CH z'-Pr Me CF 3 CF 3 CH CH N CH t-Bu Me CF 3 CF 3 CH CH N CH Et Me CF 3 OMe CH CH N CH z ' -Pr Me CF 3 OMe CH CH N CH t-Bu Me CF 3 OMe CH CH N CH Et Me CF 3 CN CH CH N CH z ' -Pr Me CF 3 CN CH CH N CH t-Bu Me CF 3 CN CH CH N CH Et Cl CF 3 Cl CH CH N CH z'-Pr Cl CF 3 Cl CH CH N CH t-Bu Cl CF 3 Cl CH CH N CH Et Cl CF 3 Br CH CH N CH z'-Pr Cl CF 3 Br CH CH N CH t-Bu Cl CF 3 Br CH CH N CH . Et Cl CF 3 I CH CH N CH z-Pr Cl CF 3 I CH CH N CH t-Bu Cl CF 3 I CH CH N CH . Et Cl CF 3 F CH CH N CH z'-Pr Cl CF 3 F CH CH N CH t-Bu Cl CF 3 ' F CH CH N CH Et Cl CF 3 Me Ω B Ω B Ω B Ω B B Ω B Ω B Ω Ω B BΩ Ω B B Ω B Ω B Ω Ω B Ω B Ω B Ω B Ω B Ω B Ω B GB Ω B ΩB ΩB Ω B Ω B ΩB Ω B Ω B ΩB Ω B Ω B Ω B Ω B Ω B Ω B Ω B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ωto Ωι.j Ω Ki Ot.j Ωu Ωu Qy Ωij ΩIJ Ωcj Ω Ω Ωu Ωu Ω κι Ωu Ou Ou Ωι. Ωu Ωu uΩ Ωu uΩ Ωu ΩCJ B B B B B B B B B B B B B B B B B B B B B B B B B B 2 2 2 2 2 2 2 2 2 2 2 Ω B Ω B Ω B O B Ω B Ω B Ω B ΩB Ω B Ω B Ω B Ω B Ω B Ω B ΩB Ω B Ω B Ω B Ω B Ω B GB Ω B ΩB Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B Ω B J- a 3 3 a » a 3 fc -I ES a 3 fc a -I 3 a a a 3 a 3 a a 3 ^ a 3 a 2 a 3 3a | τ-1J 3 3a H_J . a τJ a T * * c ι -ι 3 a Ω Ω £. £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω O Ω Ω Ω O Ω Ω o o O TJj o OTJj OTJj OTo Jj o Oa • o J OaJ Oao o J OaJ OaJ Oao J OaJ Oao o J OaJ O a o J O aJ O aJ O a o J O aJ O ao J O ao Q J O a θ J O aJ O a Ω Ω J O a Ω J O aJ O aJ O a n J Oa Ω J Oa Ωa 0 J OJ Oa ( ^ ^ ^ ( ^ J OaJ OaJ OaJ OaJ OaJ OaJ Ω Ω ' Ω Q Q | g Q Q Q £ £ £ TJ TJ TJ T o a ω o o o '^ '^ -^ ^H ^ - CO CD c 2 o2 9H H > 9 H ?; τj j g^ ^ S ^ ^ CD' S CD' CD' J OJ OJ CD 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ki ΩJ Ω ii Ou ΩIJ O Ω Ω(j Ωc J Ω(.J Ωιj Ω(.J Ωcj Ω(j Ωtj Ωtj Ω[j ΩI J Ou Ωι j Ωu Ωu B B B B B B B B B B B B B B B B B B B B B B W ΩH WΩH Ω WH WΩH Ωγ WΩH WΩH HΩH HΩH WΩH Ω WH 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω O O O Ω Ω Ω Ω Ω Ω O B B B B B B B B B B B B B B B B B B B B B B B B B B B B fc O fcΩ Ofc fcO fcO fcO fc fc fcO Ω Ω Ω Ω Ω Ω ' Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω- Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B a a a a a B B ^ a 3 £ £ £ £ £ £ -£ £ £ £ £ £ £ £ £ Ω Ω. Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ωa Ωa Ωa Ωa O 'O Ω Ω OaJ OaJ Oa Ω Ω Ω Ω O Ω Ω Q Ω Ω Ω Ω Ω Ω Ωa Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω OJ OJ OJ OJ J OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ OaJ £ j Tj T T HH Ω Ω CD £ CD £ CD a g g g g 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω θ o o o o o Ω ^ Ω Ω Ω Ω Ω Ω Ω Ω 0 Ω Ω Ω Ω Ω 0 ° o o o o o o o 2 2 2 2 Ω Ω ' Ω Ω Ω O O Q O Q Ω Ω O O Q O O O Ω Ω Q Ω Ω O O O O O Q O O O O B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B 3 a J? to g, SJ 3 a 3 Pa a 3a fc 3 a fc 3 co a £ CD £ CO £ CD £ CD Ω ' — ' iΩ— Ω i— iΩ — i Ω— ' iΩ — i iΩ — . »Ω— iΩ — ι Ω — ι iΩ— . iΩ— . ι iΩ — 1 1Ω— iΩ > Ω ^-. —O . ιO — ι Ωκ— iΩ — i iΩ — i Ωi i iΩ — i ιΩ— • C£D £ CD C£D C£D £ CD £ CD C£D C£D C£D Ωa Ωa Ωa Ωa Ωa • Ωa Ωa Ωa Ωa Ωa aΩ aΩ Ωa aΩ aΩ aΩ aΩ aΩ aΩ aΩ Ωa aΩ Qa aΩ aΩ Ωa aΩ Ωa Ωa aΩ aΩ aΩ aΩ aΩ aΩ aΩ Ωa a Ω Ω Q y G^ G^ 9£ 9£ 9£ Ωa ^ Ω ^ £ CD £ CD £ 43 43 4 CD <* w « Ω Ω Ω £ g § £ Ωa ^ ^ ^ CD £CD £CD "9 "9 fc Ωfc Ωfc Ofc Ofc Ofc Ωfc Qfc Ωfc Ωfc Ωfc Ωfc Ofc Ωfc fcO Ofc Ωfc Ofc Ofc Ofc Ωfc Ofc Ofc Ofc Ωfc Ofc Ofc Ofc Ofc Ofc Ofc Ofc Ofc fcO Ofc Ofc Ωfc 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 ώ a a 3 fc " 3 a$3 fc * a a 3 fc 3 a 3 Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω TJ Ω TJ Ω TJ O TJ ΩJ ΩJ Ω τι Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a aΩ Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω a Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B Ω BΩ BΩ BΩ ΩB ΩB BΩ ΩB BΩ BΩ BΩ BΩ BΩ ΩB ΩB BΩ BΩ BΩ BΩ ΩB BΩ BΩ BΩ BΩ ΩB ΩB B Ω B Ω B Ω BΩ 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω OΩ ΩΩ ΩΩ Ω ΩΩ ΩΩ OΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ Ω OΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ΩΩ ^2 i2- ^2 ^2 i2- 2 2 Ω Ω O Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Oa Ωa aΩ Ωa Ωa Ωa Ωa Ωa Ωa Oa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa aΩ Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa Ωa aΩ aO aΩ Ωa aΩ aΩ « « » Ω Ω 9 9 9 l i i . 9> . 93 U . 9J £ CD £ CD £ CD a a a a n Ω Ω g g g | | | Q o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o fc ffi fc fc fc fc fc fc fc fc fc fc fc fc fc HH fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc Ω Ω Ω Ω fc fc fc Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc Ω Ω Ω Ω Ω Ω O Ω O O O Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω O p Ω Ω Ω Ω Ω Ω Ω Ω Ω p o Tj Tj Tj Tj Tj Ti a a a a a a a a a a a a a Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω O Ω O Ω o Ω a a a a a a 3 a 3 a fc 3 a fc 3 a a 3 3 CO 43 3 CO g a ^ w a ^ t 3 £ 3 a 3 a 3 a 3 a a ^ g 3 I I £ £ £ £ £ £ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω T Ωj ΩTj ΩTj ΩTj ΩTj Ωj ΩTJ ΩTJ ΩJ Ωj Ωj ΩTj Ωj ΩTj OTj ΩTj OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ 0 Ω Ω Ω Ω Ω Ω Ω Ω 0 Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω B Ω Ω Ω Ω Ω Ω Ω B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Π Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc HH fc fc fc fc fc fc fc fc pH pH o o o o n n o n o Q O O o Q n n o o n o o a o n o n n o a n i O Ci O HH I^ HH HH T T T HH HH T HH H HH HH HH I^ HH HH HH HH HH HH HH HH Ω B ΩB ΩB ΩB ΩB ΩB ΩB ΩB ΩB Ωa Oa Oa Ωa Ωa Ωa Ωa Ωa Oa aΩ Ωa Ωa Oa aΩ Ωa Oa Oa Oa aΩ aΩ aO Ωa Oa Oa Oa Ωa Ωa a Ω 3 a a 3 a 3 P a fc 3 a a 3 a fc 3 a ^ 3 P ώ a 3 P a a a a 3 a a a 3 a a 3 a a 3 a 3 a £ £ £ £ £ £ £ £ £ o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ t Ω ι % t oni % on on « S? « Ω G Ω g g O O O O Ω Ω I I-" «*J O aJ £ £ £ a a a Ω Ω Ω g g g O o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o fc fc fc fc fc fc fc fc fc fc fc to fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc Ω fc ΩH Ωfc Ωfc Ωfc Ωfc ' Ωfc Ωfc Ωfc Ωffi fc Ωfc Ωfc fc fcΩ fc Ωffi Ω Ω 0 5 a P fc ™ 3 a P fc ' 3 a fc " a a 3 3 -I a P fc "t 3 a 3 a a 3 a a a a 3 a a s 5? a a 3 a fc a a a 3 fc 3 s? Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω O Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω to to to to io to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to TJ .TJ TJ ι i Ti TJ TJ TJ TJ on on on on on n on onj TJ TJ TJ on on on on on on oτn oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan oan n O ' O o ^ § £ £ £ 4 y1 4 M1 4 a1 ^^ *^ *^ Tj Tj Tj HH a a a o Ω o o β 8 S . K π S S S ϊ H « i " u a u o 90 en en en C5 ώj ώ, σι g g o o o m m rø <> Pi Pi S S S Pi Pi Pi 2 § S 2 2 2 F o o o g s G 0 O o υ o m a w Pi Pi H O en en cn m cn en en en en en en en en en en en en en en en en en en en en en en en en en en en en en en en en α. Pπ Pi Pi Pi Pi Pi Pi pH pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi lii Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi υ o o o o o o ϋ o υ o o υ o o o o o o o o o o o o o o υ o o o o o o o o υ -— --( —-. O O O O O O O O O ^ ^ o o o o o o o o o o o o o o -o o υ o o o o B B B B B B B B B B B B B B B B B B B B B B B B B B π 7 ' H ? - i7- i7 H 7 - i7 i7 i7 i7 h 7 - i7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 '^ ^ < '^ '^ ^ , , ^ '^ '^ '^ '^ '^ o υ υ o o o o o o o o o υ o o o o o o o υ o o o o o o o o o o o o o o o o fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc υ υ o υ υ o υ υ o o o υ o o o o o υ o o υ o o o o o o o o o o ϋ o o o o υ fc HH HH HH fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc u α u α α α α o o Q o u o o o α u o o o u o o u u o o u α u u o o o o O Q O O O O Q O O O O O O O O Q O O O O O O fΩ HH fc fc fc fc fc fc fc fc fc fc fc fc s fc Ω fcΩ Ofc c fcΩ Ofc fcO Ωfc Ωfc fcO fcO fcΩ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω HM HH HH fc pH fc HH fc HH fc fc HH HH O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O fc fc fc fc fc fc fc fc fc fc fc fc fc fc 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 a a 3 ώ §J 3 ώ a 3 a a 3 a 3 a a 3 a 3 ώ 3 a 3 fc1-1 3 a 3 a 3 a P a a a a 3 a 3 fc 3 a Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ a Ω Ω a aΩ aΩ Ωa Ωa Ω Ω Ωa Ωa Ωa Ωa Ωa aΩ Ωa Ωa Ω Ω Ω Ω Ω Ω Ω Ω Ω J OJ OJ OJ OJ OaJ OJ OJ OJ OJ OJ OJ OJ OJ Oa Ω J OaJ Oa Ω J OaJ OaJ OaJ OaJ OaJ O a Ω J O τJι Ω OτJι Oa Ω Ω Ω J OaJ OaJ OaJ Oa Ω J Oa Ω J Oa Ω J Oa Ω OJ OJ O a J Oa Ω J OaJ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω G Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc Ωfc Ωfc Ωfc fcΩ Ωfc fcΩ Ωfc fcΩ Ωfc fcΩ fcΩ fcΩ fcΩ fcΩ fcΩ fcΩ Ωfc fcΩ fcΩ fcΩ fcΩ fcO fcΩ fcΩ Ωfc fcΩ fcΩ fcΩ fcΩ Ωfc fcΩ Ω Ω Ω Ω 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Ω Ω fc Ωfc Ωfc Ωfc Ωfc fcΩ Ωfc Ofc Ωfc Ωfc Ωfc Ωfc Ωfc o o o o o o o o o o o o o o o o o o o o o o o f Ω- Ωι— )Ω—. »Ω_— Ω»-— Ωf- fΩ— fΩ— Ωf— Ω— >Ω_— fΩ- iΩ—i £^j £^ £^, ^£j £CD C£D C£D £CD C£D £CD C£D £CD C£D C£D C£D C£D C£D C£D £CD C£D C£D C£D C£D C£D Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω a a a j Tj j J j Tj J J TJ j a a a a a a a a a Tj Tj Tj Tj Tj TJ Tj TJ Tj Tj OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ Tj Tj Tj HH HH - « -1 s i -i a 1 -1 o— Ω — Ω 1 — Ω 2; Ω2; Ωz; |&. |&. |g« ω 9 O 9 J J 9> J £cD £ co £D a a a ω ω $ Ω Ω Ω π en cn oPi oPi , o—« ,o—. ,o—, ,o—. -o-_, _o- _o( _o< _o, ,o—, _- O £O ^ ;§ O £O §O O £ §O £O ;Og ;gO O O SO SO O SO §O ;Og ;O! υH foH o o o o o o o o o o o o o o o o o υ o o o o υ o o o o o o o o o o o o o o i^ ^ ^ ^ Λ ^ i^ i^ i^ ^ ^ Q Q tJ ζJ Q Q j t Q j ζj Q j Q Q Q tj j δ δ δ δ δ δ δ δ δ δ δ 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 © o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o fc Pi Pi g ω <u g ω S S S o o o o o o o 0 § o o o fi fi fi en en cn en en en en en en en cn en en en en en en en en en en en en en en en en Pi Pi f-H fiH fc Pi Pi Pi Pi Pi Pπ Pi Pi Pi Pi f-H pi Pi Pi Pi Pi Pi Pi Pi Pi Pi Pi υ υ o o o o o υ o o O O O O O O O O O O O O. O O O O O o o o o υ o o o o o o o o o o o o o o o -o υ ^ s ^ ^ ^ s ^ ^ ^ ^ ^ S ^ S S fc fc fc fc fc fc fc fc f c f c f c f c f c f c f c f c f c f c f c f c fc fc f c fc fc fc fc fc fc o u u α u o o o u o o o α u α o o o o u u α o o o o u u α.o α u u o o fc fc fc fc f c fc fc f c f c f c f c f c f c f c f c f c f c f c f c f c f c f c f c f c f c fc fc fc fc fc fc o υ o o υ o υ υ o o o o o o o o o o o o o o o o o o o o o o o o o o o o o 22 22222 22 222 222 2222222 δ δ δ δ θ θ B S δ S S θ S S S B B B B B B B B B B B B B B B B B B B B B B ι 7 i7 i7 i7 i7 ' - i7 i7 ^ i7 i7 5r i7 r i7 0 0 O O O O 0 0 O 0 0 0 0 , ^' ' z ' ,^; ' <i| ' ,!:, ^ , ' <ζ '^ '^ '^ ^' '^' ' ; '^ , , ω ω OJ co en en W H H 7 7 5r „ H H ι_ en cn en en en en en en en en en en en en en en ,en en _cn en en α. o pH υpi υPi Poi Poi oPi υPi oPi υPi oPi Poi Poi Poi Poi Poi foi, oPi of-H poi Poi Pυi Pυi Poi Pυi Pυi Pυi Poi Pυi oPi oi ho υ o υ o o o S ; ;£ :§ ;i ;s ;i ;i ;i o o o o o o o o o o o o o o o o o o o o o o o o ;i ; ;i ;§ 3 3 3 w Pi w « w Pi a w a 3. w -W "~ J. a ø ^ « δ ^ ^ 3 3 « £ * « w a W & PQ W 4 s fc fc fc fc fc fc fc fc fc W fc fc fc fc fc fco ffiu ufc ofc woP fcu fcu fco fco fco fcu ofc fco fco fco oK o o o o o o o u o u o u u o o u u u o o o O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O ^ ^ ^ 1 ^ 222222222 222222222222222222222222 § S o o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 O W fcH OWfcH ΩWfcH ΩWfcH ΩWfcH OWfcH ΩWfcH QfcH QWfcH ΩWfcH QWfcH OWfcH QWfcH OWfcH WOfcH QWfcH QWfcH OWfcH QWfcH QWfcH ΩWfcH ΩWfc* ΩWfcH OWfcH OHfc OWfcH OWfcH O rfc ' l'* OWfcH OWfcH OWfcH O HfcH 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 fc 3 ώ fc 3 co fc 3 2a "fc! •• 3 a fc a a a a 7 a. fc f 3 a fc 3 a fc 3 fc 3 a fc w a 21 fc v- 3 -i " ■ 3 -i fi >-l fi >* fi >-l fi >-l fi *l fi l-l 3 a fc Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω O O Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ a Ω aΩ aΩ aΩ aΩ Ωa aΩ aΩ aΩ aΩ aΩ Ωa Ωa aΩ aΩ aΩ aΩ Ωa aΩ aΩ aΩ aΩ aO Ωa Ωa aΩ Ωa Ω Tj Ωj ΩTJ ΩTJ ΩTJ ΩJ ΩTj Ωj ΩTJ ΩTj OJ OJ OJ OJ OJ OJ OJ OJ OJ OJ 9a 9 £ £ £ T] Tj TJ HH !-H a a o o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω HH HH HH HH HH ^ J^ HH HH HH HM Λ HH HH I^ HH I-H HH HH ^ HH H Ω Ω Ω Ω Ω Ω Ω O Ω O Ω Ω Ω O Q Ω Ω O Ω Ω Ω Ω O Ω O Ω O O O Ω fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc 2 2 2 2 2 2 2 Ω Ω Ω Ω Ω Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O O Ω Ω O O Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω Ω Ω Ω 2 2 2 2 2 2 2 a 3 f 3 a r 3 a 21 7- -t a -. T- c 3 a 3 3 a fc 3 a 2 3 ^ 3 a fc 3 a fc fc 3 a £ a 3 a fc 3 3 a a 3 3 a Ω Ω Ω Ω Ω Ω £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω Ω Ω Ω Ω O Tj Ω Tj Qj Oj Ωj ' Ωj Ω TJ TΩj TΩ TΩ TO TΩJ TΩJ Ωj Ω TJ TΩJ TΩJ Ω TJ TΩJ Ω TJ Q TJ τΩ TΩJ TΩJ TΩJ TΩJ TΩj TΩj TΩj TΩJ Ωj ΩJ Ω TJ Ω τ Ω TJ Ω ΩJ a a a Ω Ω Ω Ω - 92 2y 92 £ . l &, i & 9 1 9 J 1 OJ J , £ co £ £ a a a a w o o o g g g g g o o a CD CD CD Ω Ω Ω Ω Ω Ω Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc fc fc fc f c f c f c o o o o o o o Ω ^ ^ o Ω ° 0 Ω ^ ( ^ Ω Ω Ω , ^ Ω ( ^ ( ^ o o o o f c fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc o o fc ofc ofc ofc ofc ofc fc fc fc Ωfc Ωfc fc fc ^fc °fc Ωfc Ωfc 0 fc fc Ωfc n fc o fc fc fc o fc fc o fc ^fc ^fc ^fc ^ f c ^ f c fc ofc o o n o o Ω Ω Ω Ω n o o o o o o o o o Q o o o n o o o O Ω O O O O O a a a a a a a a a a a a a a a a a a a o Ω Ω o o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω 3 co fc 3 a 3 3 ώ a ι a-1 3 "* 3 a 3 P a a a ω a a a TJ 3 n a a 3 fc 3 a fc 3 a 3 fc 3 a fc 3 rt a 3 a £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ £ Ω Ω Ω • Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ■ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ^ Ω Q Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O Ω a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a TJ TJ 9 g TJ Ω Tj Ω TJ £ £ £ T J T J a a a a Ω Ω Ω Q Q Ω 8 8 8 Ω Ω Ω 2 2 2 £ £ £ ,:? .? a £ £ £ Ω B B Ω QB ΩB Ω B ΩB ΩB ΩB ΩB ΩB QB Ω B Ω B Ω B ΩB ΩB ΩB O B Ω B ΩB O B Ω B B Ω Ω B B Ω B Ω Ω B Ω B GB Ω B ΩB B Ω B Ω Ω B Ω B Ω B O O Ω Q O Ω Ω Ω Ω Ω O Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω fc fc fc fc fc fc fc fc fc fc fc fc fc fc ffi fH fc fc K fc fc fc fc pH HH fc fc fc HH W fc fc fc fc fc fc Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O Ω Ω Ω Ω a a a a Ω B a a a a o B B B B B B B B a a a o o o a o a o o a a Ω a o a Ω a π a a a Ω a o a o a o a Ω a o a £ CD £CD £CD £CD £CD £CD £CD £CD £CD Ω Ω Ω Ωi Ωf— Ωι—* Ωf— Ωi—. Ωf- Ωf- Ω_— Ωf— Ω,— Ω Ωt_- Ω»— Ω_i Ω- Ωf— Ω Ω>—i Ω— Ωf- £^ £^ £^ £^ £^ ι ^ t ^o t ^o^ t ^^ t o τ^ι t Ω τ ι t o a 3 t a Ω t o τ 1 .Ωa .Ωa .Ωa .Ωa .Ωa Ω Ω n on on on on on OΛ Cn on OJ OJ OJ OJ J .Ω Ω Ω OaJ O .aJ .aJ O .ΩaJ .OaJ O .aΩ J .Oa Ω Ω Ω J O .aJ O .aJ O .aΩ J O .aJ O .aΩ J O .aΩ J O .aΩ J . OaQ J .OaJ .OaO J .aJ .OaJ .ΩaJ .ΩaJ .aJ . Oa o J a a a o Ω o Ωc j Ω ( ^ Ω S S 9 Ω Ω £ £ £ Tj Tj HH HH HH a a Q G g g g g o S S S ^ ^ ^ ^ ^ ^ ^ S ϊS ^ ^ o o o o o o o o « fi 3 3 fc. 3 fi 3 3 3 P^ J? ^ f w c S in P f H aQ S ri P aH C aQ w C aQ w ffi C CQQ f pfiq PH P PQQ m W P %H m *? r wTl 5 PH α«a w trJ PSH CQ H S 5; t q a ϊ « w 3 o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o u u u o o u o o o o o o o u o o o o o o o o o o u o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o t~~ © t~~ Bo Bo Bo Bo Bo Bo Bo Bo Bo oB Bo Bo Bo Bo Bo oB Bo Bo Bo Bo Bo Bo Bo Bo Bo oB oB Bo Bo oB oB oB oB Bo Bo Bo oB CH CH CH CH i-Pr Cl C 2 F 5 CN CH CH CH CH t-Bu Cl C 2 F 5 CN Formulation/Utility Compounds of this invention will generally be used as a formulation or composition with an agriculturally suitable carrier comprising at least one of a liquid diluent, a solid diluent or a surfactant. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Useful formulations include liquids such as solutions (including emulsifϊable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like which optionally can be thickened into gels. Useful formulations further include solids such as dusts, powders, granules, pellets, tablets, films, and the like which can be water-dispersible ("wettable") or water-soluble. Active ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or "overcoated"). Encapsulation can control or delay release of the active ingredient. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High-strength compositions are primarily used as intermediates for further formulation. The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges that add up to 100 percent by weight. Weight Percent Active Ingredient Diluent Surfactant Water-Dispersible and Water- 5-90 0-94 1-15 soluble Granules, Tablets and Powders. Suspensions, Emulsions, 5-50 40-95 0-15 Solutions (including Emulsifiable Concentrates) Dusts 1-25 70-99 0-5 Granules and Pellets 0.01-99 5-99.99 0-15 High Strength Compositions 90-99 0-10 0-2 Typical solid diluents are described in Watkins, et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950. McCutcheon 's Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth and the like, or thickeners to increase viscosity. Surfactants include, for example, polyethoxylated alcohols, polyethoxylated alkylphenols, polyethoxylated sorbitan fatty acid esters, dialkyl sulfosuccinates, alkyl sulfates, alkylbenzene sulfonates, organosilicones, N,N-dialkyltaurates, lignin sulfonates, naphthalene sulfonate formaldehyde condensates, polycarboxylates, and. polyoxyethylene/polyoxypropylene block copolymers. Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, starch, sugar, silica, talc, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Liquid diluents include, for example, water, N,N-dimethylformamide, dimethyl sulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, paraffins, alkylbenzenes, alkylnaphthalenes, oils of olive, castor, linseed, rung, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, fatty acid esters, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, and alcohols such as methanol, cyclohexanol, decanol and tetrahydrofurfuryl alcohol. Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. Dusts and powders can be prepared by blending and, usually, grinding as in a hammer mill or fluid-energy mill. Suspensions are usually prepared by wet-milling; see, for example, U.S. 3,060,084. Granules and pellets can be prepared by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration", Chemical Engineering, December 4, 1967, pp 147-48, Perry's Chemical Engineer 's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and following, and WO 91/13546. Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in U.S. 4,144,050, U.S. 3,920,442 and DE 3,246,493. Tablets can be prepared as taught in U.S. 5,180,587, U.S. 5,232,701 and U.S. 5,208,030. Films can be prepared as taught in GB 2,095,558 and U.S. 3,299,566. For further information regarding the art of formulation, see U.S. 3,235,361 , Col. 6, line 16 through Col. 7, line 19 and Examples 10-41; U.S. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; and Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989. . In the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Compound numbers refer to compounds in Index Tables A. L62 Example A Wettable Powder Compound 1 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%. Example B Granule Compound 1 10.0% attapulgite granules (low volatile matter, 0.71/0.30 mm; U.S.S. No. 25-50 sieves) 90.0%. Example C Extruded Pellet Compound 1 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0%. Example D Emulsifiable Concentrate Compound 1 20.0% blend of oil soluble sulfonates and polyoxyethylene ethers 10.0% isophorone 70.0%. The compounds of this invention exhibit activity against a wide spectrum of foliar-feeding, fruit-feeding, stem or rqot feeding, seed-feeding, aquatic and soil-inhabiting arthropods (term "arthropods" includes insects, mites and nematodes) which are pests of growing and stored agronomic crops, forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health. Those skilled in the art will appreciate that not all compounds are equally effective against all growth stages of all pests. Nevertheless, all of the compounds of this invention display activity against pests that include: eggs, larvae and adults of the Order Lepidoptera; eggs, foliar-feeding, fruit-feeding, root-feeding, seed-feeding larvae and adults of the Order Coleoptera; eggs, immatures and adults of the Orders Hemiptera and Homoptera; eggs, larvae, nymphs and adults of the Order Acari; eggs, immatures and adults of the Orders Thysanoptera, Orthoptera and Dermaptera; eggs, immatures and adults of the Order Diptera; and eggs, juveniles and adults of the Phylum Nematoda. The compounds of this invention are also active against pests of the Orders Hymenoptera, Isoptera, Siphonaptera, Blattaria, Thysanura and Psocoptera; pests belonging to the Class Arachnida and Phylum Platyhelminthes. Specifically, the compounds are active against southern corn rootworm (Diabrotica undecimpunctata howardi), aster leafhopper (Mascrosteles fascifrons), boll weevil (Anthonomus grandis), two-spotted spider mite (Tetranychus urticae), fall armyworm (βpodopterafrugiperdd), black bean aphid (Aphis fabae), green peach aphid (Myzus persica), cotton aphid (Aphis gossypii), Russian wheat aphid (Diuraphis noxiά), English grain aphid (Sitobion avenae), whitefly (Bemisia tabacii), tobacco budworm (Heliothis virescens), rice water weevil (Lissorhoptrus oryzophilus), rice leaf beetle (Oulema oryzae), whitebacked planthopper (Sogatellafurciferd), green leafhopper (Nephotettix cincticeps), brown planthopper (Nilaparvata lugens), small brown planthopper (Laodelphax striatellus), rice stem borer (Chilo suppressάlis), rice leafroller (Cnaphalocrocis medinalis), black rice stink bug (Scotinophara luridd), rice stink bug (Oebalus pugnax), rice bug (Leptocorisa chinensis), slender rice bug (Cletus puntiger), southern green stink bug (Nezara viridula) and german cockroach (Blαtellα germαnicα). The compounds are active on mites, demonstrating ovicidal, larvicidal and chemosterilant activity against such families as Tetranychidae including Tetranychus urticae, Tetranychus cinnabarinus, Tetranychus mcdanieli, Tetranychus pacificus, Tetranychus turkestani, Byrobia rubrioculus, Panonychus ulmi, Panonychus citri, Eotetranychus carpini borealis, Eotetranychus, hicoriae, Eotetranychus sexmaculatus, Eotetranychus yumensis, Eotetranychus banksi and Oligonychus pratensis; Tenuipalpidae including Brevipalpus lewisi, Brevipalpus phoenicis, Brevipalpus calif ornicus and Brevipalpus obovatus; Eriophyidae including Phyllocoptruta oleivora, Eriophyes sheldoni, Aculus cornutus, Epitrimerus pyri and Eriophyes mangiferae. See WO 90/10623 and WO 92/00673 for more detailed pest descriptions. Compounds of this invention can also be mixed with one or more other insecticides, fungicides, nematocides, bactericides, acaricides, growth regulators, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants or other biologically active compounds to form a multi-component pesticide giving an even broader spectrum of agricultural protection. Examples of such agricultural protectants with which compounds of this invention can be formulated are: insecticides such as abamectin, acephate, avermectin, azinphos-methyl, bifenthrin, buprofezin, carbofuran, chlorfenapyr, chlorpyrifos, chlorpyrifos-methyl, clothianidin, cyfiuthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, diofenolan, emamectin, endosulfan, esfenvalerate, fenothicarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flucythrinate, tau-fluvalinate, flufenoxuron, fonophos, imidacloprid, isofenphos, malathion, metaldehyde, methamidophos, methidathion, methόmvl. methonrene. methoxvchlor. methvl 7-chloro-2,5-dihydro-2-[[N- (methoxycarbonyl)-N- [4- (trifluoromethoxy)phenyl]amino]carbonyl]indeno[l,2-e][l,3,4]oxadiazine-4a(3H)- carboxylate (indoxacarb), monocrotophos, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, pymetrozine, pyriproxyphen, rotenone, spionsad, sulprofos, tebufenozide, tefluthrin, terbufos, tetraehlorvinphos, thiacloprid, thiodicarb, tralomethrin, trichlorfon and triflumuron; fungicides such as acibenzolar, azoxystrobin, benomyl, blasticidin-S, Bordeaux mixture (Tribasic copper sulfate), bromuconazole, carpropamid (KTU 3616), captafol, captan, carbendazim, chloroneb, chlorothalonil, copper oxychloride, copper salts, cymoxanil, cyproconazole, cyprodinil (CGA 219417),(S)-3,5-dichloro-N-(3-chloro-l-ethyl-l-methyl- 2- oxopropyl)-4-methylbenzamide (RH 7281), diclocymet (S-2900), diclomezine, dicloran, difenoconazole,(S)-3,5-dihydro-5-methyl-2-(methylthio)-5-phenyl- 3-(phenylammo)-4H- imidazol-4-one (RP 407213), dimethomorph, diniconazole, diniconazole-M, dodine, edifenphos, epoxiconazole (BAS 480F), famoxadone, fenamidone, fenarimol, fenbuconazole, fencaramid (SZX0722), fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, fluazinam, fludioxonil, flumetover (RPA 403397), fluquinconazole, flusilazole, flutolanil, flutriafol, folpet, fosetyl-aluminum, furalaxyl, furametapyr (S-82658), hexaconazole, ipconazole, iprobenfos, iprodione, isoprothiolane, kasugamycin, kresoxim-methyl, mancozeb, maneb, mefenoxam, mepronil, metalaxyl, metconazole, metominostrobin/fenominostrobin (SSF-126), myclobutanil, neo-asozin (ferric methanearsonate), oxadixyl, penconazole, pencycuron, probenazole, prochloraz, propamocarb, propiconazole, pyrifenox, pyraclostrobin, pyrimethanil, pyroquilon, quinoxyfen, spiroxamine, sulfur, tebuconazole, tetraconazole, thiabendazole, thifluzamide, thiophanate-methyl, thiram, triadimefon, triadimenol, tricyclazole, trifloxystrobin, triticonazole, validamycin and vinclozolin; nematocides such as aldicarb, oxamyl and fenamiphos; bactericides such as streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad; and biological agents such as Bacillus thuringiensis, Bacillus thuringiensis delta endotoxin, baculovirus, and entomopathogenic bacteria, virus and fungi. Preferred insecticides and acaricides for mixing with compounds of this invention include pyrethroids such as cypermethrin, cyhalothrin, cyfluthrin and beta-cyfluthrin, esfenvalerate, fenvalerate and tralomethrin; carbamates such as fenothicarb, methomyl, oxamyl and thiodicarb; neonicotinoids such as clothianidin, imidacloprid and thiacloprid, neuronal sodium channel blockers such as indoxacarb, insecticidal macrocyclic lactones such as spinosad, abamectin, avermectin and emamectin; GABA antagonists such as endosulfan and fipronil; insecticidal ureas such as flufenoxuron and triflumuron, juvenile hormone mimics such as diofenolan and pyriproxyphen; pymetrozine; and amitraz. [65 Preferred biological agents for mixing with compounds of this invention include Bacillus thuringiensis and Bacillus thuringiensis delta endotoxin. . Most preferred mixtures include a mixture of a compound of this invention with cyhalothrin; a mixture of a compound of this invention with beta-cyfluthrin; a mixture of a compound of this invention with esfenvalerate; a mixture of a compound of this mvention with methomyl; a mixture of a compound of this invention with imidacloprid; a mixture of a compound of this invention with thiacloprid; a mixture of a compound of this invention with indoxacarb; a mixture of a compound of this invention with abamectin; a mixture of a compound of this invention with endosulfan; a mixture of a compound of this invention with fipronil; a mixture of a compound of this invention with flufenoxuron; a mixture of a compound of this invention with pyriproxyphen; a mixture of a compound of this invention with; a mixture of a compound of this invention with pymetrozine; a mixture of a compound of this invention with amitraz; a mixture of a compound of this invention with Bacillus thuringiensis and a mixture of a compound of this invention with Bacillus thuringiensis delta endotoxin. In certain instances, combinations with other arthropodicides having a similar spectrum of control but a different mode of action will be particularly advantageous for resistance management. Arthropod pests are controlled and protection of agronomic, horticultural and specialty crops, animal and human health is achieved by applying one or more of the compounds of this invention, in an effective amount, to the environment of the pests including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled. Thus, the present invention further comprises a method for the control of foliar and soil inhabiting arthropods and nematode pests and protection of agronomic and/or nonagronomic crops, comprising applying one or more of the compounds of the invention, or compositions containing at least one such compound, in an effective amount, to the environment of the pests including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled. A preferred method of application is by spraying. Alternatively, granular formulations of these compounds can be applied to the plant foliage or the soil. Other methods of application include direct and residual sprays, aerial sprays, seed coats, microencapsulations, systemic uptake, baits, eartags, boluses, foggers, fumigants, aerosols, dusts and many others. The compounds can be incorporated into baits that are consumed b the arthropods or in devices such as traps and the like. The compounds of this invention can be applied in their pure state, but most often application will be of a formulation comprising one or more compounds with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. A preferred method of application involves spraying a water dispersion or refined oil solution of the compounds. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as piperonyl butoxide often enhance compound efficacy. The rate of application required for effective control will depend on such factors as the species of arthropod to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredient per hectare are sufficient to control pests in agronomic ecosystems, but as little as 0.001 kg/hectare may be sufficient or as much as 8 kg/hectare may be required. For nonagronomic applications, effective use rates will range from about 1.0 to 50 mg/square meter but as little as 0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required. The following TEST demonstrates the control efficacy of compounds of this invention on specific pests. "Control efficacy" represents inhibition of arthropod development (including mortality) that causes significantly reduced feeding. The pest control protection afforded by the compounds is not limited, however, to these species. See Index Tables A through Q for compound descriptions. The following abbreviations are used in the Index Tables which follow: t is tertiary, n is normal, i is iso, c is cyclo, s is secondary, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyl, c-Pr is cyclopropyl, Bu is butyl, s- Bu is secondary butyl, Pent is pentyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is ethylthio, CN is cyano, NO 2 is nitro, and Het is heterocycle. The abbreviation "Ex." stands for "Example" and is followed by a number indicating in which example the compound is prepared. INDEX TABLE A B is O, except where indicated Compound l R 2 R3 R4 R 5 and/or R 6 m.p. °C 1 (Ex 1) H i-Pr H 2-Me 4-OCF3 207-209 r * r 0 0 <O O O O O " ■ "• r CN rCN CCN rCN-J CCMN CCN rCNi rCNi 00 B B B • 3 B B B B B B B B B B B B B en B en CN fi O O B B O o fc f c f c f c fc o & 3 3 i- 3 3 f fi 00 i i ^ ' SB 3 P* i PQ C 3Q PH έ: fi & . PA-> Q m / o — \ 1 m 2* π3 en υ P- έ CN O R CM B CN g S3 ffl 2, o &, O B £• o o 1- KO © 1- cs en © OJ en i so 00 Cl © CN en >n ^o CN r- r- 00 CN CN CN CN CN CN CN CN CN en en en en en en en en en st en en © 00 00 © vo © t-- © 00 © © st en >n 90 en σs © 00 as • st © CN ■ st 00 00 © en en r- © CN © © © cn en as as CN en cn en en C C ι — 1 < a7s © © i 00 00 00 VO m as 00 ■ st 00 00 >0 00 r- 00 en en eo © oo en Λ • st 00 00 as en CN © as ( Λ Λ Λ .as CN CN CN H en Hi f U D t en en en Pi CN t Pi t en f ■ s en en en en en en en en ft f ft en en f o t i S t cn en o t ft ft ft f O O en en ft ft Pi ft n f U υ ft t ■ st • st o ft en O en f >y t ft t f en o ft f t ft en O o O ft o ft o on bn o O U O ft ft o O U r ι ft o o o o o o o o υ o o <υ o o o o O Ά o o o o o • o % o ■ t ■ t ^ CN ■ t CN e " CN 3 ■ st υ o CN CN O S CN B B B B B ^ B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B o .A .A .A I-- o © I-- en © CN en ■ st >n VO r- 00 as © X en st ■n O r- 00 (Ti © (N en ■ t in VO I'00 as © CN en ■ st ιn en • st ■ st ^t ■ t ■ st ■ st ■ st • t st in ^ W- >n in in in <o ■n in vo O VO o VO o VO ve o o r- o l~ r- f- r- CN B B B B B B B B B B B B B B B B B B B ^ J B B B B B B B B B o B B B B B B B en 3 fi e B? B u o o o o CQ p ? J>1 CN 3 3 3 3 3 f ft 3 3 3 3 3 3 CQ CQ CQ Q CQ t f ° CQ CQ ft CQ ^ CQ t ft ft ft ft B B CQ .A .A i f υ u o ft ft 3 3 3 fi CQ en m .A ' .A n I? B B ) o & B B o o B B B B B B B B B B B B B B B B B B B B B B B B B B B B ι~~ o © I-- © ( en • st in VO t- oo OS © CN © © © © © O © © © CQ CQ J§ g O CQ CQ CQ CQ P? Q O f÷ o Pi ft ■ st ■ t ft 4 en -st st st st +• ^H m "St s s s s ^ B B S o o o o CQ CN fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc -fc fc fc fc fc fc fc fc fc fc fc B B CN i ω o B B B B B B B B B B B B B B B B B B B o o o o 5 5- B B B B B B B B B B B B o o I-- vo © I-- © en • t in VO t 00 Os © CN en • t in vo C- oo os © i-H CN en -st m vo r- oo CN CN CN CN CN CN cn en en en cn en en en en en ■ st - t -s st st st st • st st D <U CN CN CN CN CN CN O O O O O O _ o _ _ _ <D ω —, ^H — , o o Pi O ft st s s s s S o o s o o o CN CN CN CN 2 ' 2'i 2' 2' 2' 2' cN' CN H 3 i >n n en en en en en en CN CN CN CN CN CN CN (> ΓN B B B B B fc fc fc fc fc fc H fc fc fc pH fc HH fc fc fc B ffi B B B B B B B B B B B B fc fc fc fc fc © CN cn ■ st in VO t- 00 OS © N en st m vo t~- 00 σs © -H cN en st vo o VO VO VO vo VO VO VO VO r- r- r- r- t~- e- f- f- r- r- oo oo oo oo 00 ft ft ft Hi ft Hi Hi B B B B ft ft ft ft ft .ft ft ft ft ft ft HH ffi B HH B fc fc fc fc fc fc fc fc fc fc fc fc f c fc fc fc fc B vo i VO t- 00 Os © en t in vo 00 as © CN en s in >© s © l- H cN en st >n VO C- 00 00 oo oo oo 00 σs OS Os σs σs σs σs σs © © © © © © © » 00 σ © © © CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CF 3 219 H i-Pr H 2-Me 2-(3-Br-l-pyrazolyl)-4- >250 CF 3 220 H i-Pr H 2-Me 2-(3-CN-l-pyrazolyl)-4- >250 CF 3 221 H i-Pr H 2-Me 2-(4-CF 3 -l-imidazolyl)- >250 4-CF3 222 H i-Pr H 2-Me 2-(3-CH 3 -l-pyrazolyl)- 248-250 4-CF3 223 H i-Pr H 2-Me 2-(2-CH 3 -l-imidazolyl)- 186-188 4-CF3 224 H i-Pr H 2-Me 2-(3-CF3-l-(l,2,4- 254-256 triazolyl))-4-CF 3 225 H i-Pr H 2-Me 2-(l-pyrazolyl)-4-CF 3 246-248 226 H i-Pr H 2-Me 2-(3-C0 2 Et-5-Me-l- 224-225 pyrazolyl)-4-CF3 227 H i-Pr H 2-Me 2-(l-imidazolyl)-4-CF 3 240-241 228 H i-Pr H 2-Me 2-(3-CF 3 -5-Me-l- 229-231 pyrazolyl)-4-CF3 229 H i-Pr H 2-Me 2-(3,5-Me 2 -l-pyrazolyl)- 214-218 4-CF3 230 H i-Pr H 2-Me 2-(2,4-Me 2 -l- 246-248 imidazolyl)-4-CF3 231 H i-Pr H 2-Me 2-(4-Me-l-imidazolyl)- 223-225 4-CF3 232 H i-Pr H 2-C1 2-(3-CF 3 -l-pyrazolyl)-4- >250 CF 3 233 H i-Pr H 2-C1 2-(l-(l,2,4-triazoIyI))-4- 252-254 CF 3 234 H i-Pr H 2-C1 2-(3-Br-l-pyrazolyl)-4- >250 CF 3 235 H i-Pr H 2-C1 2-(3-C0 2 Et 5-Me-l- 220-221 pyrazolyl)-4-CF3 236 H i-Pr H 2-C1 2-(4-C0 2 Me-l- 255-257 i idazolyl)-4-CF3 237 H i-Pr H 2-C1 2-(3-CN-l-pyrazolyl)-4- >250 CF 3 238 H i-Pr H 2-C1 2-(l-imidazolyl)-4-CF 3 248-249 239 H i-Pr H 2-Me 2-(4-C0 2 Me-l- 219-222 imidazolyl)-4-CF3 240 H i-Pr H 2-Me 2-(2-thienyl)-4-CF 3 241-243 241 H i-Pr H 2-Me 2-(3-thienyl)-4-CF 3 229-231 242 H i-Pr H 2-Me 2-(2-furanyl)-4-CF 3 246-247 243 H i-Pr H 2-Me 2-(3-t-Bu-l-pyrazolyl)-4- 247-249 CF 3 244 H i-Pr H 2-Me 2-(3-s-Bu- 1 -pyrazolyl)- 224-225 4-CF 3 245 H i-Pr H 2-Me 2-(3 -c-Pr- 1 -pyrazolyl)-4- 220-221 CF 3 246 H i-Pr H 2-Me 2-(3 -Me-5~isoxazolyl)-4- 233-234 -4-CF3 248 H i-Pr H 2-Me 2-(CONMe 2 )-4-CF 3 188-192 249 H i-Pr H 2-Me 2-(CONMe 2 )-5-CF 3 194-196 250 H i-Pr H 2-Me 2-(C0- 1 -pyrrolidinyl)-4- 201-204 CF 3 251 H i-Pr H 2-Me 2-(CO-l-pyrrolidinyl)-5- 221-223 CF 3 252 H i-Pr H 2-Me 2-OCH3-4-CF3 188-189 253 H i-Pr H 2-Me 2-(3-Cl-5-isoxazolyl)-4- 247-248 CF 3 254 H i-Pr H 2-Me 2-Oi-Pr-4-CF 3 158-159 255 H i-Pr H 2-C1 2-(4-Me- 1 -pyrazolyl)-4- 252-253 CF 3 256 H i-Pr H 2-Me 2-(4-Me- 1 -pyrazolyl)-4- 226-227 CF 3 257 H i-Pr H 2,5-Cl 2 2-Me-4-CF 3 235-237 258 H i-Pr H 2-Me 4-Ph 221-224 259 H i-Pr H 2-Me 4-(4-OCH 3 )Ph >230 260 H i-Pr H 2-Me 4-(2-Me)Ph 156-158 261 H i-Pr H 2-Me 4-(3-CH 3 )Ph 225-226 262 H i-Pr H 2-Me 4-(3-CF 3 )Ph 214-215 263 H i-Pr H 2-Me 4-(4-F)Ph >230 1 266 H i-Pr H 2-CF3 2-Me-4-Br >230 267 H t-Bu H 2-CF3 2-Me-4-Br 234-236 268 H i-Pr Me 2-CF3 2-Me-4-Br 154-158 269 H CH(CH3)CH 2 OCH 3 H 2-CF3 2-Me-4-Br 202-204 270 H s-Bu H 2-CF3 2-Me-4-Br >230 271 H s-penty I H 2-CF3 2-Me-4-Br 215-217 272 H i-Pr H 2-CH3 2-Me-4-CF 3 >230 273 H i-Pr Me 2-OCHF 2 2-Me-4-Br 224-227 274 H i-Pr H 2-CH3 2-(CONMe 2 )-4-CF 3 130-137 275- B is S H i-Pr H 2-Me 2-Me-4-CF 3 193-195 276 H i-Pr H 2-C1 2-(l-pyrazolyl)-4-CF 3 249-250 277 B is S H i-Pr H 2-Me 4-OCF3 169-171 278 B is S H i-Pr H 2-Me 4-CF 3 Ph 204-206 INDEX TABLE B R^(c) is H, except where indicated and B is O, except where indicated Bl (Ex. 4) i-Pr H 2-Me CF 3 CH 3 247-248 B2 i-Pr H 2-Me OCH 2 CF 3 H 188-191 B3 i-Pr H 2-C1 CF 3 CH 3 234-236 B4 t-Bu H 2-C1 CF 3 CH 3 243-245 B5 CH(CH 3 )CH 2 OCH3 H 2-C1 CF 3 CH 3 198-201 B6 . CH(CH 3 )CH=CH 2 H 2-Me CF 3 CH 3 226-227 B7 i-Pr H 2-C1 OCH 2 CF 3 H 208-210 [16 90 in t H U ft 1 en en en en en en en en en cn en en O B B B B B B iff B B K B B o B B B B B B B O o en i B ft O O K B o o o o υ o υ £ o CQ o o υ o o O f υ o o o o o O β υ o o o CN en en en en en en en en en cn cn cn en ft ft ft Pi PH ft ft ft a B ft ft ft p - o o o O O u o o υ o ό CN CN CN CN CN CN CN CN CN CN CN ft ffi ft ffi ft ffi ft HH B B B ft Hi B ffi ffi H B B B Hi B B B B B HH HH HH B CN CN ft en en en en en n O en m en en en en 3 f f ft ft en ft e en ft ft en ft en en f PH ft ft ft ft ft CQ ft en t O en t t en 8 en en en ft en t Pi O f ft ft t ft υ O o O o υ O O O O O O .A δ f .A ft o Pi ft υ υ υ O B o o B tf ft ^ O o O o O o o o OO PQ CN o o o α> <D <D < <D ω α 0 <υ o o o <L> ω o § s s CN s m CN s s s s s s s s s s CN CN CN CN CN CN C CM CM CM CN CM s s s 4 o « υ o ω S S JS S s o S s s CN B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B tZ) tΛ CQ CQ CQ in vo o oo σs © CN en ■st in vo f- oo σs O i-H CN en t >n VO t oo OS © i-H cn 00 st t st t st i in m in in in vn in in in vo vo st in VO t o i VO VO VO VO *o VO t- t-- t t-- r- l C- r- « CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ OQ CQ CQ PQ CQ CQ CQ CQ CQ CQ CQ CQ Q CQ CQ ffl ffl « W CQ CQ CQ ffl CQ st en σs © en © H U ft ft ft ft ft ft fi ft ft fi ft KJ 00 —, ,— , o O r-< ^ ^ S ΪS S υ υ o ^ ;! — — i ω O O O 0 0 2 5 0 0 5 2 CN fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc fc f 3 J £ -. w t CQ W fi 3 3 3 4 W CQ & ft PQ S *V CQ w * P? c3 ft 3 PQ W ft « S ft 4 a fi PQ ft p f a ft « a p ? t~~ vo © r- 00 σs r~- 00 OS © (N en CN CN in in in vo VO O VO r> -> o B I B B B B B B B B B B B B B B B B pq B B B B B B B B B B B B B B B B B B B B ft ft ft 3 Q έ ft ft ft & ft fi 3 Jf C a CQ ft fi ^* P ft ft ft ft i ? * ft έ; f -A .A co CQ vo VO f- 00 Os CN en in vo © ,_, CN en t i vo t- 00 Os © ,_, CN en st in vo r-- 00 σs © CN en P P P CN CN CN CN CN CN CN CN P P P P Q P P P P & CJ o en en en en en en cn cn en en st st st st as P P P P P P P P P P P P P P P P P P P P P P P P en en en en en en ^1 ft ft ft ft ft ft ft f en en en en en en en en en en en en en ften ften f ten f ten ften f ten f ten ften ften ften ften ften en en o o υ o o o o t ft ft ft ft ft ft ft ft ft ft ft ft ft ft en O O O O O O O O O O o o o o o o o o o o o o ft Pi Pi O 00 en en en en en . , ° .**> en en en en en en en en en en .H en en en en ft ft ft ft ft rα ft en ft en en >y en en en en en en en ft i ft ft ft ft ft ft ft pi ft ft ft ft ft ft ft ft ft ϊp ft ft ft ft ft o υ o υ o w C w ft o ft υ o o O o υ υ o υ υ o o o υ υ υ o o o o o o 0 - 1 fi o υ O fr fc -fc fc fc pH fc fc fc fc fc fc fc fc fc fc fc fc fc ffi f c f c fc fc fc fc fc fc fc n vo Q P P P P Q P en en en en en en en en en en en en en m en en en en en en en en en en ,_, en en en en tf ft ft ft ft ft ft ft ft ft ft ft pi Pi ft ft ft ft ft ft ft tf ft ft CQ .g t f en ft ften ft ft ft ften ften ften ften pein υ o o υ o o o o o υ υ o o o o o o υ υ υ o o o o " o o o o o o o o o o s s HH ft ft B B B B B B B B B B B B ^ B B B B B B B B B B B B B B B B B B B ^ vo © oo σs o CN en t in o r- 00 OS © CN cn t in vo r- 00 σs © ( en st in VO t-~ 00 σs © en st CN CN CN CN CN CN CN CN CN en en en en en en en en en en St St st st t st St st st t i in n in P P P P P Q O P P Q Q Q P P Q P P P P P Q P P Q P P P P P P P P P P P P P D155 CH 2 C≡CH H 2-C1 CF 3 2-ClPh 226-227 D156 Et H 2-C1 CF 3 2-ClPh 244-246 D157 CH 2 CH=CH 2 H 2-C1 CF 3 2-ClPh 235-236 D158 CH 2 (2-fiιranyl) H 2-C1 CF 3 2-ClPh 207-208 D159 i-Pr H C≡CSi(CH 3 ) 3 CF 3 2-ClPh 256-258 D160 i-Pr H C≡CH CF 3 2-ClPh 228-230 D161 i-Pr H 2-C1 C≡CH 2-ClPh 219-222 D162 i-Pr H 2-Me H H, R 7 (c) is CH 3 220-223 D163 i-Pr H 2-Me CH 3 Ph, R 7 (c) is Cl 209-210 D164 B is S i-Pr H 2-C1 CF 3 Ph 169-174 D165 i-Pr H 2-Me CF 3 2,6-F 2 Ph 223-225 D166 i-Pr H 2-Me CF 3 2-Cl-6-FPh 203-206 D167 i-Pr H 2-C1 CF 3 2-Cl-6-FPh 218-221 D168 i-Pr H 2-Me-4-Br CF 3 2-FPh 232-233 D169 t-Bu H 2-C1 CF 3 2-(3-Cl-pyridinyl) 250-251 D170 H 2-C1 CF 3 2-(3-Cl-pyridinyl) >250 D171 Et Et 2-C1 CF 3 2-ClPh 243-247 D172 Me Me 2-C1 CF 3 2-ClPh 234-235 D173 Et Et 2-Me CF 3 2-ClPh 237-238 D174 Me Me 2-Me CF 3 2-ClPh 225-226 D175 CH 2 CH 2 N(Me) 2 H 2-Me CF 3 2-ClPh 188-190 D176 i-Pr H 2-C1 CF 3 2-pyrazinyl 242-243 D177 t-Bu H 2-Me-4-Br CF 3 2-ClPh >260 D178 CH(CH 3 )CH 2 OCH 3 H 2-Me CF 3 2-(3-Cl-pyridinyl) 176-177 D179 CH(CH 3 )CH 2 SCH 3 H 2-Me CF 3 2-(3-Cl-pyridinyl) 196-197 D180 CH(CH 3 )CH 2 OCH 3 H 2-C1 CF 3 2-(3-Cl-pyridinyl) 197-198 D181 CH(CH 3 )CH 2 SCH 3 H 2-C1 CF 3 2-(3-Cl-pyridinyl) 202-203 D182 i-Pr H 2-Me CF 3 2-IPh 221-222 D183 i-Pr H 2-C1 CF 3 2-IPh 238-240 D184 i-Pr H 2-Me CF 3 2-(C≡CH)-Ph 215-217 D185 i-Pr H 2-C1 CF 3 2-(C≡CH)-Ph 244-246 D186 t-Bu H 2-C1 CF3 2-(3-Cl-pyridinyl) 250-251 D187 H 2-C1 CF 3 2-(3-Cl-pyridinyl) >250 D188 i-Pr H 2-Me CF 3 2-Cl-4-FPh 203-205 D189 i-Pr H 2-C1 CF 3 2-Cl-4-FPh 218-219 f ft ft ft ft ft ften ften o ^ P B B B B B B B B B B B B B B B B B B B B B B B B B B B ^ B B B B B B B B B o o t III ft 3 w ft tf ft ft ft f o fi 3 3 1 § CQ w CQ CQ fi w <CN .A -A A PQ PQ W - -A B B o o vo © f- en r- σs en st ιn vo t-- oo σs © ι— i cN en st in vo t- oo σs © 1—i CN en st in vo h σs σs σs σs σs CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN CN o P P P P P P P P P P P P P p p p p p p p p p p p p p p p p p p p p p p p p D227 i-Pr H 2-Me CF 3 3- (2-Cl-pyridinyl) * D228 i-Pr H 2-C1 CF 3 2,3-Cl 2 Ph 217-219 D229 t-Bu H 2-C1 CF 3 2,3-Cl 2 Ph 254-256 D230 i-Pr H 2-Me CF 3 2,3-Cl 2 Ph 208-209 D231 t-Bu H 2-Me CF 3 2,3-Cl 2 Ph 232-233 D232 t-Bu H 2-Me-4-Br Br 2-ClPh 239-241 D233 Me H 2-Me-4-Br Br 2-ClPh 150-152 D234 Et H 2-Me-4-Br Br 2-ClPh 223-225 D235 i-Pr H 2-Me-4-Br Br 2-ClPh 197-198 D236 Me H 2-Me CF 3 2-FPh 245-247 D237 CH 2 CsCH H 2-Me CF 3 2-FPh 222-227 D238 O-i-Pr H 2-C1 CN 2- (3-Cl-pyridinyl) 205-206 D239 O-i-Pr H 2-Me CN 2- (3-Cl-pyridinyl) 210-211 D240 Me Me 2-C1 CF 3 2-ClPh 234-236 D241 CH 2 CsCH H 2-Me-4-Br Br 2-ClPh 187-188 *See Index Table Q for ! H NMR data INDEX TABLE E Compound 2 R3 (R 4 )n R7(a) R'(b) R7 (c) m.p. °C El L-Pr H 2-Me CH 3 CH 3 H 143-145 E2 i -Pr H 2-Me CH 3 CH 2 CF 3 H 198-199 E3 3 -Pr H 2-Me CH 3 CH 3 Cl 188-190 E4 i-Pr H 2-Me CH 3 4-CF 3 -Ph H 198-199 E5 -Pr H 2-Me CH 3 2-CF 3 -Ph H 211-213 E6 i-Pr H 2-Me CH 3 t-Bu H 125-127 E7 i-Pr H 2-Me CF 3 CH 2 Ph H 130-135 E8 i-Pr H 2-Me H Ph CH 3 249-250 E9 t-Pr H 2-Me H CH 3 Ph 268-270 E10 i-Pr H 2-C1 H Ph CH 3 260-261 Ell i-Pr H 2-Me H CH 2 CF 3 Ph 213-215 E12 i-Pr H 2-C1 H CH 2 CF 3 Ph 208-209 E13 i-Pr H 2-Me H CHF 2 Ph * E14 i-Pr H 2-Me CF 3 2-(3-Cl-pyridinyl) H 249-250 *See Index Table Q for !H NMR data INDEX TABLE F Compound R 2 R 3 (R 4 ) n R7(a) R 7 (b) R 7 (c) m.p. °C FI -Pr H 2-Me CH 2 CF 3 CH 3 H 254-255 F2 i-Pr H 2-Me CH 2 CF 3 . H CH 3 200-205 F3 -Pr H 2-Me CH 2 (3-CF 3 )Ph H CH 3 212-215 F4 i i-Pr H 2-C1 CH 2 CF 3 H CH 3 215-217 F5 i-Pr H 2-Me Ph H CF 3 223-224 F6 i-Pr H 2-C1 Ph H CF 3 206-208 F7 i-Pr H 2-Me CH 2 CF 3 H Ph 156-158 F8 i -Pr H 2-C1 CH 2 CF 3 H Ph 162-164 INDEX TABLE G Compound Q R2 R3 (R 4 )n R 7 (a) R 7 (b) m.p. °C Gl s i-Pr H 2-Me 4-OCF 3 Ph CH 3 233-234 G2 s i-Pr H 2-Me OCH 2 CF 2 CF 3 CH 3 170-173 G3 s i-Pr H 2-Me Cl CH 3 164-167 G4 s i-Pr H 2-Me CH 3 Ph 216-219 G5 s i-Pr H 2-Me C(CH 3 ) 2 OH CH 3 * G6 s i-Pr H 2-Me i-Pr CH 3 180-181 G7 s i-Pr H 2-Me i-Pr Ph 182-183 G8 o i-Pr H 2-Me i-Pr CH 3 163-164 *See Index Table Q for l R NMR data INDEX TABLE H Compound Q R RJ (R 4 )n R'(a) R'(b) R/(c) m.p. °C HI S i-Pr H 2-Me H H H 192-195 H2 s CH(CH 3 )CH 2 OCH 3 H 2-Me H H H 120-123 H3 s t-Bu H 2-Me H H H 120-123 H4 NMe i-Pr H 2-Me Me H H 193-195 H5 NPh i-Pr H 2-Me H Me H 188-192 H6 NPh i-Pr H 2-Me Br H H 176-179 H7 NPh i-Pr H 2-Me Br H Br 215-216 H8 NPh i-Pr H 2-Me H H Br 150-154 H9 NPh i-Pr H 2-Me CF 3 H H 182-184 H10 N(2-ClPh) i-Pr H 2-Me Br H H 100-110 Hl l N(2-FPh) i-Pr H 2-Me Br H H 178-179 H12 N(2-FPh) t-Bu H 2-Me Br H H 186-188 H13 N(2-ClPh) t-Bu H 2-Me Br H H 225-229 INDEX TABLE J Compound R 1 R3 (R 4 ) n , R 7 (a) R 7 (b) m.p. °C Jl i-Pr H 2-Me Me Me 221-222 J2 i-Pr H H CF 3 Ph 279-281 J3 i-Pr H 2-Me CF 3 Ph 263-268 J4 i-Pr H 2-C1 CF 3 2-ClPh 235-238 J5 i-Pr H 2-C1 CF 3 Ph 245-246 J6 i-Pr H 2-Me CF 3 2-ClPh 240-242 J7 i-Pr H 2-C1 CF 3 2-F-4-ClPh 246-247 J8 i-Pr H 2-Me CF 3 2-F-4-ClPh 266-268 J9 i-Pr H 2-Me CF 3 2-pyridinyl 258-260 INDEX TABLE K KI i-Pr H 2-Me Br H 177-180 K2 t-Bu H 2-Me Br H 188-194 INDEX TABLE L Compound R2 R 3 (R4) n R 7(a) R7(b) m.p. °C LI i-Pr H 2-Me Me Me 203-205 L2 i-Pr H 2-Me Me 2,6-Cl 2 Ph 218-223 INDEX TABLE M Compound R2 R 3 (R ) n R 7 (a) R 7 (b) R 7 (c) m.p. °C Ml S i-Pr H 2-Me Cl Me H 203-205 M2 S i-Pr H 2-C1 Cl Me H 210-213 M3 NCHF 2 t-Bu H 2-Me H H Ph 165-166 M4 NH i-Pr H 2-Me CF 3 Ph H 118-120 M5 NMe i-Pr H 2-Me CF 3 Ph H 110-112 M6 NCHF 2 i-Pr H 2-Me 2-FPh H H 143-144 M7 NCHF 2 t-Bu H 2-Me 2-FPh H H 120-123 M8 NCH 2 CF 3 i-Pr H 2-Me 2-FPh H H 235-237 INDEX TABLE N Compound Het m.p. °C INDEX TABLE P Compound m.p. °C INDEX TABLE O Compd. No. *H NMR Data (CDC1 3 solution unless indicated otherwise) a D194 (OMSO-d6) δ 1.03 (d, 6H), 2.18 (s, 3H), 3.92 (m, IH), 7.22-7.30 ( , 2H), 7.35 (m, IH), 7.62 (dd, IH), 7.81 (s, IH), 8.02 (d, IH), 8.15 (dd, IH), 8.55 (dd, IH), 10.34 (s, IH). D227 (DMSO-atø) δ 1.01 (d, 6H), 2.16 (s, 3H), 3.92 (m, IH), 7.27 (m, 2H), 7.35 (m, IH), 7.89 (s, IH), 7.96 (m, IH), 8.37 (s, 2H), 10.42 (s, IH). G5 δ 1.22 (d, 6H), 2.05 (s, 6H), 2.31 (s, 3H), 2.76 (s, 3H), 4.18 (m, IH), 5.94 (d, IH), 7.20 (dd, IH), 7.29 (d, IH), 7.38 (d, IH), 9.83 (br s, IH). E13 δ 1.12 (d, 6H), 2.32 (s, IH), 4.14 (m IH), 4.95 (d, IH), 7.19 (dd, IH), 7.28 (t, IH), 7.32 (m, 5H), 7.59 (dd, 2H), 7.92 (s, IH), 9.51 (br s, IH). a IH NMR data are in ppm downfield from tetramethylsilane. Couplings are designated by (s)-singlet, (d)-doublet, (t)-triplet, (q)-quartet, (m)-multiplet, (dd)-doublet of doublets, (dt)-doublet of triplets, (br s)-broad singlet. BIOLOGICAL EXAMPLES OF THE INVENTION TEST Application: Compounds are formulated in a 10% acetone, 90% water and 300 ppm X-77 surfactant solution, unless otherwise indicated. The formulated compounds are applied with a SUJ2 atomizer nozzle with 1/8 JJ custom body (Spraying Systems) positioned X Λ" above the top of each test unit. There are 6 of these nozzles that make up the spray boom and this is fixed in a belt sprayer. A rack (or carrier) of 6 different insect test units is placed on the conveyor belt and stops so that each unit is centered under a nozzle. Once the rack is centered, 1 mL of liquid is sprayed into each test unit; the rack then continues down the belt to the end of the sprayer to be off-loaded. All experimental compounds in this screen are sprayed at 250 ppm and replicated three times. Diamondback Moth (DBM) - Plutella Xylostella: The test unit consists of a small self-contained unit with a 12-14 day old radish plant inside. These are pre-infested (using a core sampler) with 10-15 neonate larvae on apiece of insect diet. Once 1 mL of formulated compound has been sprayed into each test unit, the test units are allowed to dry for 1 hour before a black, screened cap is placed on the top of the cylinder. They are held for 6 days in a growth chamber at 25 °C and 70% relative humidity. Plant feeding damage was visually assessed on a scale of 0-10 where 0 is no feeding, 1 is 10% or less feeding, 2 is 20% or less feeding, 3 is 30% or less feeding through a maximum score of 10 where 10 is 100% of foliage consumed. Of the compounds tested the following provided excellent levels of plant protection (ratings of 0-1, 10% or less feeding damage): 1, 2, 3, 4, 6, 7, 9, 10, 13, 14, 15, 19, 20, 24, 27, 28, 29, 30, 31, 32, 33, 35, 37, 38, 39, 51, 52, 53, 60, 61, 62, 63, 64, 65, 66, 68, 69, 72, 73, 74, 75, 76, 79, 80, 84, 86, 88, 89, 90, 92, 96, 97, 98, 99, 100, 101, 102, 103, 107, 113, 124, 126, 127, 143, 144, 146, 147, 148, 150, 151, 152, 153, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 169, 170, 171, 174, 183, 184, 185, 186, 187, 188, 189, 190, 191, 193, 194, 195, 196, 198, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 222, 223, 225, 227, 228, 229, 230, 231, 232, 233, 235, 238, 239, 240, 244, 245, 246, 248, 249, 250, 251, 252, 253, 256, 257, 275, 276, 277, 278, B2, B4, B5, B6, B7, B8, B9, BIO, Bll, B12, B13, B14, B15, B16, B17, B18, B19, B20, B21, B23, B24, B25, B28, B29, B30, B31, B32, B33, B35, B37, B38, B39, B40, B42, B43, B44, B45, B46, B47, B48, B49, B50, B53, B55, B57, B58, B59, B60, B61, B62, B63, B64, B66, B67, B68, B69, B70, B71, B72, B74, B75, B76, Cl, C2, C3, C4, C5, C7, C8, C9, CIO, Cll, C12, C79, D2, D3, D4, D5, D6, D7, D8, Dll, D12, D13, D14, D15, D16, D18, D19, D20, D23, D24, D25, D26, D27, D28, D29, D30, D32, D33, D34, D37, D38, D39, D40, D41, D42, D45, D46, D47, D48, D50, D51, D52, D53, D54, D55, D56, D57, D58, D59, D60, D61, D62, D63, D64, D65, D66, D67, D68, D69, D70, D71, D72, D73, D74, D75, D76, D77, D78, D79, D81, D83, D84, D85, D86, D87, D88, D89, D91, D92, D93, D94, D95, D96, D97, Dill, D113, D114, D115, D116, D117, D118, D119, D120, D121, D122, D123, D124, D125, D126, D162, D164, E4, F2, F5, F6, F7, F8, G2, G3, G5, HI, H2, H3, H4, J3, J4, J6, Ml, M3, N2 and PI.

Claims: CLAIMS What is claimed is: 1. A method for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidaUy effective amount of a compound of Formula 1, its N-oxide or agriculturally suitable salts wherein A and B are independently O or S; each J is independently a phenyl or naphthyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 ; or each J is independently a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R 7 ; n is 1 to 4; R 1 is H; or C^-Cg alkyl, C -Cg alkenyl, C 2 -Cg alkynyl or C 3 -Cg cycloalkyl each 1 optionally substituted with one or more substituents selected from the group consisting of halogen, CΝ, ΝO 2 , hydroxy, Cι-C 4 alkoxy, 0^4 alkylthio, Cι-C alkylsulfinyl, Cj-04 alkylsulfonyl, C 2 -C4 alkoxycarbonyl, Cι-C 4 alkylamino, C 2 -Cg dialkylamino and C 3 -C 6 cycloalkylamino; or R 1 is C 2 -C 6 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C(=A)J; R 2 is H, C^Cg alkyl, C 2 -Cg alkenyl, C 2 -C 6 alkynyl, C 3 -Cg cycloalkyl, C1-C4 alkoxy, Cj-04 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 2 -C 6 alkoxycarbonyl or C 2 -Cg alkylcarbonyl; R is H; G; C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, G, CN, NO 2 , hydroxy, 0^4 alkoxy, 0^4 haloalkoxy, C r C alkylthio, 0^4 alkylsulfinyl, 0^4 alkylsulfonyl, C 2 -Cg alkoxycarbonyl, C 2 -C 6 alkylcarbonyl, C 3 -Cg trialkylsilyl, or a phenyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from the group consisting of C^- C alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C j ^ haloalkyl, C 2 - C haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , CJ-C4 alkoxy, C2-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C j ^ alkylsulfonyl, Cj-C4 alkylamino, C 2 -Cg dialkylamino, C 3 -Cg cycloalkylamino, C -C 6 (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 - C alkylaminocarbonyl, C 3 -Cg dialkylaminocarbonyl or C3-C 6 trialkylsilyl; C r C4 alkoxy; C1-C4 alkylamino; C -Cg dialkylamino; C3-C5 cycloalkylamino; C 2 - Cg alkoxycarbonyl or C -Cg alkylcarbonyl; or R 2 and R 3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, said ring may be optionally substituted with 1 to 4 substituents selected from the group consisting of C 1 -C 2 alkyl, halogen, CN, NO 2 and C r C 2 alkoxy; G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O) 2 and optionally substituted with 1 to 4 substituents selected from the group consisting of C j -C 2 alkyl, halogen, CN, NO and Cι-C 2 alkoxy; each R 4 is independently H, Cj-C 6 alkyl, C 2 -C6 alkenyl, C 2 -C 6 alkynyl, C 3 -Cg cycloalkyl, Cj-Cg haloalkyl, C 2 -Cg haloalkenyl, C -Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO 2 , hydroxy, C1-C4 alkoxy, CJ-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C j -04 haloalkylsulfinyl, C r C4 haloalkylsulfonyl, C1-C4 alkylamino, C 2 -Cg dialkylamino, C 3 -Cg cycloalkylamino, or C3-C6 trialkylsilyl; or each R 4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C1-C4 alkyl, C 2 -C4 alkenyl, C 2 -C alkynyl, C 3 -Cg cycloalkyl, C1-C4 haloalkyl, C 2 -C haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, CJ-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, Cj- C 4 alkylsulfonyl, C1-C4 alkylamino, C -C 8 dialkylamino, C3-C5 cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -Cg dialkylaminocarbonyl or C 3 - C 6 trialkylsilyl; each R 5 is independently C^-Cg alkyl, C -C 6 alkenyl, C -C 6 alkynyl, C 3 -C 6 cycloalkyl, Cj-Cg haloalkyl, C 2 -Cg haloalkenyl, C 2 -C 6 haloalkynyl, C 3 rCg halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C 6 alkoxy, Ci-C 6 haloalkoxy, Cχ-Cg alkylthio, C j -Cg alkylsulfinyl, C j -Cg alkylsulfonyl, Cj-Cg haloalkylthio, C^-Cg haloalkylsulfinyl, C^-Cg haloalkylsulfonyl, C^-Cg alkylamino, C 2 ~Cι 2 dialkylamino, or C 3 -Cg cycloalkylamino, C 2 -Cg alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl, C -C 6 trialkylsilyl; or (R 5 ) 2 when attached to adjacent carbon atoms can be taken together as -OCF 2 O-, -CF 2 CF 2 O-, or -OCF 2 CF 2 O-; each R 6 is independently H, halogen, C r Cg alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 - Cg cycloalkyl, C 1 -C4 alkoxy or C 2 -C 4 alkoxycarbonyl; or each R 6 is independently a phenyl, benzyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from the group consisting of C 1 -C 4 alkyl, C -C 4 alkenyl, C -C 4 alkynyl, C 3 -Cg cycloalkyl, C 1 -C4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO , C 1 -C4 alkoxy, C 1 -C 4 haloalkoxy, C 1 -C 4 alkylthio, 0^ 4 alkylsulfinyl, ^-0 4 alkylsulfonyl, C 1 -C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -C 6 trialkylsilyl; each R 7 is independently H, C^-Cg alkyl, C -Cg alkenyl, C 2 -Cg alkynyl, C 3 -Cg cycloalkyl, C^-C haloalkyl, C 2 -Cg haloalkenyl, C 2 -Cg haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, 0^ 4 alkoxy, C 1 -C 4 haloalkoxy, C 1 -C 4 alkylthio, C ! -C 4 alkylsulfinyl, C 1 -C alkylsulfonyl, Cj-0 4 haloalkylthio, C ] ^ haloalkylsulfinyl, C 1 -C 4 haloalkylsulfonyl, C } ^ alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 2 -Cg alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl, C 3 -C trialkylsilyl; or each R 7 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from the group consisting of C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -Cg cycloalkyl, C 1 -C4 haloalkyl, C ~C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO , -C 4 alkoxy, Cγ-C^ haloalkoxy, Cχ-04 alkylthio, Cγ-C^ alkylsulfinyl, C 1 -C4 alkylsulfonyl, C r C 4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -Cg trialkylsilyl; •provided that (1) when A and B are both O, R 2 is H or C r C 3 alkyl, R is H or C r C 3 alkyl and R 4 is H, halogen, C r Cg alkyl, phenyl, hydroxy or Cj-Cg alkoxy, then one R 5 is other than halogen, C^-Cg alkyl, hydroxy or Cj-Cg alkoxy; or (2) J is other than an optionally substituted 1,2,3-thiadiazole. 2. The method of Claim 1 wherein J is a phenyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 . 3. The method of Claim 2 wherein A and B are both O; n is 1 to 2; R 1 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R 2 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R3 is C j -Cg alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl or C 3 -Cg cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C r C 2 alkoxy, Cj-C 2 alkylthio, Cι~C 2 alkylsulfinyl and C r C 2 alkylsulfonyl; one of the R 4 groups is attached to the phenyl ring at the 2-position or 5-position, and said R 4 is C r C 4 alkyl, C r C 4 haloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C r C 4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl; each R 5 is independently C1-C4 haloalkyl, CN, NO 2 , 0^4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C r C alkylsulfonyl, C 1 -C haloalkylthio, C r C haloalkylsulfinyl, C1-C4 haloalkylsulfonyl or Q2-C4 alkoxycarbonyl; or (R 5 )2 when attached to adjacent carbon atoms can be taken together as -OCF 2 O-, -CF 2 CF 2 O- or -OCF 2 CF 2 O-; and each R 6 is independently H, halogen, C1-C4 alkyl, C j -C 2 alkoxy or C 2 -C4 alkoxycarbonyl, or each R 6 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with C1-C4 alkyl, Q2-C4 alkenyl, C 2 -C 4 alkynyl, C 3 - Cg cycloalkyl, C1-C4 haloalkyl, C -C4 haloalkenyl, C 2 -C4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4. alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -Cg trialkylsilyl. 4. The method of Claim 3 wherein R 1 and R 2 are both H; R3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; each R 4 is independently H, CH 3 , CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; each R 5 is independently CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 or S(O) p CF 2 CHF 2 ; each R 6 is independently H, halogen or methyl; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with Cχ-04 alkyl, C1-C4 haloalkyl, halogen or CN; and p is 0, 1 or 2. 5. The method of Claim 4 wherein R 3 is t ' -propyl or t-butyl. 6. The method of Claim 1 wherein J is a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R 7 . 7. - The method of Claim 6 wherein J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J- 1 , J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R 7 J-l J-2 J-3 J-4 J-5 Q is O, S or NR 7 ; and W, X, Y and Z are independently N or CR 7 , provided that in J-4 and J-5 at least one of W, X, Y or Z is N. 8. The method of Claim 6 or 7 wherein A and B are O; n is 1 to 2; R 1 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 2 -C 6 alkylcarbonyl. or C 2 -C 6 alkoxycarbonyl; R is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R3 is H; or C^-Cg alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl or C 3 -Cg cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, Cι-C 2 alkoxy, C r C 2 alkylthio, C j -C 2 alkylsulfinyl and Ci-C 2 alkylsulfonyl; one of the R 4 groups is attached to the phenyl ring at the 2-position, and said R 4 is C^- C 4 alkyl, C r C4 haloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C r C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfϊnyl or C1-C4 haloalkylsulfonyl; and each R7 is independently H, C1-C4 alkyl, Cj-04 haloalkyl, halogen, CN, NO 2 , 0^4 haloalkoxy, C1-C4 alkylthio, Cχ-04 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl or C 2 -C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with Cj-04 alkyl, C 2 -C4 alkenyl, C 2 -C 4 alkynyl, C 3 -Cg cycloalkyl, C1-C4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C - Cg halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -C 6 alkylaminocarbonyl, C3~C dialkylaminocarbonyl or C 3 -Cg trialkylsilyl. 9. The method of Claim 8 wherein J is selected from the group consisting of pyridine, pyrimidine, pyrazole, imidazole, triazole, thiophene, thiazole and oxazole, furan, isothiazole and isoxazole, each optionally substituted with 1 to 3 R 7 . 10. The method of Claim 9 wherein J is selected from the group consisting of pyridine, pyrimidine, pyrazole, thiophene and thiazole, each optionally substituted with 1 to 3 R 7 ; R 1 and R 2 are both H; R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; each R 4 is independently H, CH 3 , CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; each R 7 is independently H, halogen, CH 3 , CF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 , S(O) p CF 2 CHF 2 ; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, halogen or CN; and p is 0, 1 or 2. 11. The method of Claim 10 wherein J is a pyridine optionally substituted with 1 to 3 R 7 . • 12. The method of Claim 11 wherein one R 7 is a phenyl optionally substituted with C!-C 4 alkyl, CJ-C4 haloalkyl, halogen or CN. 13. The method of Claim 11 wherein one R 7 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with CJ-C4 alkyl, C j ^ haloalkyl, halogen or CN. 14. The method of Claim 10 wherein J is a pyrimidine optionally substituted with 1 to 3 R 7 . 15. The method of Claim 14 wherein one R 7 is a phenyl optionally substituted with C ] -Q alkyl, C1-C4 haloalkyl, halogen or CN. 16. The method of Claim 14 wherein one R 7 is a pyrazole, imidazole j triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, halogen or CN. 17. The method of Claim 10 wherein J is a pyrazole optionally substituted with 1 to 3 R7. 18. The method of Claim 17 wherein one R 7 is a phenyl optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, halogen or CN. 19. The method of Claim 17 wherein one R 7 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, halogen or CN. 20. The method of Claim 19 wherein R 7 is a pyridine optionally substituted with Cχ-C-4 alkyl, C 1 -C 4 haloalkyl, halogen or CN. 21. The method of Claim 1 comprising a compound of Formula 1 selected from the group consisting of: 3-methyl-N-(l-methylethyl)-2-[[4-(trifluoromethyl)benzoyl]amino]-benzamide, 2-methyl-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenyl]-4- (trifluoromethyl)benzamide, 2-methyl-N-[2-methyl-6- [[( 1 -methylethyl)amino] carbonyl]phenyl] -6- (trifluoromethyl)-3-pyridmecarboxamide, l-ethyl-N-[2-me yl-6-[[(l-memyle yl)amino]carbonyl]phenyl]-3- (trifiuoromethyl)-lH-pyrazole-5-carboxamide, l-(2-fluorophenyl)-N-[2-methyl-6-[[(l-methylethyl)amino)carbonyl]phenyl]-3- (trifluoromethyl)-lH-pyrazole-5-carboxamide, l-(3-chloro-2-pyridinyl)-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenyl]3- (frifluoromeώyl)-lH-pyrazole-5-carboxamide, N-[2-chloro-6- [[( 1 -methylethyl)amino] carbonyl]phenyl] - 1 -(3 -chloro-2-pyridinyl)-3 - (trifluoromethyl)- lH-pyrazole-5-carboxamide, 5-bromo-l -(2-chlorophenyl)-N-[2-methyl-6-[[(l - methylethyl)ammo]carbonyl]phenyl]-lH-pyrazole-5-carboxamide, and 3-bromo-N-[2-chloro-6-[[(l-methylethyl)amino]carbonyl]phenyl]-l-(2- chlorophenyl)- 1 H-pyrazole-5 -carboxamide. 22. A compound of Formula 1, its N-oxides and agriculturally suitable salts 1 wherein A and B are independently O or S; optionally substituted with 1 to 3 R 6 ; or each J is independently a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R 7 ; n is 1 to 4; R 1 is H; or C^-Cg alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl or C 3 -Cg cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO 2 , hydroxy, Cγ-C 4 alkoxy, C 1 -C alkylthio, C r C 4 alkylsulfinyl, C C 4 alkylsulfonyl, Q 2 -C 4 alkoxycarbonyl, C 1 -C 4 alkylamino, C 2 -C 8 dialkylamino and C 3 -Cg cycloalkylamino; or R 1 is C 2 -Cg alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C(=A)J; R 2 is H, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 alkoxy, C 1 -C 4 alkylamino, C 2 -Cg dialkylamino, C 3 -Cg cycloalkylamino, C 2 -Cg alkoxycarbonyl or C 2 -Cg alkylcarbonyl; R 3 is H; Cj-Cg alkyl, C 2 -C 6 alkenyl, C 2 -Cg alkynyl, C 3 -Cg cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO 2 , hydroxy, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 1 -C 4 alkylthio, C r C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 2 -C 6 alkoxycarbonyl, C 2 -Cg alkylcarbonyl, C 3 -Cg trialkylsilyl, or a phenoxy ring optionally substituted with one to three substituents independently selected from the group consisting of Cj- C4 alkyl, C 2 -C4 alkenyl, C2-C4 alkynyl, C -C 6 cycloalkyl, C1-C4 haloalkyl, C 2 - C4 haloalkenyl, C 2 -C4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 - Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C 3 -Cg trialkylsilyl; C j - C4 alkoxy; C C4 alkylamino; C 2 -C 8 dialkylamino; C 3 -C 6 cycloalkylamino; C 2 - Cg alkoxycarbonyl or C 2 -Cg alkylcarbonyl; or R 2 and R 3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, said ring may be optionally substituted with 1 to 4 substituents selected from the group consisting of C 1 -C 2 alkyl, halogen, CN, NO 2 and C 1 -C 2 alkoxy; each R 4 is independently H, C}-Cg alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r Cg haloalkyl, C -Cg haloalkenyl, C 2 -Cg haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , hydroxy, C1-C4 alkoxy, -C4 haloalkoxy, C r C4 alkylthio, C1-C4 alkylsulfinyl, C!-C alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, 0^4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, or C 3 -C 6 trialkylsilyl; or each R 4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C1-C4 alkyl, Q2-C4 alkenyl, C 2 -C4 alkynyl, C 3 -Cg cycloalkyl, C1-C4 haloalkyl, C 2 -C4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C - C4 alkylsulfonyl, C1-C4 alkylamino, C 2 -Cg dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C dialkylaminocarbonyl or C 3 - Cg trialkylsilyl; each R 5 is independently C^-Cg haloalkyl, C 2 -Cg haloalkenyl, C 2 -Cg haloalkynyl, C 3 - Cg halocycloalkyl, C2-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C j - C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, CN, NO 2 , C1-C4 alkoxycarbonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 2 -C 6 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, or C 3 -C 8 dialkylaminocarbonyl; or (R 5 ) 2 attached to adjacent carbon atoms can be taken together as -OCF 2 O-, -CF 2 CF 2 O-, or -OCF 2 CF 2 O-; eachR 6 is independently H, halogen, C j -Cg alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl, C 3 ~ Cg cycloalkyl, C1-C4 alkoxy or C 2 -C alkoxycarbonyl; or each R 6 is independently a phenyl, benzyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from the group alkyl, C 2 -C 4 alkenyl, C 2 -C alkynyl, C 3 -C 6 cycloalkyl, 0^0 4 haloalkyl, C -C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C2-C haloalkoxy, C r C alkylthio, Cj-0 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -Cg dialkylaminocarbonyl or C 3 -Cg trialkylsilyl; each R 7 is independently H, C^-Cg alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl, C 3 -Cg cycloalkyl, Cj-Cg haloalkyl, C 2 -Cg haloalkenyl, C 2 -Cg haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, CO 2 H, CONH 2 , NO 2 , hydroxy, C r C 4 alkoxy, C J -C 4 haloalkoxy, 0^ 4 alkylthio, C 1 -C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, . C 1 -C 4 haloalkylthio, C j -C 4 haloalkylsulfinyl, C γ -C4 haloalkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 2 -Cg alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 ~C 8 dialkylaminocarbonyl, C 3 -Cg trialkylsilyl; or each R 7 is independently a phenyl, benzyl, benzoyl, phenoxy or 5- or 6-membered heteroaromatic ring 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from the group consisting of C 1 -C4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -Cg cycloalkyl, C 1 -C4 haloalkyl, C 2 -C 4 haloalkenyl, C -C 4 haloalkynyl, C 3 - C 6 halocycloalkyl, halogen, CN, NO 2 , C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 1 -C4 alkylthio, 0^0 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 alkylamino, C 2 -C 8 dialkylamino, C 3 -Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C 4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C -Cg alkylaminocarbonyl, C -C dialkylaminocarbonyl or C 3 -Cg trialkylsilyl; provided that (i) at least one R 4 and at least one R 7 are other than H; (ii) J is other than an optionally substituted 1,2,3-thiadiazole; (iii) when J is an optionally substituted pyridine and R 2 is H, R 3 is other than H or CH 3 ; (iv) when J is an optionally substituted pyridine, then R 7 cannot be CONH 2 , C 2 -Cg alkylaminocarbonyl or C 3 - dialkylaminocarbonyl; (v) when J is an optionally substituted pyrazole, tefrazole or pyrimidine, then R 2 and R 3 cannot both be hydrogen. 23. The compound of Claim 22 wherein J is a phenyl group substituted with 1 to 2 R 5 and optionally substituted with 1 to 3 R 6 . 24. The compound of Claim 25 wherein A and B are both O; n is 1 to 2; R 1 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R2 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R 3 is C r Cg alkyl, C 2 -Cg alkenyl, C 2 -C 6 alkynyl or C 3 -Cg cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, alkylthio, Cχ-C 2 alkylsulfinyl and Cι-C 2 alkylsulfonyl; one of the R 4 groups is attached to the phenyl ring at the 2-position or 5-position, and said R 4 is C r C 4 alkyl, C r C 4 haloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C r C haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, -C4 haloalkylthio, C r C4 haloalkylsulfinyl or C1-C4 haloalkylsulfonyl; each R 5 is independently C1-C4 haloalkyl, CN, NO 2 , alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl or C 2 -C4 alkoxycarbonyl; or (R 5 ) 2 when attached to adjacent carbon atoms can be taken together as -OCF 2 O-, -CF 2 CF 2 O- or -OCF 2 CF 2 O-; and each R 6 is independently H, halogen, C1-C4 alkyl, Cι-C 2 alkoxy or C 2 -C alkoxycarbonyl, or each R 6 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with C2-C4 alkyl, C 2 -C4 alkenyl, C2-C4 alkynyl, C 3 - Cg cycloalkyl, C1-C4 haloalkyl, C 2 -C4 haloalkenyl, C 2 -C4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C j -C 4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C3-Cg cycloalkylamino, C 3 -Cg (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -Cg alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-Cg trialkylsilyl. 25. The compound of Claim 26 wherein R 1 and R 2 are both H; R3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; each R 4 is independently H, CH 3 , CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; I ) each R5 is independently CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 or S(O) p CF 2 CHF 2 ; each R 6 is independently H, halogen or methyl; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, halogen or CN; and p is 0, 1 or 2. 26. The compound of Claim 25 wherein R 3 is z ' -propyl or t-butyl. 27. The compound of Claim 26 wherein J is a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R 7 . 28. The compound of Claim 27 wherein J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R 7 J-l J-2 J-3 J- J-5 Q is O, S orNR 7 ; and W, X, Y and Z are independently N or CR 7 , provided that in J-4 and J-5 at least one of W, X, Y or Z is N. 29. The compound of Claim 27 or Claim 28 wherein A and B are O; n is 1 to 2; R 1 is H, C r C4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 2 -C 6 alkylcarbonyl or C 2 -C 6 alkoxycarbonyl; R2 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl; R 3 is H; or Cj-Cg alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or C 3 -Cg cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, Cι-C 2 alkoxy, C r C 2 alkylthio, Cj-Gj alkylsulfinyl and Cι-C 2 alkylsulfonyl; one of the R 4 groups is attached to the phenyl ring at the 2-position, and said R 4 is C j - C 4 alkyl, haloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C!-C haloalkoxy, C r C 4 alkylthio, C^C^ alkylsulfinyl, C r C 4 alkylsulfonyl, C r C haloalkylthio, C1-C4 haloalkylsulfinyl or C1-C4 haloalkylsulfonyl; and each R 7 is independently H, C1-C4 alkyl, C1-C4 haloalkyl, halogen, CN, NO , C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfϊnyl, C r C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl or C 2 -C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with Cι~C alkyl, C 2 -C4 alkenyl, C 2 -C 4 alkynyl, C 3 -Cg cycloalkyl, C^C^ haloalkyl, C 2 -C4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 - C 6 halocycloalkyl, halogen, CN, NO 2 , C } -^ alkoxy, C ] -C haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylamino, C 2 -C 8 dialkylamino, C3-Cg cycloalkylamino, C3~C (alkyl)cycloalkylamino, C 2 -C4 alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 2 -Cg alkylaminocarbonyl, C 3 -C 8 dialkylaminocarbonyl or C3-Cg trialkylsilyl. 30. The compound of Claim 29 wherein J is selected from the group consisting of pyridine, pyrimidine, pyrazole, imidazole, triazole, thiophene, thiazole and oxazole, furan, isothiazole and isoxazole, each optionally substituted with 1 to 3 R 7 . 31. The compound of Claim 30 wherein J is selected from the group consisting of pyridine, pyrimidine, pyrazole, thiophene and thiazole, each optionally substituted with 1 to 3 R 7 ; R 1 and R2 are both H; R3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ; each R 4 is independently H, CH 3 , CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , CN or halogen; each R 7 is independently H, halogen, CH 3 , CF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 , OCH 2 CF 3 , OCF 2 CHF 2 , S(O) p CH 2 CF 3 , S(O) p CF 2 CHF 2 ; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, Cj-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C2-C4 alkylsulfonyl, halogen or CN; and p is 0, 1 or 2. 32. The compound of Claim 31 wherein J is a pyridine optionally substituted with 1 to 3 R7. 33. The compound of Claim 32 wherein one R 7 is a phenyl optionally substituted with C r C 4 alkyl, C r C 4 haloalkyl, halogen or CN. 34. The compound of Claim 32 wherein one R 7 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with haloalkyl, halogen or CN. 35. The compound of Claim 31 wherein J is a pyrimidine optionally substituted with 1 to 3 R 7 . 36. The compound of Claim 35 wherein one R 7 is a phenyl optionally substituted with Cι-C 4 alkyl, 0^0 4 haloalkyl, halogen or CN. 37. The compound of Claim 35 wherein one R 7 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C -C4 alkyl, C 2 -C 4 haloalkyl, halogen or CN. 38. The compound of Claim 32 wherein J is a pyrazole optionally substituted with 1 to 3 R 7 . 39. The compound of Claim 38 wherein one R 7 is a phenyl optionally substituted with C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, halogen or CN. 40. The compound of Claim 38 wherein one R 7 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C 2 -C 4 alkyl, C 1 -C4 haloalkyl, halogen or CN. 41. The compound of Claim 38 wherein wherein R 7 is a pyridine optionally substituted with C 1 -C4 alkyl, C j ^ haloalkyl, halogen or CN. 42. The compound of Claim 22 selected from the group consisting of: 3-methyl-N-(l-memyle1hyl)-2-[[4-(trifluoromemyl)benzoyl]amino3-benzamide, 2-me yl-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenyl]-4- (trifluoromethyl)benzamide, 2-methyl-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenyl]-6- (trifluoromethyl)-3-pyridinecarboxamide, l-ethyl-N-[2-methyl-6-[[(l-methylethyl)amino]carbonyl]phenyl]-3- (trifluoromethyl)-lH-pyrazole-5-carboxamide, l-(2-fluorophenyl)-N-[2-methyl-6-[[(l-methylethyl)amino)carbonyl]phenyl]-3- (trifluoromethyl)-lH-pyrazole-5-carboxamide, 1 -(3 -chloro-2-pyridinyl)-N- [2-methyl-6- [[(1 -methylethyl)amino]carbonyl]phenyl] 3 - (trifluoromethyl)-lH-pyrazole-5-carboxamide, N- [2-chloro-6- [[( 1 -methylethyl)amino] carbonyl]phenyl]- 1 -(3 -chloro-2-pyridinyl)-3 - (trifluoromethyl)-lH-pyrazole-5-carboxamide, 3-bromo- 1 -(2-chloroρhenyl)-N-[2-methyl-6-[[(l - methylethyl)amino]carbonyl]phenyl]-lH-pyrazole-5-carboxamide, and 3 -bromo-N-[2-chloro-6- [[( 1 -methylethyl)amino] carbonyljphenyl] - 1 -(2- chloropheny 1)- 1 H-pyrazole-5 -carboxamide. 43. An arthropodicidal composition comprising an arthropodicidaUy effective amount of a compound of Formula 1 as described in Claim 1 and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.

Inventors: LAHM GEORGE P, MYERS BRIAN J, SELBY THOMAS P, STEVENSON THOMAS M, LAHM, GEORGE, P., MYERS, BRIAN, J., SELBY, THOMAS, P., STEVENSON, THOMAS, M.
Applicants: DU PONT, LAHM GEORGE P, MYERS BRIAN J, SELBY THOMAS P, STEVENSON THOMAS M, E.I. DU PONT DE NEMOURS AND COMPANY, LAHM, GEORGE, P., MYERS, BRIAN, J., SELBY, THOMAS, P., STEVENSON, THOMAS, M.
Application year: 2001
Main classification: C07C235
IPC codes: A01N37, A01N43, A01N47, C07C237, C07C255, C07C317, C07C323, C07C327, C07D213, C07D231, C07D239, C07D295, C07D401